##fileformat=VCFv4.1
##VEP="v92" time="2018-05-31 16:50:30" cache="/home/user/.vep/homo_sapiens/92_GRCh37" ensembl-io=92.39280bd ensembl-funcgen=92.cd2ca86 ensembl=92.98e8548 ensembl-variation=92.77a06cf 1000genomes="phase3" COSMIC="81" ClinVar="201706" ESP="20141103" HGMD-PUBLIC="20164" assembly="GRCh37.p13" dbSNP="150" gencode="GENCODE 19" genebuild="2011-04" gnomAD="170228" polyphen="2.2.2" regbuild="1.0" sift="sift5.2.2"
##INFO=<ID=ANN,Number=.,Type=String,Description="Consequence annotations from Ensembl VEP. Format: Allele|Consequence|IMPACT|SYMBOL|Gene|Feature_type|Feature|BIOTYPE|EXON|INTRON|HGVSc|HGVSp|cDNA_position|CDS_position|Protein_position|Amino_acids|Codons|Existing_variation|DISTANCE|STRAND|FLAGS|SYMBOL_SOURCE|HGNC_ID|CANONICAL|SOURCE|GENE_PHENO|SIFT|PolyPhen|AF|AFR_AF|AMR_AF|EAS_AF|EUR_AF|SAS_AF|CLIN_SIG|SOMATIC|PHENO|MOTIF_NAME|MOTIF_POS|HIGH_INF_POS|MOTIF_SCORE_CHANGE|ORegAnno|DiseaseEnhancer|FANTOM_Enhancer|FANTOM_Promoter">
##INFO=<ID=ORegAnno,Number=.,Type=String,Description="/home/user/Projects/non_coding/non_coding_DB/ORegAnno_2015.hg19.bed.gz (overlap)">
##INFO=<ID=DiseaseEnhancer,Number=.,Type=String,Description="/home/user/Projects/non_coding/non_coding_DB/enh2disease-1_0_2.bed.gz (overlap)">
##INFO=<ID=FANTOM_Enhancer,Number=.,Type=String,Description="/home/user/Projects/non_coding/non_coding_DB/enhancer_data_at_2018-05-08_22-04-44.bed.gz (overlap)">
##INFO=<ID=FANTOM_Promoter,Number=.,Type=String,Description="/home/user/Projects/non_coding/non_coding_DB/promoter_data_at_2018-05-08_22-08-24.bed.gz (overlap)">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO
1	109817590	1_109817590_G/T	G	T	.	.	ANN=T|3_prime_UTR_variant|MODIFIER|CELSR2|ENSG00000143126|Transcript|ENST00000271332|protein_coding|34/34||||9752|||||rs12740374||1||HGNC|3231|YES|||||0.1955|0.2474|0.2046|0.0427|0.2127|0.2587|association||1|||||CELSR2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1186421&18971253[ORegAnno]&N/A&N/A&REGULATORY_REGION&N/A&OREG0070947&17130149[ORegAnno]&CELSR2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1651973&18971253[ORegAnno]&CELSR2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1593608&18971253[ORegAnno]&CELSR2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1898460&18971253[ORegAnno]&CELSR2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1722527&18971253[ORegAnno]&CELSR2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1746457&18971253[ORegAnno]&CELSR2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1763866&18971253[ORegAnno]&N/A&-1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG0072270&24194598[ORegAnno]&N/A&-1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1086486&24194598[ORegAnno]|SORT1&Coronary_heart_disease&DE_00459[DisEnhancer]||
1	1099342	1_1099342_C/A	C	A	.	.	ANN=A|upstream_gene_variant|MODIFIER|MIR200B|ENSG00000207730|Transcript|ENST00000384997|miRNA|||||||||||3142|1||HGNC|31579|YES|||||||||||||||||||miR-200b&Lung_cancer&DE_00664[DisEnhancer]||
1	117100957	1_117100957_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|CD58|ENSG00000116815|Transcript|ENST00000369489|protein_coding||1/5||||||||rs1335532||-1||HGNC|1688|YES|||||0.4333|0.587|0.3674|0.5893|0.1461|0.407|||1||||||CD58&Multiple_sclerosis&DE_00467[DisEnhancer]|enhancer_chr1:117100772-117101124[Fantom_enhancer]|
1	121112052	1_121112052_G/C	G	C	.	.	ANN=C|intron_variant&non_coding_transcript_variant|MODIFIER|RP11-343N15.1|ENSG00000230806|Transcript|ENST00000437515|lincRNA||2/3||||||||||-1||Clone_based_vega_gene||YES|||||||||||||||||||NOTCH2&Breast_cancer&DE_00520[DisEnhancer]||
1	150951477	1_150951477_T/C	T	C	.	.	ANN=C|upstream_gene_variant|MODIFIER|CERS2|ENSG00000143418|Transcript|ENST00000271688|protein_coding||||||||||rs267734|4037|-1||HGNC|14076|YES|||||0.0695|0.0068|0.0937|0.0258|0.1938|0.0542|||1|||||ANXA9&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1578665&18971253[ORegAnno]&CERS2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1765203&18971253[ORegAnno]|MUC1/C1orf54/THBS3/PSMB4/GBA/GBAP/APH1A/CTSS/ANP32E/ECM1/C1orf51/NBPF10/CA14/LYSMD1/CTSK/ARNT/SETDB1/LASS2/ANXA9/GOLPH3L/PRUNE/C1orf56/CDC42SE1/MLLT11/MRPS21/PRPF3/RPRD2/TARS2/VPS72/ADAMTSL4/MCL1/ENSA/SEMA6C/SCNM1/GABPB2/PIP5K1A/FAM63A/PSMD4&Chronic_kidney_disease&DE_01029[DisEnhancer]||
1	155194980	1_155194980_T/T	T	T	.	.	.
1	155271258	1_155271258_T/C	T	C	.	.	ANN=C|upstream_gene_variant|MODIFIER|PKLR|ENSG00000143627|Transcript|ENST00000342741|protein_coding|||||||||||33|-1||HGNC|9020|YES||1||||||||||||||||PKLR&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1254542&18971253[ORegAnno]|PKLR&Pyruvate_kinase_deficiency&DE_00090[DisEnhancer]||
1	160001799	1_160001799_G/C	G	C	.	.	ANN=C|upstream_gene_variant|MODIFIER|PIGM|ENSG00000143315|Transcript|ENST00000368090|protein_coding||||||||||rs587776528|16|-1||HGNC|18858|YES||1|||||||||pathogenic||1|||||PIGM&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1249409&18971253[ORegAnno]&PIGM&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1609763&18971253[ORegAnno]&PIGM&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1542448&18971253[ORegAnno]&PIGM&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1876824&18971253[ORegAnno]&N/A&-1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG0162296&24194598[ORegAnno]|PIGM&Glycosylphosphatidylinositol_deficiency&DE_00091[DisEnhancer]||
1	162020969	1_162020969_A/T	A	T	.	.	ANN=T|intergenic_variant|MODIFIER||||||||||||||||||||||||||||||||||||||||NOS1AP&Cardiac_disorders&DE_00623[DisEnhancer]&NOS1AP&Cardiac_disorders&DE_00498[DisEnhancer]||
1	162021000	1_162021000_A/G	A	G	.	.	ANN=G|intergenic_variant|MODIFIER|||||||||||||||rs2010491|||||||||||0.2720|0.1067|0.2248|0.3403|0.2525|0.4785|||||||||NOS1AP&Cardiac_disorders&DE_00623[DisEnhancer]&NOS1AP&Cardiac_disorders&DE_00498[DisEnhancer]||
1	170587340	1_170587340_C/T	C	T	.	.	ANN=T|intron_variant&non_coding_transcript_variant|MODIFIER|RP1-79C4.1|ENSG00000235303|Transcript|ENST00000413005|lincRNA||1/2||||||||rs577676||1||Clone_based_vega_gene||YES|||||0.6166|0.8427|0.5965|0.378|0.4622|0.7301|||||||||PRRX1&Atrial_fibrillation&DE_01037[DisEnhancer]||
1	173886568	1_173886568_G/C	G	C	.	.	ANN=C|upstream_gene_variant|MODIFIER|SERPINC1|ENSG00000117601|Transcript|ENST00000367698|protein_coding|||||||||||52|-1||HGNC|775|YES||1||||||||||||||||SERPINC1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1306517&18971253[ORegAnno]&SERPINC1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1728652&18971253[ORegAnno]&SERPINC1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1752181&18971253[ORegAnno]|SERPINC1&Antithrombin_deficiency&DE_00127[DisEnhancer]||
1	181020230	1_181020230_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|MR1|ENSG00000153029|Transcript|ENST00000367580|protein_coding||3/5||||||||||1||HGNC|4975|YES|||||||||||||||||||MR1&tuberculosis&DE_00411[DisEnhancer]||
1	185904001	1_185904001_T/C	T	C	.	.	ANN=C|intron_variant|MODIFIER|HMCN1|ENSG00000143341|Transcript|ENST00000271588|protein_coding||11/106||||||||||1||HGNC|19194|YES||1|||||||||||||||||HMCN1&Breast_cancer&DE_00992[DisEnhancer]||
1	185904577	1_185904577_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|HMCN1|ENSG00000143341|Transcript|ENST00000271588|protein_coding||11/106||||||||||1||HGNC|19194|YES||1|||||||||||||||||HMCN1&Breast_cancer&DE_00992[DisEnhancer]||
1	192535107	1_192535107_A/C	A	C	.	.	ANN=C|intron_variant&non_coding_transcript_variant|MODIFIER|RP5-1011O1.2|ENSG00000232498|Transcript|ENST00000434300|antisense||1/1||||||||||-1||Clone_based_vega_gene||YES|||||||||||||||||||RGS1&IgA_nephropathy&DE_00443[DisEnhancer]||
1	206946407	1_206946407_G/T	G	T	.	.	ANN=T|upstream_gene_variant|MODIFIER|IL10|ENSG00000136634|Transcript|ENST00000423557|protein_coding|||||||||||568|-1||HGNC|5962|YES||1|||||||||||||||||IL10&Advanced_liver_disease&DE_00129[DisEnhancer]&IL10&Malarial_anaemia&DE_00130[DisEnhancer]&IL10&Wegener_granulomatosis&DE_00131[DisEnhancer]||
1	206946634	1_206946634_A/G	A	G	.	.	ANN=G|upstream_gene_variant|MODIFIER|IL10|ENSG00000136634|Transcript|ENST00000423557|protein_coding||||||||||rs1800871|795|-1||HGNC|5962|YES||1|||0.5653|0.5643|0.6671|0.3244|0.7604|0.5419|||1||||||IL10&Advanced_liver_disease&DE_00129[DisEnhancer]&IL10&Malarial_anaemia&DE_00130[DisEnhancer]&IL10&Wegener_granulomatosis&DE_00131[DisEnhancer]||
1	206946862	1_206946862_C/T	C	T	.	.	ANN=T|upstream_gene_variant|MODIFIER|IL10|ENSG00000136634|Transcript|ENST00000423557|protein_coding|||||||||||1023|-1||HGNC|5962|YES||1|||||||||||||||||IL10&Advanced_liver_disease&DE_00129[DisEnhancer]&IL10&Malarial_anaemia&DE_00130[DisEnhancer]&IL10&Wegener_granulomatosis&DE_00131[DisEnhancer]||
1	209989270	1_209989270_G/A	G	A	.	.	ANN=A|regulatory_region_variant|MODIFIER|||RegulatoryFeature|ENSR00000019424|TF_binding_site||||||||||||||||||||||||||||||||||N/A&N/A&REGULATORY_REGION&N/A&OREG0070068&17130149[ORegAnno]|IRF6&Cleft_lip&DE_00132[DisEnhancer]&IRF6&Cleft_palate&DE_00597[DisEnhancer]&IRF6&Orofacial_clefting&DE_00596[DisEnhancer]|enhancer_chr1:209989263-209989693[Fantom_enhancer]|
1	209989270	1_209989270_G/A	G	A	.	.	ANN=A|regulatory_region_variant|MODIFIER|||RegulatoryFeature|ENSR00000019424|TF_binding_site||||||||||||||||||||||||||||||||||N/A&N/A&REGULATORY_REGION&N/A&OREG0070068&17130149[ORegAnno]|IRF6&Cleft_lip&DE_00132[DisEnhancer]&IRF6&Cleft_palate&DE_00597[DisEnhancer]&IRF6&Orofacial_clefting&DE_00596[DisEnhancer]|enhancer_chr1:209989263-209989693[Fantom_enhancer]|
1	209989270	1_209989270_G/A	G	A	.	.	ANN=A|regulatory_region_variant|MODIFIER|||RegulatoryFeature|ENSR00000019424|TF_binding_site||||||||||||||||||||||||||||||||||N/A&N/A&REGULATORY_REGION&N/A&OREG0070068&17130149[ORegAnno]|IRF6&Cleft_lip&DE_00132[DisEnhancer]&IRF6&Cleft_palate&DE_00597[DisEnhancer]&IRF6&Orofacial_clefting&DE_00596[DisEnhancer]|enhancer_chr1:209989263-209989693[Fantom_enhancer]|
1	21660786	1_21660786_C/G	C	G	.	.	ANN=G|intron_variant|MODIFIER|ECE1|ENSG00000117298|Transcript|ENST00000415912|protein_coding||1/18||||||||||-1||HGNC|3146|||1||||||||||||||||ECE1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1241000&18971253[ORegAnno]&ECE1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1272187&18971253[ORegAnno]&ECE1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1553167&18971253[ORegAnno]|ALPL&Breast_cancer&DE_00993[DisEnhancer]|enhancer_chr1:21660622-21661187[Fantom_enhancer]|
1	21661555	1_21661555_T/G	T	G	.	.	ANN=G|intron_variant|MODIFIER|ECE1|ENSG00000117298|Transcript|ENST00000415912|protein_coding||1/18||||||||||-1||HGNC|3146|||1||||||||||||||||ECE1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1241000&18971253[ORegAnno]&ECE1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1272187&18971253[ORegAnno]&ECE1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1404591&18971253[ORegAnno]|ALPL&Breast_cancer&DE_00993[DisEnhancer]||
1	21661745	1_21661745_C/G	C	G	.	.	ANN=G|intron_variant|MODIFIER|ECE1|ENSG00000117298|Transcript|ENST00000415912|protein_coding||1/18||||||||||-1||HGNC|3146|||1||||||||||||||||ECE1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1241000&18971253[ORegAnno]&ECE1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1272187&18971253[ORegAnno]|ALPL&Breast_cancer&DE_00993[DisEnhancer]||
1	21661878	1_21661878_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|ECE1|ENSG00000117298|Transcript|ENST00000415912|protein_coding||1/18||||||||||-1||HGNC|3146|||1||||||||||||||||ECE1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1272187&18971253[ORegAnno]|ALPL&Breast_cancer&DE_00993[DisEnhancer]||
1	241012779	1_241012779_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|RGS7|ENSG00000182901|Transcript|ENST00000366565|protein_coding||9/17||||||||||-1||HGNC|10003|YES||1|||||||||||||||||CDKN2A&Coronary_artery_disease&DE_00619[DisEnhancer]||
1	243639859	1_243639859_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|SDCCAG8|ENSG00000054282|Transcript|ENST00000366541|protein_coding||16/17||||||||rs3006916||1||HGNC|10671|YES||1|||0.1751|0.2458|0.134|0.124|0.1988|0.137|||||||||SDCCAG8&Schizophrenia&DE_00539[DisEnhancer]||
1	46476823	1_46476824_C/-	NC	N	.	.	ANN=-|intron_variant|MODIFIER|MAST2|ENSG00000086015|Transcript|ENST00000361297|protein_coding||10/28||||||||||1||HGNC|19035|YES|||||||||||||||||||MAST2&Breast_cancer&DE_00995[DisEnhancer]||
1	46476865	1_46476865_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|MAST2|ENSG00000086015|Transcript|ENST00000361297|protein_coding||10/28||||||||rs765377100||1||HGNC|19035|YES|||||||||||||||||||MAST2&Breast_cancer&DE_00995[DisEnhancer]||
1	46476944	1_46476944_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|MAST2|ENSG00000086015|Transcript|ENST00000361297|protein_coding||10/28||||||||||1||HGNC|19035|YES|||||||||||||||||||MAST2&Breast_cancer&DE_00995[DisEnhancer]||
1	46477152	1_46477152_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|MAST2|ENSG00000086015|Transcript|ENST00000361297|protein_coding||10/28||||||||||1||HGNC|19035|YES|||||||||||||||||||MAST2&Breast_cancer&DE_00995[DisEnhancer]||
1	59250452	1_59250452_A/G	A	G	.	.	ANN=G|upstream_gene_variant|MODIFIER|JUN|ENSG00000177606|Transcript|ENST00000371222|protein_coding||||||||||rs4646999|667|-1||HGNC|6204|YES||1|||0.5461|0.3245|0.647|0.628|0.6481|0.5849||||||||JUN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1794425&18971253[ORegAnno]&JUN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1907488&18971253[ORegAnno]&JUN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1516479&18971253[ORegAnno]&JUN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1789357&18971253[ORegAnno]&JUN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1824770&18971253[ORegAnno]&JUN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1705372&18971253[ORegAnno]&JUN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1846665&18971253[ORegAnno]&N/A&1&REGULATORY_REGION&POSITIVE_OUTCOME&OREG0013519&N/A[ORegAnno]&JUN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1809434&18971253[ORegAnno]|JUN&Colorectal_cancer&DE_00185[DisEnhancer]&JUN&Colorectal_cancer&DE_00186[DisEnhancer]||promoter_+_chr1:59250432-59250470[Fantom_promoter]
1	59251097	1_59251097_T/G	T	G	.	.	ANN=G|upstream_gene_variant|MODIFIER|JUN|ENSG00000177606|Transcript|ENST00000371222|protein_coding||||||||||rs2760501|1312|-1||HGNC|6204|YES||1|||0.3580|0.8578|0.2233|0.1657|0.0875|0.2546||||||||JUN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1907488&18971253[ORegAnno]&JUN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1516479&18971253[ORegAnno]&N/A&1&REGULATORY_REGION&POSITIVE_OUTCOME&OREG0013519&N/A[ORegAnno]&JUN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1789358&18971253[ORegAnno]&JUN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1194198&18971253[ORegAnno]&JUN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1406908&18971253[ORegAnno]|JUN&Colorectal_cancer&DE_00185[DisEnhancer]&JUN&Colorectal_cancer&DE_00186[DisEnhancer]||
1	66746784	1_66746784_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|PDE4B|ENSG00000184588|Transcript|ENST00000329654|protein_coding||7/16||||||||rs12142375||1||HGNC|8781|YES|||||0.2772|0.0794|0.2839|0.1647|0.5646|0.3599|||||||||PDE4B&Acute_lymphoblastic_leukemia&DE_01013[DisEnhancer]||
1	928703	1_928703_C/G	C	G	.	.	ANN=G|downstream_gene_variant|MODIFIER|RP11-54O7.17|ENSG00000272512|Transcript|ENST00000606034|lincRNA|||||||||||2643|-1||Clone_based_vega_gene||YES|||||||||||||||||||ATAD3B&Breast_cancer&DE_00997[DisEnhancer]||
1	930053	1_930053_G/A	G	A	.	.	ANN=A|downstream_gene_variant|MODIFIER|HES4|ENSG00000188290|Transcript|ENST00000428771|protein_coding||||||||||rs957509767|4289|-1||HGNC|24149|YES|||||||||||||||||||ATAD3B&Breast_cancer&DE_00997[DisEnhancer]||
1	93009313	1_93009313_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|EVI5|ENSG00000067208|Transcript|ENST00000370331|protein_coding||17/17||||||||||-1||HGNC|3501|YES|||||||||||||||||||GFI1&Multiple_sclerosis&DE_00438[DisEnhancer]||
1	930797	1_930797_G/C	G	C	.	.	ANN=C|downstream_gene_variant|MODIFIER|HES4|ENSG00000188290|Transcript|ENST00000428771|protein_coding|||||||||||3545|-1||HGNC|24149|YES|||||||||||||||||||ATAD3B&Breast_cancer&DE_00997[DisEnhancer]||
1	931772	1_931772_G/A	G	A	.	.	ANN=A|downstream_gene_variant|MODIFIER|HES4|ENSG00000188290|Transcript|ENST00000428771|protein_coding||||||||||rs368242416|2570|-1||HGNC|24149|YES|||||||||||||||||||ATAD3B&Breast_cancer&DE_00997[DisEnhancer]||
1	94375309	1_94375309_G/A	G	A	.	.	ANN=A|upstream_gene_variant|MODIFIER|GCLM|ENSG00000023909|Transcript|ENST00000370238|protein_coding||||||||||rs41303970|343|-1||HGNC|4312|YES|||||0.1841|0.2239|0.3112|0.1637|0.1521|0.0941||||||||GCLM&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1265229&18971253[ORegAnno]&GCLM&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1895423&18971253[ORegAnno]&GCLM&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1183886&18971253[ORegAnno]&GCLM&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1505357&18971253[ORegAnno]&GCLM&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1234488&18971253[ORegAnno]&GCLM&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1621232&18971253[ORegAnno]&GCLM&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1609647&18971253[ORegAnno]&GCLM&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1353069&18971253[ORegAnno]&GCLM&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1399854&18971253[ORegAnno]&N/A&1&REGULATORY_REGION&POSITIVE_OUTCOME&OREG0013608&N/A[ORegAnno]|GCLM&Myocardial_infarction&DE_00240[DisEnhancer]||
1	98497176	1_98497176_A/C	A	C	.	.	ANN=C|intron_variant&non_coding_transcript_variant|MODIFIER|MIR137HG|ENSG00000225206|Transcript|ENST00000424528|lincRNA||3/4||||||||rs1198572||-1||HGNC|42871|YES|||||0.8441|0.8427|0.8948|0.9296|0.7903|0.7771|||||||||RP11_490G2.2&Schizophrenia&DE_00440[DisEnhancer]||
10	102979207	10_102979207_C/T	C	T	.	.	ANN=T|intergenic_variant|MODIFIER|||||||||||||||||||||||||||||||||||||||TLX1-LBX1&1&REGULATORY_REGION&NEGATIVE_OUTCOME&OREG0002830&N/A[ORegAnno]|LBX1&Adolescent_idiopathic_scoliosis&DE_00433[DisEnhancer]||
10	104653545	10_104653545_T/C	T	C	.	.	ANN=C|intron_variant|MODIFIER|AS3MT|ENSG00000214435|Transcript|ENST00000369880|protein_coding||10/10||||||||rs56946876||1||HGNC|17452|YES|||||0.4425|0.3343|0.4193|0.5893|0.4165|0.4806|||||||||NT5C2&Schizophrenia&DE_00583[DisEnhancer]||
10	114758349	10_114758349_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|TCF7L2|ENSG00000148737|Transcript|ENST00000543371|protein_coding||4/13||||||||rs7903146||1||HGNC|11641|YES||1|||0.2278|0.2602|0.2349|0.0228|0.3171|0.2986|drug_response&risk_factor||1||||||TCF7L2&Type-2_diabetes&DE_00642[DisEnhancer]||
10	114758349	10_114758349_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|TCF7L2|ENSG00000148737|Transcript|ENST00000543371|protein_coding||4/13||||||||rs7903146||1||HGNC|11641|YES||1|||0.2278|0.2602|0.2349|0.0228|0.3171|0.2986|drug_response&risk_factor||1||||||TCF7L2&Type-2_diabetes&DE_00642[DisEnhancer]||
10	114808902	10_114808902_G/T	G	T	.	.	ANN=T|intron_variant|MODIFIER|TCF7L2|ENSG00000148737|Transcript|ENST00000543371|protein_coding||5/13||||||||rs12255372||1||HGNC|11641|YES||1|||0.2139|0.3018|0.219|0.0099|0.2922|0.2209|risk_factor||1||||||TCF7L2&Type-2_diabetes&DE_00451[DisEnhancer]||
10	1156165	10_1156165_T/T	T	T	.	.	.
10	12307894	10_12307894_C/T	C	T	.	.	ANN=T|downstream_gene_variant|MODIFIER|RN7SL232P|ENSG00000265824|Transcript|ENST00000582360|misc_RNA||||||||||rs11257655|3968|1||HGNC|46248|YES|||||0.3011|0.2413|0.2622|0.5397|0.2266|0.2403|||1|||||CDC123&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1270797&18971253[ORegAnno]&CDC123&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1597078&18971253[ORegAnno]&CDC123&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1655406&18971253[ORegAnno]&CDC123&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1239760&18971253[ORegAnno]&CDC123&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1189468&18971253[ORegAnno]&CDC123&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1690032&18971253[ORegAnno]&CDC123&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1934841&18971253[ORegAnno]|CAMK1D/CDC123&Type-2_diabetes&DE_00434[DisEnhancer]|enhancer_chr10:12307693-12308050[Fantom_enhancer]|
10	12307894	10_12307894_C/T	C	T	.	.	ANN=T|downstream_gene_variant|MODIFIER|RN7SL232P|ENSG00000265824|Transcript|ENST00000582360|misc_RNA||||||||||rs11257655|3968|1||HGNC|46248|YES|||||0.3011|0.2413|0.2622|0.5397|0.2266|0.2403|||1|||||CDC123&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1270797&18971253[ORegAnno]&CDC123&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1597078&18971253[ORegAnno]&CDC123&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1655406&18971253[ORegAnno]&CDC123&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1239760&18971253[ORegAnno]&CDC123&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1189468&18971253[ORegAnno]&CDC123&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1690032&18971253[ORegAnno]&CDC123&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1934841&18971253[ORegAnno]|CAMK1D/CDC123&Type-2_diabetes&DE_00434[DisEnhancer]|enhancer_chr10:12307693-12308050[Fantom_enhancer]|
10	123333997	10_123333997_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|FGFR2|ENSG00000066468|Transcript|ENST00000457416|protein_coding||2/17||||||||rs7895676||-1||HGNC|3689|YES||1|||0.3666|0.0817|0.4928|0.4276|0.4672|0.4959|||||||||FGFR2/FGER2&Breast_cancer&DE_00538[DisEnhancer]||
10	123340311	10_123340311_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|FGFR2|ENSG00000066468|Transcript|ENST00000457416|protein_coding||2/17||||||||rs2981578||-1||HGNC|3689|YES||1|||0.3720|0.0779|0.4885|0.4355|0.4811|0.5092|||1||||||FGFR2/FGER2&Breast_cancer&DE_00538[DisEnhancer]||
10	123340311	10_123340311_T/C	T	C	.	.	ANN=C|intron_variant|MODIFIER|FGFR2|ENSG00000066468|Transcript|ENST00000457416|protein_coding||2/17||||||||||-1||HGNC|3689|YES||1|||||||||||||||||FGFR2/FGER2&Breast_cancer&DE_00538[DisEnhancer]||
10	123340311	10_123340311_T/C	T	C	.	.	ANN=C|intron_variant|MODIFIER|FGFR2|ENSG00000066468|Transcript|ENST00000457416|protein_coding||2/17||||||||||-1||HGNC|3689|YES||1|||||||||||||||||FGFR2/FGER2&Breast_cancer&DE_00538[DisEnhancer]||
10	127505277	10_127505277_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|UROS|ENSG00000188690|Transcript|ENST00000368797|protein_coding||1/9||||||||rs397515349||-1||HGNC|12592|YES||1|||||||||pathogenic||1|||||UROS&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1261149&18971253[ORegAnno]&UROS&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1705787&18971253[ORegAnno]|UROS&Porphyria&DE_00030[DisEnhancer]||
10	23508305	10_23508305_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|C10orf115|ENSG00000204566|Transcript|ENST00000376501|protein_coding||3/3||||||||||-1||HGNC|31449|YES|||||||||||||||||||PTF1A&Pancreatic_agenesis&DE_00031[DisEnhancer]&PTF1A&Isolated_pancreatic_agenesis&DE_00033[DisEnhancer]&PTF1A&Pancreatic_agenesis&DE_00032[DisEnhancer]&PTF1A&Pancreatic_agenesis&DE_00034[DisEnhancer]&PTF1A&Pancreatic_agenesis&DE_00035[DisEnhancer]&PTF1A&Isolated_pancreatic_agenesis&DE_00037[DisEnhancer]&PTF1A&Pancreatic_agenesis&DE_00036[DisEnhancer]||
10	23508363	10_23508363_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|C10orf115|ENSG00000204566|Transcript|ENST00000376501|protein_coding||3/3||||||||||-1||HGNC|31449|YES|||||||||||||||||||PTF1A&Pancreatic_agenesis&DE_00031[DisEnhancer]&PTF1A&Isolated_pancreatic_agenesis&DE_00033[DisEnhancer]&PTF1A&Pancreatic_agenesis&DE_00032[DisEnhancer]&PTF1A&Pancreatic_agenesis&DE_00034[DisEnhancer]&PTF1A&Pancreatic_agenesis&DE_00035[DisEnhancer]&PTF1A&Isolated_pancreatic_agenesis&DE_00037[DisEnhancer]&PTF1A&Pancreatic_agenesis&DE_00036[DisEnhancer]||
10	23508363	10_23508363_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|C10orf115|ENSG00000204566|Transcript|ENST00000376501|protein_coding||3/3||||||||||-1||HGNC|31449|YES|||||||||||||||||||PTF1A&Pancreatic_agenesis&DE_00031[DisEnhancer]&PTF1A&Isolated_pancreatic_agenesis&DE_00033[DisEnhancer]&PTF1A&Pancreatic_agenesis&DE_00032[DisEnhancer]&PTF1A&Pancreatic_agenesis&DE_00034[DisEnhancer]&PTF1A&Pancreatic_agenesis&DE_00035[DisEnhancer]&PTF1A&Isolated_pancreatic_agenesis&DE_00037[DisEnhancer]&PTF1A&Pancreatic_agenesis&DE_00036[DisEnhancer]||
10	23508365	10_23508365_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|C10orf115|ENSG00000204566|Transcript|ENST00000376501|protein_coding||3/3||||||||||-1||HGNC|31449|YES|||||||||||||||||||PTF1A&Pancreatic_agenesis&DE_00031[DisEnhancer]&PTF1A&Isolated_pancreatic_agenesis&DE_00033[DisEnhancer]&PTF1A&Pancreatic_agenesis&DE_00032[DisEnhancer]&PTF1A&Pancreatic_agenesis&DE_00034[DisEnhancer]&PTF1A&Pancreatic_agenesis&DE_00035[DisEnhancer]&PTF1A&Isolated_pancreatic_agenesis&DE_00037[DisEnhancer]&PTF1A&Pancreatic_agenesis&DE_00036[DisEnhancer]||
10	23508437	10_23508437_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|C10orf115|ENSG00000204566|Transcript|ENST00000376501|protein_coding||3/3||||||||||-1||HGNC|31449|YES|||||||||||||||||||PTF1A&Pancreatic_agenesis&DE_00031[DisEnhancer]&PTF1A&Isolated_pancreatic_agenesis&DE_00033[DisEnhancer]&PTF1A&Pancreatic_agenesis&DE_00032[DisEnhancer]&PTF1A&Pancreatic_agenesis&DE_00034[DisEnhancer]&PTF1A&Pancreatic_agenesis&DE_00035[DisEnhancer]&PTF1A&Isolated_pancreatic_agenesis&DE_00037[DisEnhancer]&PTF1A&Pancreatic_agenesis&DE_00036[DisEnhancer]||
10	23508446	10_23508446_A/C	A	C	.	.	ANN=C|intron_variant|MODIFIER|C10orf115|ENSG00000204566|Transcript|ENST00000376501|protein_coding||3/3||||||||||-1||HGNC|31449|YES|||||||||||||||||||PTF1A&Pancreatic_agenesis&DE_00031[DisEnhancer]&PTF1A&Isolated_pancreatic_agenesis&DE_00033[DisEnhancer]&PTF1A&Pancreatic_agenesis&DE_00032[DisEnhancer]&PTF1A&Pancreatic_agenesis&DE_00034[DisEnhancer]&PTF1A&Pancreatic_agenesis&DE_00035[DisEnhancer]&PTF1A&Isolated_pancreatic_agenesis&DE_00037[DisEnhancer]&PTF1A&Pancreatic_agenesis&DE_00036[DisEnhancer]||
10	23508446	10_23508446_A/C	A	C	.	.	ANN=C|intron_variant|MODIFIER|C10orf115|ENSG00000204566|Transcript|ENST00000376501|protein_coding||3/3||||||||||-1||HGNC|31449|YES|||||||||||||||||||PTF1A&Pancreatic_agenesis&DE_00031[DisEnhancer]&PTF1A&Isolated_pancreatic_agenesis&DE_00033[DisEnhancer]&PTF1A&Pancreatic_agenesis&DE_00032[DisEnhancer]&PTF1A&Pancreatic_agenesis&DE_00034[DisEnhancer]&PTF1A&Pancreatic_agenesis&DE_00035[DisEnhancer]&PTF1A&Isolated_pancreatic_agenesis&DE_00037[DisEnhancer]&PTF1A&Pancreatic_agenesis&DE_00036[DisEnhancer]||
10	27389383	10_27389383_C/T	C	T	.	.	ANN=T|5_prime_UTR_variant|MODIFIER|ANKRD26|ENSG00000107890|Transcript|ENST00000376087|protein_coding|1/34||||39|||||||-1||HGNC|29186|YES||1||||||||||||||||ANKRD26&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1508207&18971253[ORegAnno]&ANKRD26&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1705429&18971253[ORegAnno]&ANKRD26&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1946487&18971253[ORegAnno]&ANKRD26&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1746471&18971253[ORegAnno]&ANKRD26&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1722538&18971253[ORegAnno]&ANKRD26&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1551260&18971253[ORegAnno]|ANKRD26&Thrombocytopaenia_2&DE_00038[DisEnhancer]||promoter_-_chr10:27389351-27389384[Fantom_promoter]
10	43447847	10_43447847_A/G	A	G	.	.	ANN=G|regulatory_region_variant|MODIFIER|||RegulatoryFeature|ENSR00000027173|promoter_flanking_region||||||||||rs2506030|||||||||||0.4127|0.0855|0.4625|0.6905|0.3936|0.5532||||||||RNU6-885P&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1193822&18971253[ORegAnno]|RET&Hirschsprung_disease&DE_00516[DisEnhancer]||
10	43447847	10_43447847_A/G	A	G	.	.	ANN=G|regulatory_region_variant|MODIFIER|||RegulatoryFeature|ENSR00000027173|promoter_flanking_region||||||||||rs2506030|||||||||||0.4127|0.0855|0.4625|0.6905|0.3936|0.5532||||||||RNU6-885P&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1193822&18971253[ORegAnno]|RET&Hirschsprung_disease&DE_00516[DisEnhancer]||
10	43552895	10_43552895_C/T	C	T	.	.	ANN=T|intergenic_variant|MODIFIER||||||||||||||||||||||||||||||||||||||||RET&Hirschsprung_disease&DE_00609[DisEnhancer]||
10	43582056	10_43582056_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|RET|ENSG00000165731|Transcript|ENST00000355710|protein_coding||1/19||||||||||1||HGNC|9967|YES||1||||||||||||||||RET&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1540679&18971253[ORegAnno]&RET&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1525712&18971253[ORegAnno]|RET&Hirschsprung_disease&DE_00039[DisEnhancer]&RET&Hirschsprung_disease&DE_00513[DisEnhancer]&RET&Hirschsprung_disease&DE_00002[DisEnhancer]||
10	43582056	10_43582056_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|RET|ENSG00000165731|Transcript|ENST00000355710|protein_coding||1/19||||||||||1||HGNC|9967|YES||1||||||||||||||||RET&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1540679&18971253[ORegAnno]&RET&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1525712&18971253[ORegAnno]|RET&Hirschsprung_disease&DE_00039[DisEnhancer]&RET&Hirschsprung_disease&DE_00513[DisEnhancer]&RET&Hirschsprung_disease&DE_00002[DisEnhancer]||
10	43582056	10_43582056_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|RET|ENSG00000165731|Transcript|ENST00000355710|protein_coding||1/19||||||||||1||HGNC|9967|YES||1||||||||||||||||RET&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1540679&18971253[ORegAnno]&RET&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1525712&18971253[ORegAnno]|RET&Hirschsprung_disease&DE_00039[DisEnhancer]&RET&Hirschsprung_disease&DE_00513[DisEnhancer]&RET&Hirschsprung_disease&DE_00002[DisEnhancer]||
10	51543344	10_51543344_C/T	C	T	.	.	ANN=T|regulatory_region_variant|MODIFIER|||RegulatoryFeature|ENSR00000353884|TF_binding_site||||||||||||||||||||||||||||||||||TIMM23B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1634133&18971253[ORegAnno]&TIMM23B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1575398&18971253[ORegAnno]|AGAP7P&Prostate_cancer&DE_00562[DisEnhancer]||
10	51549496	10_51549496_C/T	C	T	.	.	ANN=T|upstream_gene_variant|MODIFIER|MSMB|ENSG00000138294|Transcript|ENST00000358559|protein_coding|||||||||||2|1||HGNC|7372|YES||1|||||||||||||||||MSMB/AGAP7P&Prostate_cancer&DE_00040[DisEnhancer]||
10	54531685	10_54531685_C/G	C	G	.	.	ANN=G|upstream_gene_variant|MODIFIER|MBL2|ENSG00000165471|Transcript|ENST00000373968|protein_coding|||||||||||225|-1||HGNC|6922|YES||1||||||||||||||||MBL2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1644924&18971253[ORegAnno]&MBL2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1586486&18971253[ORegAnno]&MBL2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1231046&18971253[ORegAnno]|MBL2&Mannose-binding_protein_deficiency&DE_00041[DisEnhancer]||
10	54532014	10_54532014_C/G	C	G	.	.	ANN=G|upstream_gene_variant|MODIFIER|MBL2|ENSG00000165471|Transcript|ENST00000373968|protein_coding|||||||||||554|-1||HGNC|6922|YES||1||||||||||||||||MBL2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1231046&18971253[ORegAnno]|MBL2&Mannose-binding_protein_deficiency&DE_00041[DisEnhancer]||
10	6093139	10_6093139_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|IL2RA|ENSG00000134460|Transcript|ENST00000379959|protein_coding||1/7||||||||||-1||HGNC|6008|YES||1||||||||||||||||IL2RA&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1248926&18971253[ORegAnno]&IL2RA&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1542223&18971253[ORegAnno]|IL2RA&Acute_lymphoblastic_leukemia&DE_00458[DisEnhancer]&IL2RA&Autoimmune_disease&DE_00437[DisEnhancer]&IL2RA&Crohns_disease&DE_01039[DisEnhancer]&IL2RA/PFKFB3&Multiple_sclerosis&DE_00540[DisEnhancer]&IL2RA&Type-1_diabetes&DE_01040[DisEnhancer]&PFKFB3&Celiac_disease&DE_00541[DisEnhancer]&PFKFB3&Crohn_disease&DE_00545[DisEnhancer]&PFKFB3&Lupus&DE_00544[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00543[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00542[DisEnhancer]||
10	6093140	10_6093140_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|IL2RA|ENSG00000134460|Transcript|ENST00000379959|protein_coding||1/7||||||||||-1||HGNC|6008|YES||1||||||||||||||||IL2RA&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1248926&18971253[ORegAnno]&IL2RA&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1542223&18971253[ORegAnno]|IL2RA&Acute_lymphoblastic_leukemia&DE_00458[DisEnhancer]&IL2RA&Autoimmune_disease&DE_00437[DisEnhancer]&IL2RA&Crohns_disease&DE_01039[DisEnhancer]&IL2RA/PFKFB3&Multiple_sclerosis&DE_00540[DisEnhancer]&IL2RA&Type-1_diabetes&DE_01040[DisEnhancer]&PFKFB3&Celiac_disease&DE_00541[DisEnhancer]&PFKFB3&Crohn_disease&DE_00545[DisEnhancer]&PFKFB3&Lupus&DE_00544[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00543[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00542[DisEnhancer]||
10	6094697	10_6094697_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|IL2RA|ENSG00000134460|Transcript|ENST00000379959|protein_coding||1/7||||||||rs61839660||-1||HGNC|6008|YES||1|||0.0282|0.0038|0.0346|0|0.0696|0.0429|||1|||||IL2RA&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1248926&18971253[ORegAnno]&N/A&-1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG0937018&24194598[ORegAnno]|IL2RA&Acute_lymphoblastic_leukemia&DE_00458[DisEnhancer]&IL2RA&Autoimmune_disease&DE_00437[DisEnhancer]&IL2RA&Crohns_disease&DE_01039[DisEnhancer]&IL2RA/PFKFB3&Multiple_sclerosis&DE_00540[DisEnhancer]&IL2RA&Type-1_diabetes&DE_01040[DisEnhancer]&PFKFB3&Celiac_disease&DE_00541[DisEnhancer]&PFKFB3&Crohn_disease&DE_00545[DisEnhancer]&PFKFB3&Lupus&DE_00544[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00543[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00542[DisEnhancer]||
10	6094697	10_6094697_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|IL2RA|ENSG00000134460|Transcript|ENST00000379959|protein_coding||1/7||||||||rs61839660||-1||HGNC|6008|YES||1|||0.0282|0.0038|0.0346|0|0.0696|0.0429|||1|||||IL2RA&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1248926&18971253[ORegAnno]&N/A&-1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG0937018&24194598[ORegAnno]|IL2RA&Acute_lymphoblastic_leukemia&DE_00458[DisEnhancer]&IL2RA&Autoimmune_disease&DE_00437[DisEnhancer]&IL2RA&Crohns_disease&DE_01039[DisEnhancer]&IL2RA/PFKFB3&Multiple_sclerosis&DE_00540[DisEnhancer]&IL2RA&Type-1_diabetes&DE_01040[DisEnhancer]&PFKFB3&Celiac_disease&DE_00541[DisEnhancer]&PFKFB3&Crohn_disease&DE_00545[DisEnhancer]&PFKFB3&Lupus&DE_00544[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00543[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00542[DisEnhancer]||
10	6094697	10_6094697_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|IL2RA|ENSG00000134460|Transcript|ENST00000379959|protein_coding||1/7||||||||rs61839660||-1||HGNC|6008|YES||1|||0.0282|0.0038|0.0346|0|0.0696|0.0429|||1|||||IL2RA&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1248926&18971253[ORegAnno]&N/A&-1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG0937018&24194598[ORegAnno]|IL2RA&Acute_lymphoblastic_leukemia&DE_00458[DisEnhancer]&IL2RA&Autoimmune_disease&DE_00437[DisEnhancer]&IL2RA&Crohns_disease&DE_01039[DisEnhancer]&IL2RA/PFKFB3&Multiple_sclerosis&DE_00540[DisEnhancer]&IL2RA&Type-1_diabetes&DE_01040[DisEnhancer]&PFKFB3&Celiac_disease&DE_00541[DisEnhancer]&PFKFB3&Crohn_disease&DE_00545[DisEnhancer]&PFKFB3&Lupus&DE_00544[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00543[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00542[DisEnhancer]||
10	6096036	10_6096036_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|IL2RA|ENSG00000134460|Transcript|ENST00000379959|protein_coding||1/7||||||||rs115133228||-1||HGNC|6008|YES||1|||0.0040|0.0129|0.0014|0|0.002|0||||||||IL2RA&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1248926&18971253[ORegAnno]&IL2RA&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1683187&18971253[ORegAnno]&IL2RA&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1704247&18971253[ORegAnno]|IL2RA&Acute_lymphoblastic_leukemia&DE_00458[DisEnhancer]&IL2RA&Autoimmune_disease&DE_00437[DisEnhancer]&IL2RA&Crohns_disease&DE_01039[DisEnhancer]&IL2RA/PFKFB3&Multiple_sclerosis&DE_00540[DisEnhancer]&IL2RA&Type-1_diabetes&DE_01040[DisEnhancer]&PFKFB3&Celiac_disease&DE_00541[DisEnhancer]&PFKFB3&Crohn_disease&DE_00545[DisEnhancer]&PFKFB3&Lupus&DE_00544[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00543[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00542[DisEnhancer]|enhancer_chr10:6095822-6096104[Fantom_enhancer]|
10	6098949	10_6098949_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|IL2RA|ENSG00000134460|Transcript|ENST00000379959|protein_coding||1/7||||||||rs706778||-1||HGNC|6008|YES||1|||0.5008|0.5008|0.5562|0.5585|0.4135|0.4918|||1||||||IL2RA&Acute_lymphoblastic_leukemia&DE_00458[DisEnhancer]&IL2RA&Autoimmune_disease&DE_00437[DisEnhancer]&IL2RA&Crohns_disease&DE_01039[DisEnhancer]&IL2RA/PFKFB3&Multiple_sclerosis&DE_00540[DisEnhancer]&IL2RA&Type-1_diabetes&DE_01040[DisEnhancer]&PFKFB3&Celiac_disease&DE_00541[DisEnhancer]&PFKFB3&Crohn_disease&DE_00545[DisEnhancer]&PFKFB3&Lupus&DE_00544[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00543[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00542[DisEnhancer]||
10	6098949	10_6098949_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|IL2RA|ENSG00000134460|Transcript|ENST00000379959|protein_coding||1/7||||||||rs706778||-1||HGNC|6008|YES||1|||0.5008|0.5008|0.5562|0.5585|0.4135|0.4918|||1||||||IL2RA&Acute_lymphoblastic_leukemia&DE_00458[DisEnhancer]&IL2RA&Autoimmune_disease&DE_00437[DisEnhancer]&IL2RA&Crohns_disease&DE_01039[DisEnhancer]&IL2RA/PFKFB3&Multiple_sclerosis&DE_00540[DisEnhancer]&IL2RA&Type-1_diabetes&DE_01040[DisEnhancer]&PFKFB3&Celiac_disease&DE_00541[DisEnhancer]&PFKFB3&Crohn_disease&DE_00545[DisEnhancer]&PFKFB3&Lupus&DE_00544[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00543[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00542[DisEnhancer]||
10	6098949	10_6098949_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|IL2RA|ENSG00000134460|Transcript|ENST00000379959|protein_coding||1/7||||||||rs706778||-1||HGNC|6008|YES||1|||0.5008|0.5008|0.5562|0.5585|0.4135|0.4918|||1||||||IL2RA&Acute_lymphoblastic_leukemia&DE_00458[DisEnhancer]&IL2RA&Autoimmune_disease&DE_00437[DisEnhancer]&IL2RA&Crohns_disease&DE_01039[DisEnhancer]&IL2RA/PFKFB3&Multiple_sclerosis&DE_00540[DisEnhancer]&IL2RA&Type-1_diabetes&DE_01040[DisEnhancer]&PFKFB3&Celiac_disease&DE_00541[DisEnhancer]&PFKFB3&Crohn_disease&DE_00545[DisEnhancer]&PFKFB3&Lupus&DE_00544[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00543[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00542[DisEnhancer]||
10	6098949	10_6098949_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|IL2RA|ENSG00000134460|Transcript|ENST00000379959|protein_coding||1/7||||||||rs706778||-1||HGNC|6008|YES||1|||0.5008|0.5008|0.5562|0.5585|0.4135|0.4918|||1||||||IL2RA&Acute_lymphoblastic_leukemia&DE_00458[DisEnhancer]&IL2RA&Autoimmune_disease&DE_00437[DisEnhancer]&IL2RA&Crohns_disease&DE_01039[DisEnhancer]&IL2RA/PFKFB3&Multiple_sclerosis&DE_00540[DisEnhancer]&IL2RA&Type-1_diabetes&DE_01040[DisEnhancer]&PFKFB3&Celiac_disease&DE_00541[DisEnhancer]&PFKFB3&Crohn_disease&DE_00545[DisEnhancer]&PFKFB3&Lupus&DE_00544[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00543[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00542[DisEnhancer]||
10	6098949	10_6098949_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|IL2RA|ENSG00000134460|Transcript|ENST00000379959|protein_coding||1/7||||||||rs706778||-1||HGNC|6008|YES||1|||0.5008|0.5008|0.5562|0.5585|0.4135|0.4918|||1||||||IL2RA&Acute_lymphoblastic_leukemia&DE_00458[DisEnhancer]&IL2RA&Autoimmune_disease&DE_00437[DisEnhancer]&IL2RA&Crohns_disease&DE_01039[DisEnhancer]&IL2RA/PFKFB3&Multiple_sclerosis&DE_00540[DisEnhancer]&IL2RA&Type-1_diabetes&DE_01040[DisEnhancer]&PFKFB3&Celiac_disease&DE_00541[DisEnhancer]&PFKFB3&Crohn_disease&DE_00545[DisEnhancer]&PFKFB3&Lupus&DE_00544[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00543[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00542[DisEnhancer]||
10	6098949	10_6098949_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|IL2RA|ENSG00000134460|Transcript|ENST00000379959|protein_coding||1/7||||||||rs706778||-1||HGNC|6008|YES||1|||0.5008|0.5008|0.5562|0.5585|0.4135|0.4918|||1||||||IL2RA&Acute_lymphoblastic_leukemia&DE_00458[DisEnhancer]&IL2RA&Autoimmune_disease&DE_00437[DisEnhancer]&IL2RA&Crohns_disease&DE_01039[DisEnhancer]&IL2RA/PFKFB3&Multiple_sclerosis&DE_00540[DisEnhancer]&IL2RA&Type-1_diabetes&DE_01040[DisEnhancer]&PFKFB3&Celiac_disease&DE_00541[DisEnhancer]&PFKFB3&Crohn_disease&DE_00545[DisEnhancer]&PFKFB3&Lupus&DE_00544[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00543[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00542[DisEnhancer]||
10	6099045	10_6099045_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|IL2RA|ENSG00000134460|Transcript|ENST00000379959|protein_coding||1/7||||||||||-1||HGNC|6008|YES||1|||||||||||||||||IL2RA&Acute_lymphoblastic_leukemia&DE_00458[DisEnhancer]&IL2RA&Autoimmune_disease&DE_00437[DisEnhancer]&IL2RA&Crohns_disease&DE_01039[DisEnhancer]&IL2RA/PFKFB3&Multiple_sclerosis&DE_00540[DisEnhancer]&IL2RA&Type-1_diabetes&DE_01040[DisEnhancer]&PFKFB3&Celiac_disease&DE_00541[DisEnhancer]&PFKFB3&Crohn_disease&DE_00545[DisEnhancer]&PFKFB3&Lupus&DE_00544[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00543[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00542[DisEnhancer]||
10	6100725	10_6100725_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|IL2RA|ENSG00000134460|Transcript|ENST00000379959|protein_coding||1/7||||||||||-1||HGNC|6008|YES||1|||||||||||||||||IL2RA&Acute_lymphoblastic_leukemia&DE_00458[DisEnhancer]&IL2RA&Autoimmune_disease&DE_00437[DisEnhancer]&IL2RA&Crohns_disease&DE_01039[DisEnhancer]&IL2RA/PFKFB3&Multiple_sclerosis&DE_00540[DisEnhancer]&IL2RA&Type-1_diabetes&DE_01040[DisEnhancer]&PFKFB3&Celiac_disease&DE_00541[DisEnhancer]&PFKFB3&Crohn_disease&DE_00545[DisEnhancer]&PFKFB3&Lupus&DE_00544[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00543[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00542[DisEnhancer]||
10	6100725	10_6100725_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|IL2RA|ENSG00000134460|Transcript|ENST00000379959|protein_coding||1/7||||||||||-1||HGNC|6008|YES||1|||||||||||||||||IL2RA&Acute_lymphoblastic_leukemia&DE_00458[DisEnhancer]&IL2RA&Autoimmune_disease&DE_00437[DisEnhancer]&IL2RA&Crohns_disease&DE_01039[DisEnhancer]&IL2RA/PFKFB3&Multiple_sclerosis&DE_00540[DisEnhancer]&IL2RA&Type-1_diabetes&DE_01040[DisEnhancer]&PFKFB3&Celiac_disease&DE_00541[DisEnhancer]&PFKFB3&Crohn_disease&DE_00545[DisEnhancer]&PFKFB3&Lupus&DE_00544[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00543[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00542[DisEnhancer]||
10	6100725	10_6100725_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|IL2RA|ENSG00000134460|Transcript|ENST00000379959|protein_coding||1/7||||||||||-1||HGNC|6008|YES||1|||||||||||||||||IL2RA&Acute_lymphoblastic_leukemia&DE_00458[DisEnhancer]&IL2RA&Autoimmune_disease&DE_00437[DisEnhancer]&IL2RA&Crohns_disease&DE_01039[DisEnhancer]&IL2RA/PFKFB3&Multiple_sclerosis&DE_00540[DisEnhancer]&IL2RA&Type-1_diabetes&DE_01040[DisEnhancer]&PFKFB3&Celiac_disease&DE_00541[DisEnhancer]&PFKFB3&Crohn_disease&DE_00545[DisEnhancer]&PFKFB3&Lupus&DE_00544[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00543[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00542[DisEnhancer]||
10	6100725	10_6100725_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|IL2RA|ENSG00000134460|Transcript|ENST00000379959|protein_coding||1/7||||||||||-1||HGNC|6008|YES||1|||||||||||||||||IL2RA&Acute_lymphoblastic_leukemia&DE_00458[DisEnhancer]&IL2RA&Autoimmune_disease&DE_00437[DisEnhancer]&IL2RA&Crohns_disease&DE_01039[DisEnhancer]&IL2RA/PFKFB3&Multiple_sclerosis&DE_00540[DisEnhancer]&IL2RA&Type-1_diabetes&DE_01040[DisEnhancer]&PFKFB3&Celiac_disease&DE_00541[DisEnhancer]&PFKFB3&Crohn_disease&DE_00545[DisEnhancer]&PFKFB3&Lupus&DE_00544[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00543[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00542[DisEnhancer]||
10	6100725	10_6100725_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|IL2RA|ENSG00000134460|Transcript|ENST00000379959|protein_coding||1/7||||||||||-1||HGNC|6008|YES||1|||||||||||||||||IL2RA&Acute_lymphoblastic_leukemia&DE_00458[DisEnhancer]&IL2RA&Autoimmune_disease&DE_00437[DisEnhancer]&IL2RA&Crohns_disease&DE_01039[DisEnhancer]&IL2RA/PFKFB3&Multiple_sclerosis&DE_00540[DisEnhancer]&IL2RA&Type-1_diabetes&DE_01040[DisEnhancer]&PFKFB3&Celiac_disease&DE_00541[DisEnhancer]&PFKFB3&Crohn_disease&DE_00545[DisEnhancer]&PFKFB3&Lupus&DE_00544[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00543[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00542[DisEnhancer]||
10	6100725	10_6100725_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|IL2RA|ENSG00000134460|Transcript|ENST00000379959|protein_coding||1/7||||||||||-1||HGNC|6008|YES||1|||||||||||||||||IL2RA&Acute_lymphoblastic_leukemia&DE_00458[DisEnhancer]&IL2RA&Autoimmune_disease&DE_00437[DisEnhancer]&IL2RA&Crohns_disease&DE_01039[DisEnhancer]&IL2RA/PFKFB3&Multiple_sclerosis&DE_00540[DisEnhancer]&IL2RA&Type-1_diabetes&DE_01040[DisEnhancer]&PFKFB3&Celiac_disease&DE_00541[DisEnhancer]&PFKFB3&Crohn_disease&DE_00545[DisEnhancer]&PFKFB3&Lupus&DE_00544[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00543[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00542[DisEnhancer]||
10	6100790	10_6100790_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|IL2RA|ENSG00000134460|Transcript|ENST00000379959|protein_coding||1/7||||||||rs139767239||-1||HGNC|6008|YES||1|||0.0006|0.0015|0|0.001|0|0|||||||||IL2RA&Acute_lymphoblastic_leukemia&DE_00458[DisEnhancer]&IL2RA&Autoimmune_disease&DE_00437[DisEnhancer]&IL2RA&Crohns_disease&DE_01039[DisEnhancer]&IL2RA/PFKFB3&Multiple_sclerosis&DE_00540[DisEnhancer]&IL2RA&Type-1_diabetes&DE_01040[DisEnhancer]&PFKFB3&Celiac_disease&DE_00541[DisEnhancer]&PFKFB3&Crohn_disease&DE_00545[DisEnhancer]&PFKFB3&Lupus&DE_00544[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00543[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00542[DisEnhancer]|enhancer_chr10:6100768-6101025[Fantom_enhancer]|
10	6101713	10_6101713_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|IL2RA|ENSG00000134460|Transcript|ENST00000379959|protein_coding||1/7||||||||||-1||HGNC|6008|YES||1|||||||||||||||||IL2RA&Acute_lymphoblastic_leukemia&DE_00458[DisEnhancer]&IL2RA&Autoimmune_disease&DE_00437[DisEnhancer]&IL2RA&Crohns_disease&DE_01039[DisEnhancer]&IL2RA/PFKFB3&Multiple_sclerosis&DE_00540[DisEnhancer]&IL2RA&Type-1_diabetes&DE_01040[DisEnhancer]&PFKFB3&Celiac_disease&DE_00541[DisEnhancer]&PFKFB3&Crohn_disease&DE_00545[DisEnhancer]&PFKFB3&Lupus&DE_00544[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00543[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00542[DisEnhancer]||
10	6101713	10_6101713_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|IL2RA|ENSG00000134460|Transcript|ENST00000379959|protein_coding||1/7||||||||||-1||HGNC|6008|YES||1|||||||||||||||||IL2RA&Acute_lymphoblastic_leukemia&DE_00458[DisEnhancer]&IL2RA&Autoimmune_disease&DE_00437[DisEnhancer]&IL2RA&Crohns_disease&DE_01039[DisEnhancer]&IL2RA/PFKFB3&Multiple_sclerosis&DE_00540[DisEnhancer]&IL2RA&Type-1_diabetes&DE_01040[DisEnhancer]&PFKFB3&Celiac_disease&DE_00541[DisEnhancer]&PFKFB3&Crohn_disease&DE_00545[DisEnhancer]&PFKFB3&Lupus&DE_00544[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00543[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00542[DisEnhancer]||
10	6101713	10_6101713_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|IL2RA|ENSG00000134460|Transcript|ENST00000379959|protein_coding||1/7||||||||||-1||HGNC|6008|YES||1|||||||||||||||||IL2RA&Acute_lymphoblastic_leukemia&DE_00458[DisEnhancer]&IL2RA&Autoimmune_disease&DE_00437[DisEnhancer]&IL2RA&Crohns_disease&DE_01039[DisEnhancer]&IL2RA/PFKFB3&Multiple_sclerosis&DE_00540[DisEnhancer]&IL2RA&Type-1_diabetes&DE_01040[DisEnhancer]&PFKFB3&Celiac_disease&DE_00541[DisEnhancer]&PFKFB3&Crohn_disease&DE_00545[DisEnhancer]&PFKFB3&Lupus&DE_00544[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00543[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00542[DisEnhancer]||
10	6101713	10_6101713_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|IL2RA|ENSG00000134460|Transcript|ENST00000379959|protein_coding||1/7||||||||||-1||HGNC|6008|YES||1|||||||||||||||||IL2RA&Acute_lymphoblastic_leukemia&DE_00458[DisEnhancer]&IL2RA&Autoimmune_disease&DE_00437[DisEnhancer]&IL2RA&Crohns_disease&DE_01039[DisEnhancer]&IL2RA/PFKFB3&Multiple_sclerosis&DE_00540[DisEnhancer]&IL2RA&Type-1_diabetes&DE_01040[DisEnhancer]&PFKFB3&Celiac_disease&DE_00541[DisEnhancer]&PFKFB3&Crohn_disease&DE_00545[DisEnhancer]&PFKFB3&Lupus&DE_00544[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00543[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00542[DisEnhancer]||
10	6101713	10_6101713_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|IL2RA|ENSG00000134460|Transcript|ENST00000379959|protein_coding||1/7||||||||||-1||HGNC|6008|YES||1|||||||||||||||||IL2RA&Acute_lymphoblastic_leukemia&DE_00458[DisEnhancer]&IL2RA&Autoimmune_disease&DE_00437[DisEnhancer]&IL2RA&Crohns_disease&DE_01039[DisEnhancer]&IL2RA/PFKFB3&Multiple_sclerosis&DE_00540[DisEnhancer]&IL2RA&Type-1_diabetes&DE_01040[DisEnhancer]&PFKFB3&Celiac_disease&DE_00541[DisEnhancer]&PFKFB3&Crohn_disease&DE_00545[DisEnhancer]&PFKFB3&Lupus&DE_00544[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00543[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00542[DisEnhancer]||
10	6101713	10_6101713_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|IL2RA|ENSG00000134460|Transcript|ENST00000379959|protein_coding||1/7||||||||||-1||HGNC|6008|YES||1|||||||||||||||||IL2RA&Acute_lymphoblastic_leukemia&DE_00458[DisEnhancer]&IL2RA&Autoimmune_disease&DE_00437[DisEnhancer]&IL2RA&Crohns_disease&DE_01039[DisEnhancer]&IL2RA/PFKFB3&Multiple_sclerosis&DE_00540[DisEnhancer]&IL2RA&Type-1_diabetes&DE_01040[DisEnhancer]&PFKFB3&Celiac_disease&DE_00541[DisEnhancer]&PFKFB3&Crohn_disease&DE_00545[DisEnhancer]&PFKFB3&Lupus&DE_00544[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00543[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00542[DisEnhancer]||
10	6101713	10_6101713_T/C	T	C	.	.	ANN=C|intron_variant|MODIFIER|IL2RA|ENSG00000134460|Transcript|ENST00000379959|protein_coding||1/7||||||||rs3118470||-1||HGNC|6008|YES||1|||0.3185|0.1263|0.2939|0.4931|0.3241|0.41|||1||||||IL2RA&Acute_lymphoblastic_leukemia&DE_00458[DisEnhancer]&IL2RA&Autoimmune_disease&DE_00437[DisEnhancer]&IL2RA&Crohns_disease&DE_01039[DisEnhancer]&IL2RA/PFKFB3&Multiple_sclerosis&DE_00540[DisEnhancer]&IL2RA&Type-1_diabetes&DE_01040[DisEnhancer]&PFKFB3&Celiac_disease&DE_00541[DisEnhancer]&PFKFB3&Crohn_disease&DE_00545[DisEnhancer]&PFKFB3&Lupus&DE_00544[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00543[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00542[DisEnhancer]||
10	6102012	10_6102012_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|IL2RA|ENSG00000134460|Transcript|ENST00000379959|protein_coding||1/7||||||||||-1||HGNC|6008|YES||1|||||||||||||||||IL2RA&Acute_lymphoblastic_leukemia&DE_00458[DisEnhancer]&IL2RA&Autoimmune_disease&DE_00437[DisEnhancer]&IL2RA&Crohns_disease&DE_01039[DisEnhancer]&IL2RA/PFKFB3&Multiple_sclerosis&DE_00540[DisEnhancer]&IL2RA&Type-1_diabetes&DE_01040[DisEnhancer]&PFKFB3&Celiac_disease&DE_00541[DisEnhancer]&PFKFB3&Crohn_disease&DE_00545[DisEnhancer]&PFKFB3&Lupus&DE_00544[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00543[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00542[DisEnhancer]||
10	6102012	10_6102012_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|IL2RA|ENSG00000134460|Transcript|ENST00000379959|protein_coding||1/7||||||||||-1||HGNC|6008|YES||1|||||||||||||||||IL2RA&Acute_lymphoblastic_leukemia&DE_00458[DisEnhancer]&IL2RA&Autoimmune_disease&DE_00437[DisEnhancer]&IL2RA&Crohns_disease&DE_01039[DisEnhancer]&IL2RA/PFKFB3&Multiple_sclerosis&DE_00540[DisEnhancer]&IL2RA&Type-1_diabetes&DE_01040[DisEnhancer]&PFKFB3&Celiac_disease&DE_00541[DisEnhancer]&PFKFB3&Crohn_disease&DE_00545[DisEnhancer]&PFKFB3&Lupus&DE_00544[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00543[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00542[DisEnhancer]||
10	6110829	10_6110829_C/T	C	T	.	.	ANN=T|downstream_gene_variant|MODIFIER|RP11-414H17.2|ENSG00000214015|Transcript|ENST00000397237|processed_pseudogene||||||||||rs7090512|2648|-1||Clone_based_vega_gene||YES|||||0.652|0.5877|0.6628|0.6885|0.6531|0.6922|||1||||||IL2RA/PFKFB3&Multiple_sclerosis&DE_00610[DisEnhancer]&PFKFB3&Celiac_disease&DE_00614[DisEnhancer]&PFKFB3&Crohn_disease&DE_00615[DisEnhancer]&PFKFB3&Lupus&DE_00611[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00612[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00613[DisEnhancer]||
10	6110875	10_6110875_A/C	A	C	.	.	ANN=C|downstream_gene_variant|MODIFIER|RP11-414H17.2|ENSG00000214015|Transcript|ENST00000397237|processed_pseudogene|||||||||||2602|-1||Clone_based_vega_gene||YES|||||||||||||||||||IL2RA/PFKFB3&Multiple_sclerosis&DE_00610[DisEnhancer]&PFKFB3&Celiac_disease&DE_00614[DisEnhancer]&PFKFB3&Crohn_disease&DE_00615[DisEnhancer]&PFKFB3&Lupus&DE_00611[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00612[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00613[DisEnhancer]||
10	6110875	10_6110875_A/C	A	C	.	.	ANN=C|downstream_gene_variant|MODIFIER|RP11-414H17.2|ENSG00000214015|Transcript|ENST00000397237|processed_pseudogene|||||||||||2602|-1||Clone_based_vega_gene||YES|||||||||||||||||||IL2RA/PFKFB3&Multiple_sclerosis&DE_00610[DisEnhancer]&PFKFB3&Celiac_disease&DE_00614[DisEnhancer]&PFKFB3&Crohn_disease&DE_00615[DisEnhancer]&PFKFB3&Lupus&DE_00611[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00612[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00613[DisEnhancer]||
10	6110875	10_6110875_A/C	A	C	.	.	ANN=C|downstream_gene_variant|MODIFIER|RP11-414H17.2|ENSG00000214015|Transcript|ENST00000397237|processed_pseudogene|||||||||||2602|-1||Clone_based_vega_gene||YES|||||||||||||||||||IL2RA/PFKFB3&Multiple_sclerosis&DE_00610[DisEnhancer]&PFKFB3&Celiac_disease&DE_00614[DisEnhancer]&PFKFB3&Crohn_disease&DE_00615[DisEnhancer]&PFKFB3&Lupus&DE_00611[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00612[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00613[DisEnhancer]||
10	6110875	10_6110875_A/C	A	C	.	.	ANN=C|downstream_gene_variant|MODIFIER|RP11-414H17.2|ENSG00000214015|Transcript|ENST00000397237|processed_pseudogene|||||||||||2602|-1||Clone_based_vega_gene||YES|||||||||||||||||||IL2RA/PFKFB3&Multiple_sclerosis&DE_00610[DisEnhancer]&PFKFB3&Celiac_disease&DE_00614[DisEnhancer]&PFKFB3&Crohn_disease&DE_00615[DisEnhancer]&PFKFB3&Lupus&DE_00611[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00612[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00613[DisEnhancer]||
10	6110875	10_6110875_A/C	A	C	.	.	ANN=C|downstream_gene_variant|MODIFIER|RP11-414H17.2|ENSG00000214015|Transcript|ENST00000397237|processed_pseudogene|||||||||||2602|-1||Clone_based_vega_gene||YES|||||||||||||||||||IL2RA/PFKFB3&Multiple_sclerosis&DE_00610[DisEnhancer]&PFKFB3&Celiac_disease&DE_00614[DisEnhancer]&PFKFB3&Crohn_disease&DE_00615[DisEnhancer]&PFKFB3&Lupus&DE_00611[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00612[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00613[DisEnhancer]||
10	6110875	10_6110875_A/C	A	C	.	.	ANN=C|downstream_gene_variant|MODIFIER|RP11-414H17.2|ENSG00000214015|Transcript|ENST00000397237|processed_pseudogene|||||||||||2602|-1||Clone_based_vega_gene||YES|||||||||||||||||||IL2RA/PFKFB3&Multiple_sclerosis&DE_00610[DisEnhancer]&PFKFB3&Celiac_disease&DE_00614[DisEnhancer]&PFKFB3&Crohn_disease&DE_00615[DisEnhancer]&PFKFB3&Lupus&DE_00611[DisEnhancer]&PFKFB3&Rheumatoid_arthritis&DE_00612[DisEnhancer]&PFKFB3&Ulcerative_colitis&DE_00613[DisEnhancer]||
10	64445564	10_64445564_A/G	A	G	.	.	ANN=G|intergenic_variant|MODIFIER|||||||||||||||rs10761659|||||||||||0.4794|0.0787|0.6124|0.7361|0.503|0.638|||1||||||ADO&Celiac_disease&DE_00422[DisEnhancer]&ADO&Crohn_disease&DE_00424[DisEnhancer]&ADO&Lupus&DE_00425[DisEnhancer]&ADO&Multiple_sclerosis&DE_00421[DisEnhancer]&ADO&Rheumatoid_arthritis&DE_00426[DisEnhancer]&ADO&Ulcerative_colitis&DE_00423[DisEnhancer]|enhancer_chr10:64445329-64445644[Fantom_enhancer]|
10	64445564	10_64445564_A/G	A	G	.	.	ANN=G|intergenic_variant|MODIFIER|||||||||||||||rs10761659|||||||||||0.4794|0.0787|0.6124|0.7361|0.503|0.638|||1||||||ADO&Celiac_disease&DE_00422[DisEnhancer]&ADO&Crohn_disease&DE_00424[DisEnhancer]&ADO&Lupus&DE_00425[DisEnhancer]&ADO&Multiple_sclerosis&DE_00421[DisEnhancer]&ADO&Rheumatoid_arthritis&DE_00426[DisEnhancer]&ADO&Ulcerative_colitis&DE_00423[DisEnhancer]|enhancer_chr10:64445329-64445644[Fantom_enhancer]|
10	64445564	10_64445564_A/G	A	G	.	.	ANN=G|intergenic_variant|MODIFIER|||||||||||||||rs10761659|||||||||||0.4794|0.0787|0.6124|0.7361|0.503|0.638|||1||||||ADO&Celiac_disease&DE_00422[DisEnhancer]&ADO&Crohn_disease&DE_00424[DisEnhancer]&ADO&Lupus&DE_00425[DisEnhancer]&ADO&Multiple_sclerosis&DE_00421[DisEnhancer]&ADO&Rheumatoid_arthritis&DE_00426[DisEnhancer]&ADO&Ulcerative_colitis&DE_00423[DisEnhancer]|enhancer_chr10:64445329-64445644[Fantom_enhancer]|
10	64445564	10_64445564_A/G	A	G	.	.	ANN=G|intergenic_variant|MODIFIER|||||||||||||||rs10761659|||||||||||0.4794|0.0787|0.6124|0.7361|0.503|0.638|||1||||||ADO&Celiac_disease&DE_00422[DisEnhancer]&ADO&Crohn_disease&DE_00424[DisEnhancer]&ADO&Lupus&DE_00425[DisEnhancer]&ADO&Multiple_sclerosis&DE_00421[DisEnhancer]&ADO&Rheumatoid_arthritis&DE_00426[DisEnhancer]&ADO&Ulcerative_colitis&DE_00423[DisEnhancer]|enhancer_chr10:64445329-64445644[Fantom_enhancer]|
10	64445564	10_64445564_A/G	A	G	.	.	ANN=G|intergenic_variant|MODIFIER|||||||||||||||rs10761659|||||||||||0.4794|0.0787|0.6124|0.7361|0.503|0.638|||1||||||ADO&Celiac_disease&DE_00422[DisEnhancer]&ADO&Crohn_disease&DE_00424[DisEnhancer]&ADO&Lupus&DE_00425[DisEnhancer]&ADO&Multiple_sclerosis&DE_00421[DisEnhancer]&ADO&Rheumatoid_arthritis&DE_00426[DisEnhancer]&ADO&Ulcerative_colitis&DE_00423[DisEnhancer]|enhancer_chr10:64445329-64445644[Fantom_enhancer]|
10	64445564	10_64445564_A/G	A	G	.	.	ANN=G|intergenic_variant|MODIFIER|||||||||||||||rs10761659|||||||||||0.4794|0.0787|0.6124|0.7361|0.503|0.638|||1||||||ADO&Celiac_disease&DE_00422[DisEnhancer]&ADO&Crohn_disease&DE_00424[DisEnhancer]&ADO&Lupus&DE_00425[DisEnhancer]&ADO&Multiple_sclerosis&DE_00421[DisEnhancer]&ADO&Rheumatoid_arthritis&DE_00426[DisEnhancer]&ADO&Ulcerative_colitis&DE_00423[DisEnhancer]|enhancer_chr10:64445329-64445644[Fantom_enhancer]|
10	89622988	10_89622988_A/G	A	G	.	.	ANN=G|5_prime_UTR_variant|MODIFIER|PTEN|ENSG00000171862|Transcript|ENST00000371953|protein_coding|1/9||||119|||||||1||HGNC|9588|YES||1||||||||||||||||PTEN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1249502&18971253[ORegAnno]&PTEN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1167633&18971253[ORegAnno]&PTEN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1796365&18971253[ORegAnno]&PTEN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1777823&18971253[ORegAnno]&PTEN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1811995&18971253[ORegAnno]|PTEN&Cowden_disease&DE_00057[DisEnhancer]&PTEN&Cowden_disease&DE_00058[DisEnhancer]&PTEN&Cowden_disease&DE_00059[DisEnhancer]||
10	89623392	10_89623392_C/T	C	T	.	.	ANN=T|5_prime_UTR_variant|MODIFIER|PTEN|ENSG00000171862|Transcript|ENST00000371953|protein_coding|1/9||||523|||||rs587779994||1||HGNC|9588|YES||1|||||||||uncertain_significance&likely_benign||1|||||PTEN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1249502&18971253[ORegAnno]&PTEN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1167633&18971253[ORegAnno]&PTEN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1219405&18971253[ORegAnno]&PTEN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1609695&18971253[ORegAnno]&PTEN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1542492&18971253[ORegAnno]&PTEN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1845338&18971253[ORegAnno]&PTEN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1811996&18971253[ORegAnno]&PTEN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1796366&18971253[ORegAnno]|PTEN&Cowden_disease&DE_00057[DisEnhancer]&PTEN&Cowden_disease&DE_00058[DisEnhancer]&PTEN&Cowden_disease&DE_00059[DisEnhancer]||promoter_+_chr10:89623352-89623426[Fantom_promoter]
10	89623462	10_89623462_A/G	A	G	.	.	ANN=G|5_prime_UTR_variant|MODIFIER|PTEN|ENSG00000171862|Transcript|ENST00000371953|protein_coding|1/9||||593|||||||1||HGNC|9588|YES||1||||||||||||||||PTEN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1249502&18971253[ORegAnno]&PTEN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1167633&18971253[ORegAnno]&PTEN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1219405&18971253[ORegAnno]&PTEN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1609695&18971253[ORegAnno]&PTEN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1811996&18971253[ORegAnno]|PTEN&Cowden_disease&DE_00057[DisEnhancer]&PTEN&Cowden_disease&DE_00058[DisEnhancer]&PTEN&Cowden_disease&DE_00059[DisEnhancer]||
11	112026156	11_112026156_C/G	C	G	.	.	ANN=G|intron_variant|MODIFIER|IL18|ENSG00000150782|Transcript|ENST00000280357|protein_coding||1/5||||||||||-1||HGNC|5986|YES||||||||||||||||||IL18&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1259277&18971253[ORegAnno]|IL-18&Bronchial_asthma&DE_00584[DisEnhancer]||
11	113846006	11_113846006_C/T	C	T	.	.	ANN=T|5_prime_UTR_variant|MODIFIER|HTR3A|ENSG00000166736|Transcript|ENST00000355556|protein_coding|1/8||||210|||||||1||HGNC|5297|YES||||||||||||||||||HTR3A&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1883283&18971253[ORegAnno]|HTR3A&Bipolar_affective_disorder&DE_00074[DisEnhancer]||
11	118900338	11_118900338_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|SLC37A4|ENSG00000137700|Transcript|ENST00000357590|protein_coding||2/11||||||||rs56258965||-1||HGNC|4061|YES||1|||0.1294|0.056|0.1758|0.129|0.1889|0.135||||||||SLC37A4&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1499259&18971253[ORegAnno]|SLC37A4&Sudden_infant_death_syndrome&DE_00075[DisEnhancer]||
11	118955641	11_118955641_C/T	C	T	.	.	ANN=T|5_prime_UTR_variant|MODIFIER|HMBS|ENSG00000256269|Transcript|ENST00000278715|protein_coding|1/14||||49|||||rs72997366||1||HGNC|4982|YES||1|||0.0002|0|0|0|0.001|0||||||||HMBS&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1273062&18971253[ORegAnno]&HMBS&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1793716&18971253[ORegAnno]&HMBS&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1808262&18971253[ORegAnno]&HMBS&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1823612&18971253[ORegAnno]&HMBS&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1842593&18971253[ORegAnno]&HMBS&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1303882&18971253[ORegAnno]&HMBS&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1788313&18971253[ORegAnno]&HMBS&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1845282&18971253[ORegAnno]&HMBS&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1553527&18971253[ORegAnno]&HMBS&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1853804&18971253[ORegAnno]&HMBS&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1625645&18971253[ORegAnno]|HMBS&Porphyria&DE_00076[DisEnhancer]||
11	124609907	11_124609907_C/G	C	G	.	.	ANN=G|5_prime_UTR_variant|MODIFIER|NRGN|ENSG00000154146|Transcript|ENST00000284292|protein_coding|1/4||||166|||||||1||HGNC|8000|YES||||||||||||||||||NRGN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1492076&18971253[ORegAnno]&NRGN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1814103&18971253[ORegAnno]&NRGN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1779737&18971253[ORegAnno]&NRGN&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1614399&18971253[ORegAnno]|NRGN&Schizophrenia&DE_00077[DisEnhancer]||
11	2020124	11_2020124_C/A	C	A	.	.	ANN=A|upstream_gene_variant|MODIFIER|H19|ENSG00000130600|Transcript|ENST00000414790|lincRNA|||||||||||1019|-1||HGNC|4713|YES||1||||||||||||||||N/A&1&REGULATORY_REGION&POSITIVE_OUTCOME&OREG0020674&N/A[ORegAnno]|H19&Silver-russell_syndrome&DE_00080[DisEnhancer]||
11	2182419	11_2182419_T/G	T	G	.	.	ANN=G|5_prime_UTR_variant|MODIFIER|INS-IGF2|ENSG00000129965|Transcript|ENST00000397270|protein_coding|1/5||||21|||||||-1||HGNC|33527|YES||||||||||||||||||INS&-1&REGULATORY_REGION&POSITIVE_OUTCOME&OREG0003768&12566409[ORegAnno]|INS&Type-2_diabetes&DE_00081[DisEnhancer]||
11	2186335	11_2186335_T/C	T	C	.	.	ANN=C|intron_variant|MODIFIER|TH|ENSG00000180176|Transcript|ENST00000381178|protein_coding||13/13||||||||||-1||HGNC|11782|YES||1||||||||||||||||TH&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1177415&18971253[ORegAnno]|Pgl3&Hypertension&DE_00501[DisEnhancer]||
11	2193085	11_2193085_A/T	A	T	.	.	ANN=T|upstream_gene_variant|MODIFIER|TH|ENSG00000180176|Transcript|ENST00000381178|protein_coding|||||||||||50|-1||HGNC|11782|YES||1||||||||||||||||TH&-1&REGULATORY_REGION&POSITIVE_OUTCOME&OREG0003769&12566409[ORegAnno]|TH&Tyrosine_hydroxylase_deficiency&DE_00082[DisEnhancer]||
11	2193086	11_2193086_C/T	C	T	.	.	ANN=T|upstream_gene_variant|MODIFIER|TH|ENSG00000180176|Transcript|ENST00000381178|protein_coding|||||||||||51|-1||HGNC|11782|YES||1||||||||||||||||TH&-1&REGULATORY_REGION&POSITIVE_OUTCOME&OREG0003769&12566409[ORegAnno]|TH&Tyrosine_hydroxylase_deficiency&DE_00082[DisEnhancer]||
11	2193087	11_2193087_G/A	G	A	.	.	ANN=A|upstream_gene_variant|MODIFIER|TH|ENSG00000180176|Transcript|ENST00000381178|protein_coding||||||||||rs549435434|52|-1||HGNC|11782|YES||1|||0.0002|0|0|0|0|0.001||||||||TH&-1&REGULATORY_REGION&POSITIVE_OUTCOME&OREG0003769&12566409[ORegAnno]|TH&Tyrosine_hydroxylase_deficiency&DE_00082[DisEnhancer]||
11	2847069	11_2847069_T/G	T	G	.	.	ANN=G|intron_variant|MODIFIER|KCNQ1|ENSG00000053918|Transcript|ENST00000155840|protein_coding||15/15||||||||rs163184||1||HGNC|6294|YES||1|||0.3726|0.1384|0.4049|0.4206|0.493|0.4928|||1|||||KCNQ1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1890769&18971253[ORegAnno]&KCNQ1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1500703&18971253[ORegAnno]&KCNQ1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1802440&18971253[ORegAnno]&KCNQ1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1705803&18971253[ORegAnno]&KCNQ1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1817965&18971253[ORegAnno]|KCNQ1&Type-2_diabetes&DE_00482[DisEnhancer]||
11	35440976	11_35440976_T/G	T	G	.	.	ANN=G|upstream_gene_variant|MODIFIER|SLC1A2|ENSG00000110436|Transcript|ENST00000278379|protein_coding||||||||||rs4354668|180|-1||HGNC|10940|YES||1|||0.6196|0.82|0.5994|0.7292|0.4145|0.4611|||||||||SLC1A2&Progressing_stroke&DE_00084[DisEnhancer]||
11	5248393	11_5248393_G/A	G	A	.	.	ANN=A|upstream_gene_variant|MODIFIER|HBB|ENSG00000244734|Transcript|ENST00000335295|protein_coding||||||||||rs34883338|92|-1||HGNC|4827|YES||1|||||||||pathogenic||1|||||HBB&-1&REGULATORY_REGION&POSITIVE_OUTCOME&OREG0003733&12566409[ORegAnno]&HBB_gene_family&1&REGULATORY_REGION&POSITIVE_OUTCOME&OREG0002369&16024817[ORegAnno]|HBB&Thalassaemia&DE_00086[DisEnhancer]&HBB&Thalassaemia&DE_00087[DisEnhancer]&HBB&Thalassaemia&DE_00085[DisEnhancer]||
11	5248402	11_5248402_G/A	G	A	.	.	ANN=A|upstream_gene_variant|MODIFIER|HBB|ENSG00000244734|Transcript|ENST00000335295|protein_coding||||||||||rs63751208|101|-1||HGNC|4827|YES||1|||||||||pathogenic||1|||||HBB&-1&REGULATORY_REGION&POSITIVE_OUTCOME&OREG0003733&12566409[ORegAnno]&HBB_gene_family&1&REGULATORY_REGION&POSITIVE_OUTCOME&OREG0002369&16024817[ORegAnno]|HBB&Thalassaemia&DE_00086[DisEnhancer]&HBB&Thalassaemia&DE_00087[DisEnhancer]||
11	5248491	11_5248491_C/T	C	T	.	.	ANN=T|upstream_gene_variant|MODIFIER|HBB|ENSG00000244734|Transcript|ENST00000335295|protein_coding||||||||||rs753344875|190|-1||HGNC|4827|YES||1||||||||||||||||HBB&-1&REGULATORY_REGION&POSITIVE_OUTCOME&OREG0003733&12566409[ORegAnno]&HBB_gene_family&1&REGULATORY_REGION&POSITIVE_OUTCOME&OREG0002369&16024817[ORegAnno]|HBB&Thalassaemia&DE_00086[DisEnhancer]&HBB&Thalassaemia&DE_00087[DisEnhancer]||
11	5255749	11_5255749_G/T	G	T	.	.	ANN=T|5_prime_UTR_variant|MODIFIER|HBD|ENSG00000223609|Transcript|ENST00000380299|protein_coding|1/3||||130|||||rs34235091||-1||HGNC|4829|YES||1||||||||||||||||HBD&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1232774&18971253[ORegAnno]&HBB_gene_family&1&REGULATORY_REGION&POSITIVE_OUTCOME&OREG0002368&16024817[ORegAnno]|HBD&Thalassaemia&DE_00088[DisEnhancer]||
11	5255778	11_5255778_C/T	C	T	.	.	ANN=T|5_prime_UTR_variant|MODIFIER|HBD|ENSG00000223609|Transcript|ENST00000380299|protein_coding|1/3||||101|||||||-1||HGNC|4829|YES||1||||||||||||||||HBD&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1232774&18971253[ORegAnno]&HBB_gene_family&1&REGULATORY_REGION&POSITIVE_OUTCOME&OREG0002368&16024817[ORegAnno]&HBD&-1&REGULATORY_REGION&POSITIVE_OUTCOME&OREG0003734&12566409[ORegAnno]|HBD&Thalassaemia&DE_00088[DisEnhancer]||promoter_-_chr11:5255755-5255802[Fantom_promoter]
11	5271262	11_5271262_A/G	A	G	.	.	ANN=G|upstream_gene_variant|MODIFIER|HBG1|ENSG00000213934|Transcript|ENST00000330597|protein_coding||||||||||rs34153902|140|-1||HGNC|4831|YES||1|||||||||||||||||HBG1/HBG2&Hereditary_persistence_of_foetal_haemoglobin&DE_00089[DisEnhancer]||
11	5271289	11_5271289_G/A	G	A	.	.	ANN=A|upstream_gene_variant|MODIFIER|HBG1|ENSG00000213934|Transcript|ENST00000330597|protein_coding||||||||||rs34619194|167|-1||HGNC|4831|YES||1|||||||||||||||||HBG1/HBG2&Hereditary_persistence_of_foetal_haemoglobin&DE_00089[DisEnhancer]||
11	5276120	11_5276120_C/A	C	A	.	.	ANN=A|5_prime_UTR_variant|MODIFIER|HBG2|ENSG00000196565|Transcript|ENST00000380259|protein_coding|6/8||||1080|||||||-1||HGNC|4832|YES||1||||||||||||||||HBG1&-1&REGULATORY_REGION&POSITIVE_OUTCOME&OREG0003736&12566409[ORegAnno]|HBG1/HBG2&Hereditary_persistence_of_foetal_haemoglobin&DE_00089[DisEnhancer]||
11	5276172	11_5276172_C/T	C	T	.	.	ANN=T|5_prime_UTR_variant|MODIFIER|HBG2|ENSG00000196565|Transcript|ENST00000380259|protein_coding|6/8||||1028|||||||-1||HGNC|4832|YES||1||||||||||||||||HBG1&-1&REGULATORY_REGION&POSITIVE_OUTCOME&OREG0003736&12566409[ORegAnno]|HBG1/HBG2&Hereditary_persistence_of_foetal_haemoglobin&DE_00089[DisEnhancer]||
11	5276186	11_5276186_A/G	A	G	.	.	ANN=G|5_prime_UTR_variant|MODIFIER|HBG2|ENSG00000196565|Transcript|ENST00000380259|protein_coding|6/8||||1014|||||rs63750654||-1||HGNC|4832|YES||1|||||||||pathogenic||1|||||HBG1&-1&REGULATORY_REGION&POSITIVE_OUTCOME&OREG0003736&12566409[ORegAnno]|HBG1/HBG2&Hereditary_persistence_of_foetal_haemoglobin&DE_00089[DisEnhancer]||
11	5276213	11_5276213_G/C	G	C	.	.	ANN=C|5_prime_UTR_variant|MODIFIER|HBG2|ENSG00000196565|Transcript|ENST00000380259|protein_coding|6/8||||987|||||rs35617911||-1||HGNC|4832|YES||1|||||||||pathogenic||1|||||HBG1&-1&REGULATORY_REGION&POSITIVE_OUTCOME&OREG0003736&12566409[ORegAnno]|HBG1/HBG2&Hereditary_persistence_of_foetal_haemoglobin&DE_00089[DisEnhancer]||
11	69234620	11_69234620_T/C	T	C	.	.	ANN=C|downstream_gene_variant|MODIFIER|RP11-211G23.1|ENSG00000259854|Transcript|ENST00000562341|lincRNA||||||||||rs7948643|3020|1||Clone_based_vega_gene||YES|||||0.2222|0.6475|0.0908|0.0605|0.0795|0.0542|||||||||CCND1&Renal_cancer&DE_00643[DisEnhancer]||
11	69239741	11_69239741_G/A	G	A	.	.	ANN=A|upstream_gene_variant|MODIFIER|AP000439.1|ENSG00000255980|Transcript|ENST00000545202|lincRNA||||||||||rs7105934|717|1||Clone_based_vega_gene||YES|||||0.2216|0.6445|0.0908|0.0605|0.0805|0.0542|||1||||||CCND1&Renal_cancer&DE_00616[DisEnhancer]||
11	69251982	11_69251982_C/T	C	T	.	.	ANN=T|downstream_gene_variant|MODIFIER|AP000439.2|ENSG00000255606|Transcript|ENST00000544004|lincRNA||||||||||rs77247065|1151|-1||Clone_based_vega_gene||YES|||||0.0563|0.0484|0.0519|0.0248|0.0755|0.0828||||||||MYEOV&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1193676&18971253[ORegAnno]&MYEOV&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1660099&18971253[ORegAnno]&MYEOV&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1601793&18971253[ORegAnno]&MYEOV&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1906902&18971253[ORegAnno]&MYEOV&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1751548&18971253[ORegAnno]&MYEOV&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1406538&18971253[ORegAnno]&MYEOV&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1515980&18971253[ORegAnno]&MYEOV&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1536576&18971253[ORegAnno]|CCND1&Breast_cancer&DE_00101[DisEnhancer]&CCND1&Renal_cancer&DE_00274[DisEnhancer]||
11	69331418	11_69331418_C/T	C	T	.	.	ANN=T|intergenic_variant|MODIFIER|||||||||||||||rs78540526|||||||||||0.0413|0.0038|0.0331|0.005|0.0676|0.1084||||||||CCND1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1518234&18971253[ORegAnno]|CCND1&Breast_cancer&DE_00116[DisEnhancer]&CCND1&Breast_cancer&DE_00117[DisEnhancer]||
11	69331642	11_69331642_C/G	C	G	.	.	ANN=G|intergenic_variant|MODIFIER|||||||||||||||rs554219||||||||||||||||||||||||CCND1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1518234&18971253[ORegAnno]|CCND1&Breast_cancer&DE_00116[DisEnhancer]&CCND1&Breast_cancer&DE_00117[DisEnhancer]||
11	73694754	11_73694754_C/T	C	T	.	.	ANN=T|upstream_gene_variant|MODIFIER|UCP2|ENSG00000175567|Transcript|ENST00000310473|protein_coding||||||||||rs659366|402|-1||HGNC|12518|YES||1|||0.4089|0.4539|0.4236|0.4206|0.3648|0.3712|risk_factor||1|||||UCP2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1251703&18971253[ORegAnno]&UCP2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1792033&18971253[ORegAnno]&UCP2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1813194&18971253[ORegAnno]&UCP2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1832965&18971253[ORegAnno]|UCP2&Obesity&DE_00126[DisEnhancer]||
11	8255408	11_8255408_T/G	T	G	.	.	ANN=G|intron_variant|MODIFIER|LMO1|ENSG00000166407|Transcript|ENST00000335790|protein_coding||1/3||||||||||-1||HGNC|6641|YES||1|||||||||||||||||LMO1&Neuroblastoma&DE_00502[DisEnhancer]||
11	8289480	11_8289480_C/T	C	T	.	.	ANN=T|upstream_gene_variant|MODIFIER|LMO1|ENSG00000166407|Transcript|ENST00000335790|protein_coding|||||||||||4075|-1||HGNC|6641|YES||1|||||||||||||||||LMO1&Acute_lymphoblastic_leukemia&DE_00128[DisEnhancer]||
12	110718411	12_110718411_G/T	G	T	.	.	ANN=T|upstream_gene_variant|MODIFIER|ATP2A2|ENSG00000174437|Transcript|ENST00000539276|protein_coding|||||||||||1075|1||HGNC|812|YES||1||||||||||||||||ATP2A2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1270458&18971253[ORegAnno]&ATP2A2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1511216&18971253[ORegAnno]&ATP2A2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1189168&18971253[ORegAnno]|SERCA2B&Colorectal_cancer&DE_00133[DisEnhancer]||promoter_+_chr12:110718407-110718426[Fantom_promoter]
12	112007756	12_112007756_C/C	C	C	.	.	.
12	114704515	12_114704515_G/T	G	T	.	.	ANN=T|intergenic_variant|MODIFIER|||||||||||||||rs141875471|||||||||||0.0010|0.0008|0.0058|0|0|0|||||||||TBX5&Holt-oram_syndrome&DE_00135[DisEnhancer]&TBX5&Isolated_congenital_heart_defect&DE_00134[DisEnhancer]||
12	114704515	12_114704515_G/T	G	T	.	.	ANN=T|intergenic_variant|MODIFIER|||||||||||||||rs141875471|||||||||||0.0010|0.0008|0.0058|0|0|0|||||||||TBX5&Holt-oram_syndrome&DE_00135[DisEnhancer]&TBX5&Isolated_congenital_heart_defect&DE_00134[DisEnhancer]||
12	12009741	12_12009741_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|ETV6|ENSG00000139083|Transcript|ENST00000396373|protein_coding||4/7||||||||rs2238126||1||HGNC|3495|YES||1|||0.2300|0.1815|0.2493|0.4673|0.1899|0.0787|||1|||||ETV6&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1243631&18971253[ORegAnno]|ETV6&Colorectal_cancer&DE_00505[DisEnhancer]||
12	121416034	12_121416034_G/C	G	C	.	.	ANN=C|upstream_gene_variant|MODIFIER|HNF1A|ENSG00000135100|Transcript|ENST00000257555|protein_coding|||||||||||312|1||HGNC|11621|YES||1||||||||||||||||HNF1A&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1746682&18971253[ORegAnno]&HNF1A&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1722753&18971253[ORegAnno]|HNF1A&Type-2_diabetes&DE_00139[DisEnhancer]||
12	121416448	12_121416448_G/C	G	C	.	.	ANN=C|5_prime_UTR_variant|MODIFIER|HNF1A|ENSG00000135100|Transcript|ENST00000257555|protein_coding|1/10||||103|||||rs563304627||1||HGNC|11621|YES||1|||0.0008|0|0|0.003|0.001|0||||||||HNF1A&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1746682&18971253[ORegAnno]&HNF1A&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1722753&18971253[ORegAnno]|HNF1A&Type-2_diabetes&DE_00140[DisEnhancer]||
12	14410634	12_14410634_C/T	C	T	.	.	ANN=T|downstream_gene_variant|MODIFIER|GNAI2P1|ENSG00000255749|Transcript|ENST00000541815|processed_pseudogene||||||||||rs11055880|2474|1||HGNC|4386|YES|||||0.1420|0.0106|0.1182|0.2054|0.2137|0.1973||||||||RNU6-491P&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1250808&18971253[ORegAnno]&RNU6-491P&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1220633&18971253[ORegAnno]&N/A&N/A&REGULATORY_REGION&N/A&OREG0070518&17130149[ORegAnno]&RNU6-491P&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1797089&18971253[ORegAnno]&RNU6-491P&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1878620&18971253[ORegAnno]&GNAI2P1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1609008&18971253[ORegAnno]&RNU6-491P&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1778514&18971253[ORegAnno]&RNU6-491P&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1169104&18971253[ORegAnno]&ATF7IP&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1928116&18971253[ORegAnno]|ATP7IP&Breast_cancer&DE_01008[DisEnhancer]|enhancer_chr12:14410616-14411017[Fantom_enhancer]|
12	2346393	12_2346393_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|CACNA1C|ENSG00000151067|Transcript|ENST00000347598|protein_coding||3/48||||||||rs2159100||1||HGNC|1390|YES||1|||0.3019|0.5393|0.2839|0.0506|0.3161|0.2382|||||||||CACNA1C&Bipolar_disorder&DE_00571[DisEnhancer]&CACNA1C&Schizophrenia&DE_00452[DisEnhancer]||
12	2349584	12_2349584_G/C	G	C	.	.	ANN=C|intron_variant|MODIFIER|CACNA1C|ENSG00000151067|Transcript|ENST00000347598|protein_coding||3/48||||||||rs4765905||1||HGNC|1390|YES||1|||0.3009|0.5333|0.2824|0.0506|0.3201|0.2382|||1||||||CACNA1C&Bipolar_disorder&DE_00571[DisEnhancer]&CACNA1C&Schizophrenia&DE_00452[DisEnhancer]||
12	2349584	12_2349584_G/C	G	C	.	.	ANN=C|intron_variant|MODIFIER|CACNA1C|ENSG00000151067|Transcript|ENST00000347598|protein_coding||3/48||||||||rs4765905||1||HGNC|1390|YES||1|||0.3009|0.5333|0.2824|0.0506|0.3201|0.2382|||1||||||CACNA1C&Bipolar_disorder&DE_00571[DisEnhancer]&CACNA1C&Schizophrenia&DE_00452[DisEnhancer]||
12	2361460	12_2361460_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|CACNA1C|ENSG00000151067|Transcript|ENST00000347598|protein_coding||3/48||||||||rs758170||1||HGNC|1390|YES||1|||0.2622|0.4145|0.268|0.0506|0.3201|0.2106|||||||||CACNA1C&Bipolar_disorder&DE_00571[DisEnhancer]&CACNA1C&Schizophrenia&DE_00452[DisEnhancer]||
12	26472562	12_26472562_G/A	G	A	.	.	ANN=A|intron_variant&non_coding_transcript_variant|MODIFIER|RP11-513G19.1|ENSG00000255968|Transcript|ENST00000535324|antisense||1/5||||||||||1||Clone_based_vega_gene||YES|||||||||||||||||||BHLHE41&Renal_cancer&DE_00617[DisEnhancer]||
12	349298	12_349298_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|SLC6A13|ENSG00000010379|Transcript|ENST00000343164|protein_coding||4/14||||||||rs10774021||-1||HGNC|11046|YES|||||0.4527|0.4463|0.3718|0.2232|0.6471|0.5552|||1||||||KDM5A/CCDC77/LOC100288778&Chronic_kidney_disease&DE_01005[DisEnhancer]||
12	54360232	12_54360232_C/T	C	T	.	.	ANN=T|intron_variant&non_coding_transcript_variant|MODIFIER|HOTAIR|ENSG00000228630|Transcript|ENST00000424518|antisense||3/6||||||||||-1||HGNC|33510|YES||||||||||||||||||HOTAIR&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1835221&18971253[ORegAnno]|HOTAIR&Esophageal_carcinoma&DE_00655[DisEnhancer]||
12	57534470	12_57534470_T/C	T	C	.	.	ANN=C|intron_variant|MODIFIER|LRP1|ENSG00000123384|Transcript|ENST00000243077|protein_coding||2/88||||||||||1||HGNC|6692|YES||1||||||||||||||||STAT6&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1823664&18971253[ORegAnno]&STAT6&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1808320&18971253[ORegAnno]|LRP1&Abdominal_aortic_aneurysm&DE_00477[DisEnhancer]||
12	58133256	12_58133256_G/A	G	A	.	.	ANN=A|upstream_gene_variant|MODIFIER|AGAP2|ENSG00000135439|Transcript|ENST00000547588|protein_coding||||||||||rs12368653|1227|-1||HGNC|16921|YES|||||0.2979|0.236|0.3401|0.1865|0.492|0.2669|||1||||||CYP27B1&Multiple_sclerosis&DE_00454[DisEnhancer]||
12	58165085	12_58165085_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|METTL1|ENSG00000037897|Transcript|ENST00000324871|protein_coding||1/5||||||||||-1||HGNC|7030|YES||||||||||||||||||METTL1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1507908&18971253[ORegAnno]|TSPAN31/CYP27B1/TSFM/AVIL/FAM119B&Multiple_sclerosis&DE_00429[DisEnhancer]||
12	6440009	12_6440009_T/C	T	C	.	.	ANN=C|intron_variant|MODIFIER|TNFRSF1A|ENSG00000067182|Transcript|ENST00000162749|protein_coding||6/9||||||||rs1800693||-1||HGNC|11916|YES||1|||0.2997|0.3608|0.281|0.123|0.4254|0.2832|benign&likely_benign&risk_factor||1||||||TNFRSF1A&Multiple_sclerosis&DE_00492[DisEnhancer]||
12	66581616	12_66581616_A/G	A	G	.	.	ANN=G|upstream_gene_variant|MODIFIER|IRAK3|ENSG00000090376|Transcript|ENST00000261233|protein_coding|||||||||||1043|1||HGNC|17020|YES||1||||||||||||||||IRAK3&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1247609&18971253[ORegAnno]|IRAK3&Acute_lung_injury&DE_00146[DisEnhancer]||
12	9876091	12_9876091_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|CLECL1|ENSG00000184293|Transcript|ENST00000327839|protein_coding||1/1||||||||rs10466829||-1||HGNC|24462|YES||||||0.6944|0.4481|0.3829|0.496|0.5726|||1||||||CLECL1&Multiple_sclerosis&DE_00409[DisEnhancer]||
13	113760095	13_113760095_T/G	T	G	.	.	ANN=G|upstream_gene_variant|MODIFIER|F7|ENSG00000057593|Transcript|ENST00000375581|protein_coding|||||||||||26|1||HGNC|3544|YES||1||||||||||||||||F7&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1599474&18971253[ORegAnno]&F7&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1657764&18971253[ORegAnno]&F7&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1191566&18971253[ORegAnno]&F7&1&REGULATORY_REGION&POSITIVE_OUTCOME&OREG0003852&12566409[ORegAnno]&F7&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1750196&18971253[ORegAnno]&F7&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1726510&18971253[ORegAnno]&F7&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1303836&18971253[ORegAnno]&N/A&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG0292707&24194598[ORegAnno]&F7&-1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1754450&18971253[ORegAnno]&N/A&-1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG0696744&24194598[ORegAnno]|F7&Factor_vii_deficiency&DE_00151[DisEnhancer]||
13	113760101	13_113760101_C/T	C	T	.	.	ANN=T|upstream_gene_variant|MODIFIER|F7|ENSG00000057593|Transcript|ENST00000375581|protein_coding|||||||||||20|1||HGNC|3544|YES||1||||||||||||||||F7&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1599474&18971253[ORegAnno]&F7&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1657764&18971253[ORegAnno]&F7&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1191566&18971253[ORegAnno]&F7&1&REGULATORY_REGION&POSITIVE_OUTCOME&OREG0003852&12566409[ORegAnno]&F7&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1750196&18971253[ORegAnno]&F7&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1726510&18971253[ORegAnno]&F7&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1303836&18971253[ORegAnno]&N/A&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG0292707&24194598[ORegAnno]&F7&-1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1754450&18971253[ORegAnno]&N/A&-1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG0696744&24194598[ORegAnno]|F7&Factor_vii_deficiency&DE_00151[DisEnhancer]||promoter_+_chr13:113760098-113760110[Fantom_promoter]
13	47471478	13_47471478_C/T	C	T	.	.	ANN=T|upstream_gene_variant|MODIFIER|HTR2A|ENSG00000102468|Transcript|ENST00000378688|protein_coding||||||||||rs6311|1305|-1||HGNC|5293|YES|||||0.4435|0.4092|0.3617|0.5883|0.4374|0.4049|||||||||HTR2A&Anorexia_nervosa&DE_00155[DisEnhancer]||
13	50945011	13_50945011_G/A	G	A	.	.	ANN=A|intron_variant&non_coding_transcript_variant|MODIFIER|DLEU1|ENSG00000176124|Transcript|ENST00000490577|processed_transcript||2/5||||||||rs2532975||1||HGNC|13747||||||0.1797|0.0688|0.1816|0.1181|0.2594|0.3098|||||||||ARLTS1&Prostate_cancer&DE_00518[DisEnhancer]||
13	72347696	13_72347696_A/A	A	A	.	.	.
13	72428647	13_72428647_G/T	G	T	.	.	ANN=T|intron_variant|MODIFIER|DACH1|ENSG00000165659|Transcript|ENST00000305425|protein_coding||1/10||||||||||-1||HGNC|2663|YES||||||||||||||||||DACH1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1277468&18971253[ORegAnno]|DACH1&Cardiovascular_disease&DE_00471[DisEnhancer]&DACH1&Type-2_diabetes&DE_00470[DisEnhancer]||
13	72428647	13_72428647_G/T	G	T	.	.	ANN=T|intron_variant|MODIFIER|DACH1|ENSG00000165659|Transcript|ENST00000305425|protein_coding||1/10||||||||||-1||HGNC|2663|YES||||||||||||||||||DACH1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1277468&18971253[ORegAnno]|DACH1&Cardiovascular_disease&DE_00471[DisEnhancer]&DACH1&Type-2_diabetes&DE_00470[DisEnhancer]||
14	30000405	14_30000405_G/T	G	T	.	.	ANN=T|intergenic_variant|MODIFIER||||||||||||||||||||||||||||||||||||||||FOXG1&Neuropsychiatric_disorders&DE_00439[DisEnhancer]||
14	54410919	14_54410919_T/C	T	C	.	.	ANN=C|downstream_gene_variant|MODIFIER|MIR5580|ENSG00000266431|Transcript|ENST00000580850|miRNA||||||||||rs4444235|4226|-1||HGNC|43482|YES|||||0.4321|0.2935|0.4467|0.4673|0.493|0.5102|||1||||||BMP4&Colorectal_cancer&DE_00559[DisEnhancer]||
14	60974449	14_60974449_A/G	A	G	.	.	ANN=G|upstream_gene_variant|MODIFIER|SIX6|ENSG00000184302|Transcript|ENST00000327720|protein_coding||||||||||rs762476361|1220|1||HGNC|10892|YES||1||||||||||||||||SIX6&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1929150&18971253[ORegAnno]|SIX6&Primary_open-angle_glaucoma&DE_00994[DisEnhancer]&SIX6&Primary_open-angle_glaucoma&DE_00180[DisEnhancer]||
14	69254191	14_69254191_C/T	C	T	.	.	ANN=T|downstream_gene_variant|MODIFIER|ZFP36L1|ENSG00000185650|Transcript|ENST00000439696|protein_coding||||||||||rs4902647|188|-1||HGNC|1107|YES|||||0.4876|0.3396|0.5231|0.6935|0.4652|0.4734|||1||||||ZFP36L1&Multiple_sclerosis&DE_00574[DisEnhancer]||
14	73602899	14_73602899_C/G	C	G	.	.	ANN=G|upstream_gene_variant|MODIFIER|PSEN1|ENSG00000080815|Transcript|ENST00000324501|protein_coding||||||||||rs34086577|256|1||HGNC|9508|YES||1|||0.0030|0|0.0043|0|0.003|0.0092||||||||PSEN1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1263704&18971253[ORegAnno]|PSEN1&Alzheimers_disease&DE_00181[DisEnhancer]||
14	76005557	14_76005557_T/C	T	C	.	.	ANN=C|intron_variant|MODIFIER|BATF|ENSG00000156127|Transcript|ENST00000286639|protein_coding||2/2||||||||rs2300603||1||HGNC|958|YES|||||0.2113|0.056|0.232|0.2927|0.2614|0.271|||1||||||BATF&Multiple_sclerosis&DE_00512[DisEnhancer]||
15	32993111	15_32993111_C/T	C	T	.	.	ANN=T|downstream_gene_variant|MODIFIER|SCG5|ENSG00000166922|Transcript|ENST00000300175|protein_coding||||||||||rs16969681|3812|1||HGNC|10816|YES|||||0.1975|0.1377|0.1758|0.371|0.0736|0.2423||||||||SCG5&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1576286&18971253[ORegAnno]&SCG5&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1635001&18971253[ORegAnno]&SCG5&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1701618&18971253[ORegAnno]|GREM1&Orofacial_clefting&DE_00484[DisEnhancer]||
15	40397936	15_40397936_C/A	C	A	.	.	ANN=A|intron_variant|MODIFIER|BMF|ENSG00000104081|Transcript|ENST00000354670|protein_coding||3/4||||||||||-1||HGNC|24132|YES||||||||||||||||||BMF&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1229095&18971253[ORegAnno]&BMF&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1946177&18971253[ORegAnno]|BMF&Chronic_lymphocytic_leukemia&DE_00579[DisEnhancer]||
15	45641225	15_45641225_C/C	C	C	.	.	.
15	53942928	15_53942928_T/C	T	C	.	.	ANN=C|intron_variant|MODIFIER|WDR72|ENSG00000166415|Transcript|ENST00000396328|protein_coding||14/19||||||||rs17730436||-1||HGNC|26790|YES||1|||0.2624|0.1248|0.366|0.4772|0.1918|0.226|||1||||||ONECUT1&Chronic_kidney_disease&DE_01022[DisEnhancer]||
15	62391608	15_62391608_T/C	T	C	.	.	ANN=C|regulatory_region_variant|MODIFIER|||RegulatoryFeature|ENSR00000077566|promoter_flanking_region||||||||||||||||||||||||||||||||||C2CD4A&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1179214&18971253[ORegAnno]|VPS13C&Type-2_diabetes&DE_00618[DisEnhancer]||
15	67442596	15_67442596_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|SMAD3|ENSG00000166949|Transcript|ENST00000327367|protein_coding||1/8||||||||rs17293632||1||HGNC|6769|YES||1|||0.0992|0.0242|0.1239|0.0278|0.2147|0.138|||1|||||SMAD3&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1197309&18971253[ORegAnno]&SMAD3&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1910932&18971253[ORegAnno]&SMAD3&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1246734&18971253[ORegAnno]&SMAD3&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1664206&18971253[ORegAnno]&SMAD3&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1605981&18971253[ORegAnno]&SMAD3&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1684831&18971253[ORegAnno]&SMAD3&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1628643&18971253[ORegAnno]&SMAD3&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1541087&18971253[ORegAnno]&SMAD3&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1669442&18971253[ORegAnno]&SMAD3&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1531518&18971253[ORegAnno]&N/A&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG0723869&24194598[ORegAnno]&N/A&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG0732116&24194598[ORegAnno]&N/A&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG0762724&24194598[ORegAnno]|SMAD3&Crohn_disease&DE_00487[DisEnhancer]|enhancer_chr15:67442347-67443164[Fantom_enhancer]|
15	78292380	15_78292380_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|TBC1D2B|ENSG00000167202|Transcript|ENST00000300584|protein_coding||12/12||||||||||-1||HGNC|29183|YES||||||||||||||||||TBC1D2B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1609518&18971253[ORegAnno]|ACSBG1&Breast_cancer&DE_00996[DisEnhancer]||
15	78292544	15_78292544_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|TBC1D2B|ENSG00000167202|Transcript|ENST00000300584|protein_coding||12/12||||||||||-1||HGNC|29183|YES||||||||||||||||||TBC1D2B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1609518&18971253[ORegAnno]&TBC1D2B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1389132&18971253[ORegAnno]&TBC1D2B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1340580&18971253[ORegAnno]|ACSBG1&Breast_cancer&DE_00996[DisEnhancer]||
15	78292823	15_78292823_G/C	G	C	.	.	ANN=C|intron_variant|MODIFIER|TBC1D2B|ENSG00000167202|Transcript|ENST00000300584|protein_coding||12/12||||||||rs926886287||-1||HGNC|29183|YES||||||||||||||||||TBC1D2B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1609518&18971253[ORegAnno]|ACSBG1&Breast_cancer&DE_00996[DisEnhancer]||
16	11448517	16_11448517_G/A	G	A	.	.	ANN=A|downstream_gene_variant|MODIFIER|RMI2|ENSG00000175643|Transcript|ENST00000312499|protein_coding||||||||||rs8052717|2898|1||HGNC|28349|YES||1|||0.1502|0.1604|0.085|0.2272|0.1213|0.1329||||||||RMI2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1222548&18971253[ORegAnno]|CLEC16A&Multiple_sclerosis&DE_01048[DisEnhancer]||
16	209709	16_209709_T/C	T	C	.	.	ANN=C|upstream_gene_variant|MODIFIER|HBZP1|ENSG00000206178|Transcript|ENST00000354915|unprocessed_pseudogene|||||||||||3412|1||HGNC|4836|YES||||||||||||||||||HBM&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1497938&18971253[ORegAnno]|HBM&Thalassaemia&DE_00187[DisEnhancer]||
16	31276811	16_31276811_G/A	G	A	.	.	ANN=A|missense_variant|MODERATE|ITGAM|ENSG00000169896|Transcript|ENST00000544665|protein_coding|3/30||||301|230|77|R/H|cGc/cAc|rs1143679||1||HGNC|6149|YES||1|tolerated|benign|0.0851|0.1203|0.0893|0.0149|0.1312|0.0593|||1|||||ITGAM&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1233449&18971253[ORegAnno]|ITGAM&Systemic_lupus_erythematosus&DE_00436[DisEnhancer]||
16	52586341	16_52586341_A/G	A	G	.	.	ANN=G|non_coding_transcript_exon_variant|MODIFIER|CASC16|ENSG00000249231|Transcript|ENST00000510238|lincRNA|4/4||||619|||||rs3803662||-1||HGNC|48608|YES|||||0.5597|0.4327|0.6095|0.381|0.7087|0.727|||1||||||TOX3&Breast_cancer&DE_00551[DisEnhancer]||
16	52599188	16_52599188_C/T	C	T	.	.	ANN=T|intron_variant&non_coding_transcript_variant|MODIFIER|CASC16|ENSG00000249231|Transcript|ENST00000510238|lincRNA||2/3||||||||rs4784227||-1||HGNC|48608|YES|||||0.2001|0.0416|0.3127|0.255|0.2545|0.2219|||1|||||TOX3&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1664560&18971253[ORegAnno]&TOX3&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1606320&18971253[ORegAnno]&TOX3&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1684628&18971253[ORegAnno]|TOX3&Breast_cancer&DE_00572[DisEnhancer]||
16	53800954	16_53800954_T/C	T	C	.	.	ANN=C|intron_variant|MODIFIER|FTO|ENSG00000140718|Transcript|ENST00000471389|protein_coding||1/8||||||||rs1421085||1||HGNC|24678|YES||1|||0.2286|0.056|0.2392|0.1687|0.4324|0.3067|risk_factor||1||||||IRX5/IRX3&Obesity&DE_00472[DisEnhancer]||
16	53816275	16_53816275_C/A	C	A	.	.	ANN=A|intron_variant|MODIFIER|FTO|ENSG00000140718|Transcript|ENST00000471389|protein_coding||1/8||||||||rs8050136||1||HGNC|24678|YES||1|||0.3225|0.4327|0.255|0.1657|0.4135|0.2894|||1|||||FTO&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1900779&18971253[ORegAnno]|FTO&Type-2_diabetes&DE_00646[DisEnhancer]||
16	53816752	16_53816752_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|FTO|ENSG00000140718|Transcript|ENST00000471389|protein_coding||1/8||||||||rs8051591||1||HGNC|24678|YES||1|||0.3241|0.4365|0.255|0.1677|0.4145|0.2894|||1||||||FTO&Type-2_diabetes&DE_00646[DisEnhancer]||
16	53816838	16_53816838_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|FTO|ENSG00000140718|Transcript|ENST00000471389|protein_coding||1/8||||||||rs9935401||1||HGNC|24678|YES||1|||0.3235|0.4342|0.255|0.1677|0.4145|0.2894|||1||||||FTO&Type-2_diabetes&DE_00646[DisEnhancer]||
16	53830465	16_53830465_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|FTO|ENSG00000140718|Transcript|ENST00000471389|protein_coding||1/8||||||||||1||HGNC|24678|YES||1|||||||||||||||||IRX3&Obesity&DE_00669[DisEnhancer]&IRX3&Type-2_diabetes&DE_00670[DisEnhancer]||
16	53830465	16_53830465_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|FTO|ENSG00000140718|Transcript|ENST00000471389|protein_coding||1/8||||||||||1||HGNC|24678|YES||1|||||||||||||||||IRX3&Obesity&DE_00669[DisEnhancer]&IRX3&Type-2_diabetes&DE_00670[DisEnhancer]||
16	56995796	16_56995796_G/A	G	A	.	.	ANN=A|5_prime_UTR_variant|MODIFIER|CETP|ENSG00000087237|Transcript|ENST00000200676|protein_coding|1/16||||35|||||||1||HGNC|1869|YES||1|||||||||||||||||CETP&Hyperalphalipoproteinaemia&DE_00188[DisEnhancer]||
16	68820946	16_68820946_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|CDH1|ENSG00000039068|Transcript|ENST00000261769|protein_coding||2/15||||||||rs9929218||1||HGNC|1748|YES||1|||0.2576|0.267|0.2176|0.2331|0.2942|0.2607|||1|||||CDH1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1747752&18971253[ORegAnno]&CDH1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1723912&18971253[ORegAnno]|CDH1&Breast_cancer&DE_00193[DisEnhancer]&JMJD2C/TMED6&Colorectal_cancer&DE_00668[DisEnhancer]||
16	79645989	16_79645989_C/A	C	A	.	.	ANN=A|intergenic_variant|MODIFIER|||||||||||||||rs889472|||||||||||0.4507|0.3238|0.4827|0.4048|0.6243|0.4683|||1||||||MAF&Chronic_kidney_disease&DE_01050[DisEnhancer]||
17	28564170	17_28564170_A/G	A	G	.	.	ANN=G|upstream_gene_variant|MODIFIER|SLC6A4|ENSG00000108576|Transcript|ENST00000401766|protein_coding|||||||||||1150|-1||HGNC|11050|YES||1||||||||||||||||SLC6A4&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1393248&18971253[ORegAnno]|SLC6A4&Obsessive-compulsive_disorder&DE_00196[DisEnhancer]||
17	32579788	17_32579788_A/G	A	G	.	.	ANN=G|upstream_gene_variant|MODIFIER|CCL2|ENSG00000108691|Transcript|ENST00000225831|protein_coding||||||||||rs1024611|2516|1||HGNC|10618|YES||1|||0.3636|0.2277|0.4856|0.5466|0.3161|0.3211|pathogenic&risk_factor||1|||||CCL2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1219885&18971253[ORegAnno]&CCL2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1778106&18971253[ORegAnno]&CCL2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1682062&18971253[ORegAnno]|CCL2&HCV-related_liver_disease&DE_00197[DisEnhancer]|enhancer_chr17:32579434-32580053[Fantom_enhancer]|
17	34207780	17_34207780_C/T	C	T	.	.	ANN=T|upstream_gene_variant|MODIFIER|CCL5|ENSG00000161570|Transcript|ENST00000293272|protein_coding||||||||||rs2107538|268|-1||HGNC|10632|YES|||||0.3077|0.4508|0.2248|0.3224|0.161|0.3088||||||||CCL5&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1672912&18971253[ORegAnno]|CCL5&Atopic_dermatitis&DE_00198[DisEnhancer]||
17	37912377	17_37912377_C/T	C	T	.	.	ANN=T|downstream_gene_variant|MODIFIER|RP11-94L15.2|ENSG00000264198|Transcript|ENST00000488188|lincRNA||||||||||rs12946510|1597|-1||Clone_based_vega_gene||YES|||||0.3099|0.1732|0.3415|0.3016|0.4712|0.3149|||1||||||IKZF3&Multiple_sclerosis&DE_00461[DisEnhancer]|enhancer_chr17:37912171-37912498[Fantom_enhancer]|
17	38029120	17_38029120_G/C	G	C	.	.	ANN=C|intron_variant|MODIFIER|ZPBP2|ENSG00000186075|Transcript|ENST00000348931|protein_coding||5/7||||||||||1||HGNC|20678|YES|||||||||||||||||||ORMDL3&Asthma&DE_00460[DisEnhancer]||
17	38080865	17_38080865_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|ORMDL3|ENSG00000172057|Transcript|ENST00000394169|protein_coding||3/5||||||||rs4065275||-1||HGNC|16038|YES||1||||0.6256|0.6095|0.6994|0.496|0.6227||||||||ORMDL3&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1751808&18971253[ORegAnno]&ORMDL3&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1728269&18971253[ORegAnno]&ORMDL3&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1406815&18971253[ORegAnno]|ORMDL3&Asthma&DE_00554[DisEnhancer]||
17	40507980	17_40507980_A/C	A	C	.	.	ANN=C|intron_variant|MODIFIER|STAT3|ENSG00000168610|Transcript|ENST00000264657|protein_coding||1/23||||||||rs9891119||-1||HGNC|11364|YES||1|||0.3932|0.4228|0.2378|0.3978|0.3668|0.4857|||1||||||STAT3&Multiple_sclerosis&DE_00666[DisEnhancer]||
17	41278377	17_41278377_G/A	G	A	.	.	ANN=A|upstream_gene_variant|MODIFIER|BRCA1|ENSG00000012048|Transcript|ENST00000471181|protein_coding|||||||||||877|-1||HGNC|1100|YES||1||||||||||||||||BRCA1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1791488&18971253[ORegAnno]&NBR2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1194240&18971253[ORegAnno]|BRCA1&Breast_cancer&DE_00199[DisEnhancer]||
17	54773238	17_54773238_A/T	A	T	.	.	ANN=T|intergenic_variant|MODIFIER||||||||||||||||||||||||||||||||||||||||NOG&Cleft_lip&DE_00511[DisEnhancer]||
17	5519006	17_5519006_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|NLRP1|ENSG00000091592|Transcript|ENST00000576905|protein_coding||1/2||||||||rs2670660||-1|cds_end_NF|HGNC|14374|||1|||0.3480|0.3169|0.3977|0.1855|0.4602|0.407|||||||||PTEN&Prostate_cancer&DE_00522[DisEnhancer]||
17	59239221	17_59239221_A/A	A	A	.	.	.
17	59456589	17_59456589_C/C	C	C	.	.	.
17	64306133	17_64306133_T/C	T	C	.	.	ANN=C|intron_variant|MODIFIER|PRKCA|ENSG00000154229|Transcript|ENST00000413366|protein_coding||2/16||||||||||1||HGNC|9393|YES|||||||||||||||||||PRKCA&Heart_disease&DE_00667[DisEnhancer]||
17	68676303	17_68676303_T/C	T	C	.	.	ANN=C|intergenic_variant|MODIFIER|||||||||||||||rs78542003|||||||||||0.0134|0.0469|0.0072|0|0|0|||||||||SOX9&Pierre_robin_sequence&DE_00223[DisEnhancer]||
17	68698977	17_68698977_C/T	C	T	.	.	ANN=T|intergenic_variant|MODIFIER|||||||||||||||rs558502558|||||||||||||||||||||||||SOX9&Pierre_robin_sequence&DE_00224[DisEnhancer]||
17	68735530	17_68735530_G/A	G	A	.	.	ANN=A|intergenic_variant|MODIFIER|||||||||||||||rs529054628|||||||||||||||||||||||||SOX9&Pierre_robin_sequence&DE_00225[DisEnhancer]||
17	68747322	17_68747322_T/C	T	C	.	.	ANN=C|intergenic_variant|MODIFIER|||||||||||||||rs372174229|||||||||||0.0014|0|0|0.0069|0|0|||||||||SOX9&Pierre_robin_sequence&DE_00226[DisEnhancer]||
17	68772750	17_68772750_G/A	G	A	.	.	ANN=A|downstream_gene_variant|MODIFIER|RP11-238F2.1|ENSG00000271239|Transcript|ENST00000605009|lincRNA|||||||||||1995|-1||Clone_based_vega_gene||YES|||||||||||||||||||SOX9&Pierre_robin_sequence&DE_00227[DisEnhancer]||
17	69107816	17_69107816_G/A	G	A	.	.	ANN=A|intron_variant&non_coding_transcript_variant|MODIFIER|CASC17|ENSG00000260785|Transcript|ENST00000569074|lincRNA||3/3||||||||||-1||HGNC|43911|YES||||||||||||||||||RNU7-155P&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1714449&18971253[ORegAnno]&RNU7-155P&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1738902&18971253[ORegAnno]|SOX9&Prostate_cancer&DE_00647[DisEnhancer]&SOX9&Prostate_cancer&DE_00493[DisEnhancer]&SOX9&Prostate_cancer&DE_00494[DisEnhancer]||
17	69108655	17_69108655_A/G	A	G	.	.	ANN=G|intron_variant&non_coding_transcript_variant|MODIFIER|CASC17|ENSG00000260785|Transcript|ENST00000569074|lincRNA||3/3||||||||rs1859961||-1||HGNC|43911|YES|||||0.0036|0.0121|0.0029|0|0|0|||||||||SOX9&Prostate_cancer&DE_00493[DisEnhancer]&SOX9&Prostate_cancer&DE_00494[DisEnhancer]||
17	69108753	17_69108753_T/G	T	G	.	.	ANN=G|intron_variant&non_coding_transcript_variant|MODIFIER|CASC17|ENSG00000260785|Transcript|ENST00000569074|lincRNA||3/3||||||||||-1||HGNC|43911|YES|||||||||||||||||||SOX9&Prostate_cancer&DE_00493[DisEnhancer]&SOX9&Prostate_cancer&DE_00494[DisEnhancer]||
17	69706044	17_69706044_A/C	A	C	.	.	ANN=C|intergenic_variant|MODIFIER|||||||||||||||rs573334886|||||||||||||||||||||||||SOX9&Pierre_robin_sequence&DE_00230[DisEnhancer]||
17	71006512	17_71006512_A/C	A	C	.	.	ANN=C|intron_variant|MODIFIER|SLC39A11|ENSG00000133195|Transcript|ENST00000542342|protein_coding||4/9||||||||rs11077654||-1||HGNC|14463|YES|||||0.6567|0.2451|0.7723|0.7817|0.8181|0.8364||||||||SLC39A11&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1262646&18971253[ORegAnno]&SLC39A11&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1587720&18971253[ORegAnno]&SLC39A11&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1646156&18971253[ORegAnno]|ZIP11&Bladder_cancer&DE_00432[DisEnhancer]||
17	71012473	17_71012473_G/C	G	C	.	.	ANN=C|intron_variant|MODIFIER|SLC39A11|ENSG00000133195|Transcript|ENST00000542342|protein_coding||4/9||||||||rs4969054||-1||HGNC|14463|YES|||||0.6532|0.2254|0.7723|0.7768|0.825|0.8425|||||||||ZIP11&Bladder_cancer&DE_00577[DisEnhancer]||
18	43187130	18_43187130_A/A	A	A	.	.	.
18	45446307	18_45446307_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|SMAD2|ENSG00000175387|Transcript|ENST00000402690|protein_coding||1/10||||||||||-1||HGNC|6768|YES||1|||||||||||||||||SMAD2&Pancreatic_cancer&DE_00576[DisEnhancer]||
18	46448805	18_46448805_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|SMAD7|ENSG00000101665|Transcript|ENST00000262158|protein_coding||3/3||||||||||-1||HGNC|6773|YES||1|||||||||||||||||SMAD7&Colorectal_cancer&DE_00586[DisEnhancer]||
18	46448819	18_46448819_G/C	G	C	.	.	ANN=C|intron_variant|MODIFIER|SMAD7|ENSG00000101665|Transcript|ENST00000262158|protein_coding||3/3||||||||||-1||HGNC|6773|YES||1|||||||||||||||||SMAD7&Colorectal_cancer&DE_00586[DisEnhancer]||
18	46449111	18_46449111_T/C	T	C	.	.	ANN=C|intron_variant|MODIFIER|SMAD7|ENSG00000101665|Transcript|ENST00000262158|protein_coding||3/3||||||||rs8085824||-1||HGNC|6773|YES||1|||0.3029|0.2216|0.3242|0.3046|0.4443|0.2505|||||||||SMAD7&Colorectal_cancer&DE_00586[DisEnhancer]|enhancer_chr18:46449093-46449527[Fantom_enhancer]|
18	46449565	18_46449565_C/G	C	G	.	.	ANN=G|intron_variant|MODIFIER|SMAD7|ENSG00000101665|Transcript|ENST00000262158|protein_coding||3/3||||||||rs58920878||-1||HGNC|6773|YES||1|||0.3251|0.2973|0.3285|0.3056|0.4493|0.2526||||||||SMAD7&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1240526&18971253[ORegAnno]|SMAD7&Colorectal_cancer&DE_00586[DisEnhancer]||
18	56085917	18_56085917_C/A	C	A	.	.	ANN=A|downstream_gene_variant|MODIFIER|RP11-1151B14.2|ENSG00000267675|Transcript|ENST00000585470|lincRNA|||||||||||1057|1||Clone_based_vega_gene||YES|||||||||||||||||||miR-122&Hepatocellular_carcinoma&DE_00558[DisEnhancer]||
19	10520064	19_10520064_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|CDC37|ENSG00000105401|Transcript|ENST00000593124|protein_coding||2/7||||||||rs8112449||-1|cds_end_NF|HGNC|1735||||||0.3758|0.3192|0.2277|0.5417|0.2992|0.4652|||1||||||TYK2/ICAM3&Multiple_sclerosis&DE_00649[DisEnhancer]||
19	13049218	19_13049218_C/T	C	T	.	.	ANN=T|upstream_gene_variant|MODIFIER|FARSA|ENSG00000179115|Transcript|ENST00000314606|protein_coding||||||||||rs556992558|4689|-1||HGNC|3592|YES|||||0.0002|0|0|0|0|0.001||||||||CALR&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1261373&18971253[ORegAnno]&CALR&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1230908&18971253[ORegAnno]&CALR&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1501004&18971253[ORegAnno]&CALR&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1794792&18971253[ORegAnno]&CALR&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1818070&18971253[ORegAnno]&CALR&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1783248&18971253[ORegAnno]&CALR&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1802549&18971253[ORegAnno]&CALR&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1179925&18971253[ORegAnno]&CALR&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1855847&18971253[ORegAnno]&CALR&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1619049&18971253[ORegAnno]|CALR&Schizoaffective_disorder&DE_00237[DisEnhancer]&CALR&Schizophrenia&DE_00238[DisEnhancer]||
19	13049375	19_13049375_G/C	G	C	.	.	ANN=C|upstream_gene_variant|MODIFIER|FARSA|ENSG00000179115|Transcript|ENST00000314606|protein_coding||||||||||rs993491729|4846|-1||HGNC|3592|YES||||||||||||||||||CALR&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1261373&18971253[ORegAnno]&CALR&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1230908&18971253[ORegAnno]&CALR&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1501004&18971253[ORegAnno]&CALR&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1794792&18971253[ORegAnno]&CALR&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1818070&18971253[ORegAnno]&CALR&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1783248&18971253[ORegAnno]&CALR&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1802549&18971253[ORegAnno]&CALR&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1179925&18971253[ORegAnno]&CALR&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1855847&18971253[ORegAnno]&CALR&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1619049&18971253[ORegAnno]|CALR&Schizoaffective_disorder&DE_00237[DisEnhancer]&CALR&Schizophrenia&DE_00238[DisEnhancer]||
19	19431963	19_19431963_G/T	G	T	.	.	ANN=T|intron_variant|MODIFIER|MAU2|ENSG00000129933|Transcript|ENST00000392313|protein_coding||1/18||||||||rs12460764||1||HGNC|29140|YES||||||0.3495|0.5432|0.6756|0.673|0.4744||||||||SUGP1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1816004&18971253[ORegAnno]&SUGP1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1781419&18971253[ORegAnno]|HAPLN4&Schizophrenia&DE_00455[DisEnhancer]||
19	19434350	19_19434350_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|MAU2|ENSG00000129933|Transcript|ENST00000392313|protein_coding||1/18||||||||rs7254230||1||HGNC|29140|YES|||||0.5312|0.348|0.5432|0.6756|0.674|0.4744|||||||||GATAD2A&Schizophrenia&DE_00621[DisEnhancer]||
19	30296853	19_30296853_T/C	T	C	.	.	ANN=C|regulatory_region_variant|MODIFIER|||RegulatoryFeature|ENSR00000381424|open_chromatin_region||||||||||rs8102137|||||||||||0.1573|0.0477|0.1729|0.1062|0.2893|0.2117|||1||||||CCNE1&Bladder_cancer&DE_00648[DisEnhancer]||
19	33356891	19_33356891_T/C	T	C	.	.	ANN=C|intron_variant|MODIFIER|SLC7A9|ENSG00000021488|Transcript|ENST00000023064|protein_coding||2/12||||||||rs12460876||-1||HGNC|11067|YES||1|||0.4235|0.27|0.3746|0.6389|0.4225|0.4448|||1|||||SLC7A9&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1943842&18971253[ORegAnno]|C19orf40/SLC7A10/CEBPG/GPATCH1/TDRD12/SLC7A9/ANKRD27/NUDT19/CCDC123/PDCD5&Chronic_kidney_disease&DE_01014[DisEnhancer]||
19	51773802	19_51773802_A/G	A	G	.	.	ANN=G|downstream_gene_variant|MODIFIER|SIGLECL1|ENSG00000179213|Transcript|ENST00000316401|protein_coding||||||||||rs1878047|1218|1||HGNC|26856|YES|||||0.4691|0.7829|0.5562|0.3601|0.3569|0.2106|||1||||||KLK14/SYT3/LRRC4B/IGLON5&Obesity&DE_00496[DisEnhancer]||
19	9945179	19_9945179_G/C	G	C	.	.	ANN=C|upstream_gene_variant|MODIFIER|PIN1|ENSG00000127445|Transcript|ENST00000247970|protein_coding||||||||||rs2233678|820|1||HGNC|8988|YES|||||0.1510|0.3162|0.0764|0.0377|0.1054|0.1442||||||||PIN1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1491883&18971253[ORegAnno]|PIN1&Alzheimers_disease&DE_00244[DisEnhancer]||
2	112753097	2_112753097_C/A	C	A	.	.	ANN=A|intron_variant|MODIFIER|MERTK|ENSG00000153208|Transcript|ENST00000295408|protein_coding||9/18||||||||||1||HGNC|7027|YES||1||||||||||||||||MERTK&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1723978&18971253[ORegAnno]&MERTK&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1747828&18971253[ORegAnno]|MERTK&Hepatocellular_carcinoma&DE_00604[DisEnhancer]||
2	113542960	2_113542960_T/C	T	C	.	.	ANN=C|upstream_gene_variant|MODIFIER|IL1A|ENSG00000115008|Transcript|ENST00000263339|protein_coding|||||||||||793|-1||HGNC|5991|YES|||||||||||||||||||IL-1A&Periodontal_diseases&DE_00491[DisEnhancer]||
2	113590390	2_113590390_C/T	C	T	.	.	ANN=T|synonymous_variant|LOW|IL1B|ENSG00000125538|Transcript|ENST00000263341|protein_coding|5/7||||526|315|105|L|ttG/ttA|||-1||HGNC|5992|YES|||||||||||||||||||IL-1B&Periodontal_diseases&DE_00435[DisEnhancer]||promoter_-_chr2:113590332-113590401[Fantom_promoter]
2	113978940	2_113978940_C/G	C	G	.	.	ANN=G|intron_variant|MODIFIER|PAX8|ENSG00000125618|Transcript|ENST00000429538|protein_coding||10/11||||||||rs11123170||-1||HGNC|8622|YES||1|||0.3626|0.2784|0.3674|0.3333|0.3936|0.4714|||1||||||PRPF40A&Chronic_kidney_disease&DE_01009[DisEnhancer]||
2	171678379	2_171678379_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|GAD1|ENSG00000128683|Transcript|ENST00000358196|protein_coding||2/16||||||||||1||HGNC|4092|YES||1||||||||||||||||GAD1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1248333&18971253[ORegAnno]|GAD1&Psychiatric_diseases&DE_00506[DisEnhancer]||
2	171690121	2_171690121_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|GAD1|ENSG00000128683|Transcript|ENST00000358196|protein_coding||5/16||||||||||1||HGNC|4092|YES||1|||||||||||||||||GAD1&Psychiatric_diseases&DE_00499[DisEnhancer]||
2	175629600	2_175629600_T/C	T	C	.	.	ANN=C|upstream_gene_variant|MODIFIER|CHRNA1|ENSG00000138435|Transcript|ENST00000261007|protein_coding||||||||||rs16862847|411|-1||HGNC|1955|YES||1|||0.1438|0.1861|0.072|0.0556|0.1252|0.2474|likely_benign||1|||||CHRNA1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1600052&18971253[ORegAnno]&CHRNA1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1658346&18971253[ORegAnno]|chrNA1&Myasthenia_gravis&DE_00253[DisEnhancer]||
2	200780737	2_200780737_T/C	T	C	.	.	ANN=C|intron_variant|MODIFIER|C2orf69|ENSG00000178074|Transcript|ENST00000319974|protein_coding||1/1||||||||rs35220450||1||HGNC|26799|YES|||||0.0779|0.0083|0.0735|0.0952|0.168|0.0644|||||||||TYW5&Schizophrenia&DE_00548[DisEnhancer]||
2	202204741	2_202204741_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|ALS2CR12|ENSG00000155749|Transcript|ENST00000405148|protein_coding||7/14||||||||||-1||HGNC|14439|YES|||||||||||||||||||CASP8&Breast_cancer&DE_00408[DisEnhancer]||
2	216532560	2_216532560_G/T	G	T	.	.	ANN=T|intron_variant&non_coding_transcript_variant|MODIFIER|LINC00607|ENSG00000235770|Transcript|ENST00000445174|lincRNA||5/9||||||||||-1||HGNC|43944|YES|||||||||||||||||||FN1&Breast_cancer&DE_00999[DisEnhancer]||
2	216532635	2_216532635_G/A	G	A	.	.	ANN=A|intron_variant&non_coding_transcript_variant|MODIFIER|LINC00607|ENSG00000235770|Transcript|ENST00000445174|lincRNA||5/9||||||||rs529830232||-1||HGNC|43944|YES|||||0.0002|0|0|0|0.001|0|||||||||FN1&Breast_cancer&DE_00999[DisEnhancer]||
2	216532985	2_216532985_A/T	A	T	.	.	ANN=T|intron_variant&non_coding_transcript_variant|MODIFIER|LINC00607|ENSG00000235770|Transcript|ENST00000445174|lincRNA||5/9||||||||||-1||HGNC|43944|YES|||||||||||||||||||FN1&Breast_cancer&DE_00999[DisEnhancer]||
2	216533394	2_216533394_G/A	G	A	.	.	ANN=A|intron_variant&non_coding_transcript_variant|MODIFIER|LINC00607|ENSG00000235770|Transcript|ENST00000445174|lincRNA||5/9||||||||||-1||HGNC|43944|YES|||||||||||||||||||FN1&Breast_cancer&DE_00999[DisEnhancer]||
2	217909463	2_217909463_G/A	G	A	.	.	ANN=A|intergenic_variant|MODIFIER|||||||||||||||rs6721996|||||||||||0.5663|0.3563|0.6556|0.9038|0.492|0.5153|||||||||IGFBP5&Breast_cancer&DE_00603[DisEnhancer]||
2	224466344	2_224466344_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|SCG2|ENSG00000171951|Transcript|ENST00000305409|protein_coding||1/1||||||||rs1017448||-1||HGNC|10575|YES|||||0.1214|0.3654|0.049|0.0367|0.0209|0.0337|||||||||SCG2&Hypertension&DE_00259[DisEnhancer]||
2	233743109	2_233743109_A/G	A	G	.	.	ANN=G|downstream_gene_variant|MODIFIER|NGEF|ENSG00000066248|Transcript|ENST00000264051|protein_coding||||||||||rs778371|287|-1||HGNC|7807|YES|||||0.2041|0.2171|0.3256|0.122|0.2952|0.091|||1||||||NGEF&Schizophrenia&DE_00635[DisEnhancer]||
2	27730940	2_27730940_T/T	T	T	.	.	.
2	30448344	2_30448344_T/G	T	G	.	.	ANN=G|regulatory_region_variant|MODIFIER|||RegulatoryFeature|ENSR00000114786|promoter_flanking_region||||||||||||||||||||||||||||||||||LBH&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1232587&18971253[ORegAnno]|LBH&Rheumatoid_arthritis&DE_00653[DisEnhancer]|enhancer_chr2:30448125-30448425[Fantom_enhancer]|
2	60718043	2_60718043_G/T	G	T	.	.	ANN=T|intron_variant|MODIFIER|BCL11A|ENSG00000119866|Transcript|ENST00000335712|protein_coding||2/3||||||||||-1||HGNC|13221|YES||1||||||||||||||||BCL11A&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1249584&18971253[ORegAnno]|BCL11A&Fetal_hemoglobin_level&DE_00473[DisEnhancer]&BCL11A&Hemoglobinopathies&DE_00474[DisEnhancer]||
2	60718043	2_60718043_G/T	G	T	.	.	ANN=T|intron_variant|MODIFIER|BCL11A|ENSG00000119866|Transcript|ENST00000335712|protein_coding||2/3||||||||||-1||HGNC|13221|YES||1||||||||||||||||BCL11A&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1249584&18971253[ORegAnno]|BCL11A&Fetal_hemoglobin_level&DE_00473[DisEnhancer]&BCL11A&Hemoglobinopathies&DE_00474[DisEnhancer]||
2	68647095	2_68647095_C/T	C	T	.	.	ANN=T|intergenic_variant|MODIFIER|||||||||||||||rs7595037|||||||||||0.6715|0.5129|0.6931|0.9038|0.5666|0.7393|||1||||||PLEK&Multiple_sclerosis&DE_00624[DisEnhancer]||
2	71079245	2_71079245_C/A	C	A	.	.	ANN=A|intergenic_variant|MODIFIER|||||||||||||||rs4852714|||||||||||0.7742|0.8623|0.8487|0.751|0.8002|0.5992||||||||CD207&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1239910&18971253[ORegAnno]|CD207&Atopic_dermatitis&DE_00573[DisEnhancer]||
2	73868328	2_73868328_A/G	A	G	.	.	ANN=G|missense_variant|MODERATE|NAT8|ENSG00000144035|Transcript|ENST00000272425|protein_coding|2/2||||578|428|143|F/S|tTt/tCt|rs13538||-1||HGNC|18069|YES|||tolerated|benign|0.2696|0.6172|0.2622|0.005|0.2097|0.1391|||1||||||CCDC142/SLC4A5/CCT7/STAMBP/FBXO41/ACTG2/NAT8B/DUSP11/NAT8/ALMS1/TPRKB/DGUOK/TET3/BOLA3/DCTN1/TTC31/MOBKL1B&Chronic_kidney_disease&DE_01019[DisEnhancer]||
2	8450123	2_8450123_A/G	A	G	.	.	ANN=G|intron_variant&non_coding_transcript_variant|MODIFIER|LINC00299|ENSG00000236790|Transcript|ENST00000442956|lincRNA||3/9||||||||rs367023||-1||HGNC|27940|YES|||||0.3588|0.531|0.3156|0.2817|0.3231|0.273|||1||||||ID2&Allergy&DE_01033[DisEnhancer]||
20	10016207	20_10016207_C/G	C	G	.	.	ANN=G|intron_variant|MODIFIER|ANKEF1|ENSG00000132623|Transcript|ENST00000378380|protein_coding||1/9||||||||rs6057110||1||HGNC|15803|YES|||||0.1647|0.2655|0.1398|0.0208|0.1918|0.1667|||||||||ANKEF1&Prostate_cancer&DE_00587[DisEnhancer]||
20	23612737	20_23612737_C/C	C	C	.	.	.
20	32605327	20_32605327_G/C	G	C	.	.	ANN=C|intron_variant|MODIFIER|RALY|ENSG00000125970|Transcript|ENST00000246194|protein_coding||1/9||||||||rs1054534||1||HGNC|15921|YES||||||0.1853|0.5605|0.7212|0.6412|0.7761|||||||||RALY&Breast_cancer&DE_00412[DisEnhancer]||
20	32610401	20_32610401_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|RALY|ENSG00000125970|Transcript|ENST00000246194|protein_coding||1/9||||||||||1||HGNC|15921|YES|||||||||||||||||||RALY&Breast_cancer&DE_00412[DisEnhancer]||
20	32648738	20_32648738_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|RALY|ENSG00000125970|Transcript|ENST00000246194|protein_coding||2/9||||||||||1||HGNC|15921|YES|||||||||||||||||||RALY&Breast_cancer&DE_00508[DisEnhancer]||
20	32649064	20_32649064_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|RALY|ENSG00000125970|Transcript|ENST00000246194|protein_coding||2/9||||||||||1||HGNC|15921|YES|||||||||||||||||||RALY&Breast_cancer&DE_00508[DisEnhancer]||
20	32654562	20_32654562_C/A	C	A	.	.	ANN=A|intron_variant|MODIFIER|RALY|ENSG00000125970|Transcript|ENST00000246194|protein_coding||2/9||||||||rs4911401||1||HGNC|15921|YES|||||0.7961|0.8684|0.6542|0.8304|0.7068|0.8558||||||||RALY&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1771581&18971253[ORegAnno]|RALY&Breast_cancer&DE_00508[DisEnhancer]||
20	32655741	20_32655741_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|RALY|ENSG00000125970|Transcript|ENST00000246194|protein_coding||2/9||||||||||1||HGNC|15921|YES|||||||||||||||||||RALY&Breast_cancer&DE_00508[DisEnhancer]||
20	32656841	20_32656841_C/G	C	G	.	.	ANN=G|intron_variant|MODIFIER|RALY|ENSG00000125970|Transcript|ENST00000246194|protein_coding||2/9||||||||rs2284389||1||HGNC|15921|YES|||||0.6595|0.3767|0.6037|0.8313|0.7068|0.8558|||||||||RALY&Breast_cancer&DE_00508[DisEnhancer]||
20	32657378	20_32657378_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|RALY|ENSG00000125970|Transcript|ENST00000246194|protein_coding||2/9||||||||rs932388||1||HGNC|15921|YES|||||0.5539|0.1853|0.5591|0.7302|0.6431|0.7751||||||||RALY&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1386452&18971253[ORegAnno]&RALY&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1245878&18971253[ORegAnno]&N/A&1&REGULATORY_REGION&POSITIVE_OUTCOME&OREG0025875&N/A[ORegAnno]|RALY&Breast_cancer&DE_00508[DisEnhancer]||
20	42568164	20_42568164_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|TOX2|ENSG00000124191|Transcript|ENST00000341197|protein_coding||1/8||||||||rs79645278||1||HGNC|16095|YES|||||0.1657|0.2065|0.2233|0.2569|0.0845|0.0593||||||||TOX2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1894201&18971253[ORegAnno]|TOX2&Major_depressive_disorder&DE_00644[DisEnhancer]||
20	42984276	20_42984276_C/T	C	T	.	.	ANN=T|downstream_gene_variant|MODIFIER|R3HDML|ENSG00000101074|Transcript|ENST00000217043|protein_coding|||||||||||4401|1||HGNC|16249|YES||||||||||||||||||HNF4A&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1719378&18971253[ORegAnno]|HNF4A&Type-2_diabetes&DE_00245[DisEnhancer]||
20	44740196	20_44740196_T/C	T	C	.	.	ANN=C|regulatory_region_variant|MODIFIER|||RegulatoryFeature|ENSR00000390442|CTCF_binding_site||||||||||||||||||||||||||||||||||CD40&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1489965&18971253[ORegAnno]|CD40&Celiac_disease&DE_00592[DisEnhancer]&CD40&Crohn_disease&DE_00589[DisEnhancer]&CD40&Lupus&DE_00591[DisEnhancer]&CD40&Multiple_sclerosis&DE_00588[DisEnhancer]&CD40&Rheumatoid_arthritis&DE_00590[DisEnhancer]&CD40&Ulcerative_colitis&DE_00593[DisEnhancer]||
20	44740196	20_44740196_T/C	T	C	.	.	ANN=C|regulatory_region_variant|MODIFIER|||RegulatoryFeature|ENSR00000390442|CTCF_binding_site||||||||||||||||||||||||||||||||||CD40&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1489965&18971253[ORegAnno]|CD40&Celiac_disease&DE_00592[DisEnhancer]&CD40&Crohn_disease&DE_00589[DisEnhancer]&CD40&Lupus&DE_00591[DisEnhancer]&CD40&Multiple_sclerosis&DE_00588[DisEnhancer]&CD40&Rheumatoid_arthritis&DE_00590[DisEnhancer]&CD40&Ulcerative_colitis&DE_00593[DisEnhancer]||
20	44740196	20_44740196_T/C	T	C	.	.	ANN=C|regulatory_region_variant|MODIFIER|||RegulatoryFeature|ENSR00000390442|CTCF_binding_site||||||||||||||||||||||||||||||||||CD40&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1489965&18971253[ORegAnno]|CD40&Celiac_disease&DE_00592[DisEnhancer]&CD40&Crohn_disease&DE_00589[DisEnhancer]&CD40&Lupus&DE_00591[DisEnhancer]&CD40&Multiple_sclerosis&DE_00588[DisEnhancer]&CD40&Rheumatoid_arthritis&DE_00590[DisEnhancer]&CD40&Ulcerative_colitis&DE_00593[DisEnhancer]||
20	44740196	20_44740196_T/C	T	C	.	.	ANN=C|regulatory_region_variant|MODIFIER|||RegulatoryFeature|ENSR00000390442|CTCF_binding_site||||||||||||||||||||||||||||||||||CD40&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1489965&18971253[ORegAnno]|CD40&Celiac_disease&DE_00592[DisEnhancer]&CD40&Crohn_disease&DE_00589[DisEnhancer]&CD40&Lupus&DE_00591[DisEnhancer]&CD40&Multiple_sclerosis&DE_00588[DisEnhancer]&CD40&Rheumatoid_arthritis&DE_00590[DisEnhancer]&CD40&Ulcerative_colitis&DE_00593[DisEnhancer]||
20	44740196	20_44740196_T/C	T	C	.	.	ANN=C|regulatory_region_variant|MODIFIER|||RegulatoryFeature|ENSR00000390442|CTCF_binding_site||||||||||||||||||||||||||||||||||CD40&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1489965&18971253[ORegAnno]|CD40&Celiac_disease&DE_00592[DisEnhancer]&CD40&Crohn_disease&DE_00589[DisEnhancer]&CD40&Lupus&DE_00591[DisEnhancer]&CD40&Multiple_sclerosis&DE_00588[DisEnhancer]&CD40&Rheumatoid_arthritis&DE_00590[DisEnhancer]&CD40&Ulcerative_colitis&DE_00593[DisEnhancer]||
20	44740196	20_44740196_T/C	T	C	.	.	ANN=C|regulatory_region_variant|MODIFIER|||RegulatoryFeature|ENSR00000390442|CTCF_binding_site||||||||||||||||||||||||||||||||||CD40&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1489965&18971253[ORegAnno]|CD40&Celiac_disease&DE_00592[DisEnhancer]&CD40&Crohn_disease&DE_00589[DisEnhancer]&CD40&Lupus&DE_00591[DisEnhancer]&CD40&Multiple_sclerosis&DE_00588[DisEnhancer]&CD40&Rheumatoid_arthritis&DE_00590[DisEnhancer]&CD40&Ulcerative_colitis&DE_00593[DisEnhancer]||
20	47905499	20_47905499_T/G	T	G	.	.	ANN=G|intron_variant&non_coding_transcript_variant|MODIFIER|ZFAS1|ENSG00000177410|Transcript|ENST00000450535|antisense||5/5||||||||||1||HGNC|33101|YES||||||||||||||||||ZFAS1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1270787&18971253[ORegAnno]&ZFAS1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1597033&18971253[ORegAnno]&ZFAS1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1655364&18971253[ORegAnno]&ZFAS1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1690056&18971253[ORegAnno]|ZFAS1&Hepatocellular_carcinoma&DE_00246[DisEnhancer]||
20	56942557	20_56942557_A/G	A	G	.	.	ANN=G|3_prime_UTR_variant|MODIFIER|RAB22A|ENSG00000124209|Transcript|ENST00000244040|protein_coding|7/7||||8664|||||rs6128327||1||HGNC|9764|YES|||||0.2959|0.3086|0.2089|0.254|0.4095|0.2669|||||||||RAB22A&Pancreatic_cancer&DE_00594[DisEnhancer]||
20	57469073	20_57469073_T/T	T	T	.	.	.
20	62116270	20_62116270_A/G	A	G	.	.	ANN=G|downstream_gene_variant|MODIFIER|EEF1A2|ENSG00000101210|Transcript|ENST00000217182|protein_coding|||||||||||3096|-1||HGNC|3192|YES||1|||||||||||||||||ARFGAP1&Breast_cancer&DE_00998[DisEnhancer]||
20	62116557	20_62116557_C/T	C	T	.	.	ANN=T|downstream_gene_variant|MODIFIER|EEF1A2|ENSG00000101210|Transcript|ENST00000217182|protein_coding|||||||||||2809|-1||HGNC|3192|YES||1|||||||||||||||||ARFGAP1&Breast_cancer&DE_00998[DisEnhancer]||
20	62116577	20_62116577_C/T	C	T	.	.	ANN=T|downstream_gene_variant|MODIFIER|EEF1A2|ENSG00000101210|Transcript|ENST00000217182|protein_coding|||||||||||2789|-1||HGNC|3192|YES||1|||||||||||||||||ARFGAP1&Breast_cancer&DE_00998[DisEnhancer]||
20	62116662	20_62116662_A/C	A	C	.	.	ANN=C|downstream_gene_variant|MODIFIER|EEF1A2|ENSG00000101210|Transcript|ENST00000217182|protein_coding|||||||||||2704|-1||HGNC|3192|YES||1|||||||||||||||||ARFGAP1&Breast_cancer&DE_00998[DisEnhancer]||
20	62116771	20_62116771_C/T	C	T	.	.	ANN=T|downstream_gene_variant|MODIFIER|EEF1A2|ENSG00000101210|Transcript|ENST00000217182|protein_coding|||||||||||2595|-1||HGNC|3192|YES||1||||||||||||||||N/A&-1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1136885&24194598[ORegAnno]|ARFGAP1&Breast_cancer&DE_00998[DisEnhancer]||
20	62116885	20_62116885_G/T	G	T	.	.	ANN=T|downstream_gene_variant|MODIFIER|EEF1A2|ENSG00000101210|Transcript|ENST00000217182|protein_coding|||||||||||2481|-1||HGNC|3192|YES||1|||||||||||||||||ARFGAP1&Breast_cancer&DE_00998[DisEnhancer]||
20	62117683	20_62117683_G/T	G	T	.	.	ANN=T|downstream_gene_variant|MODIFIER|EEF1A2|ENSG00000101210|Transcript|ENST00000217182|protein_coding|||||||||||1683|-1||HGNC|3192|YES||1||||||||||||||||EEF1A2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1501759&18971253[ORegAnno]|ARFGAP1&Breast_cancer&DE_00998[DisEnhancer]||
20	62117868	20_62117868_C/T	C	T	.	.	ANN=T|downstream_gene_variant|MODIFIER|EEF1A2|ENSG00000101210|Transcript|ENST00000217182|protein_coding||||||||||rs917396099|1498|-1||HGNC|3192|YES||1||||||||||||||||EEF1A2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1501759&18971253[ORegAnno]|ARFGAP1&Breast_cancer&DE_00998[DisEnhancer]||
20	62118212	20_62118212_C/T	C	T	.	.	ANN=T|downstream_gene_variant|MODIFIER|EEF1A2|ENSG00000101210|Transcript|ENST00000217182|protein_coding|||||||||||1154|-1||HGNC|3192|YES||1||||||||||||||||EEF1A2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1501759&18971253[ORegAnno]|ARFGAP1&Breast_cancer&DE_00998[DisEnhancer]||
20	62118213	20_62118213_C/T	C	T	.	.	ANN=T|downstream_gene_variant|MODIFIER|EEF1A2|ENSG00000101210|Transcript|ENST00000217182|protein_coding|||||||||||1153|-1||HGNC|3192|YES||1||||||||||||||||EEF1A2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1501759&18971253[ORegAnno]|ARFGAP1&Breast_cancer&DE_00998[DisEnhancer]||
20	62118250	20_62118250_C/T	C	T	.	.	ANN=T|downstream_gene_variant|MODIFIER|EEF1A2|ENSG00000101210|Transcript|ENST00000217182|protein_coding|||||||||||1116|-1||HGNC|3192|YES||1||||||||||||||||EEF1A2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1501759&18971253[ORegAnno]|ARFGAP1&Breast_cancer&DE_00998[DisEnhancer]||
20	62118282	20_62118282_A/G	A	G	.	.	ANN=G|downstream_gene_variant|MODIFIER|EEF1A2|ENSG00000101210|Transcript|ENST00000217182|protein_coding||||||||||rs973660050|1084|-1||HGNC|3192|YES||1||||||||||||||||EEF1A2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1501759&18971253[ORegAnno]|ARFGAP1&Breast_cancer&DE_00998[DisEnhancer]||
20	62118486	20_62118486_C/T	C	T	.	.	ANN=T|downstream_gene_variant|MODIFIER|EEF1A2|ENSG00000101210|Transcript|ENST00000217182|protein_coding||||||||||rs796810493|880|-1||HGNC|3192|YES||1||||||||||||||||EEF1A2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1501759&18971253[ORegAnno]|ARFGAP1&Breast_cancer&DE_00998[DisEnhancer]||
20	62119030	20_62119030_G/T	G	T	.	.	ANN=T|downstream_gene_variant|MODIFIER|EEF1A2|ENSG00000101210|Transcript|ENST00000217182|protein_coding|||||||||||336|-1||HGNC|3192|YES||1||||||||||||||||EEF1A2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1501759&18971253[ORegAnno]|ARFGAP1&Breast_cancer&DE_00998[DisEnhancer]||
20	62119047	20_62119047_C/A	C	A	.	.	ANN=A|downstream_gene_variant|MODIFIER|EEF1A2|ENSG00000101210|Transcript|ENST00000217182|protein_coding|||||||||||319|-1||HGNC|3192|YES||1||||||||||||||||EEF1A2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1501759&18971253[ORegAnno]|ARFGAP1&Breast_cancer&DE_00998[DisEnhancer]||
20	62594247	20_62594247_T/C	T	C	.	.	ANN=C|intron_variant|MODIFIER|ZNF512B|ENSG00000196700|Transcript|ENST00000450537|protein_coding||12/16||||||||||-1||HGNC|29212|YES||||||||||||||||||ZNF512B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1494527&18971253[ORegAnno]|ZNF512B&Amyotrophic_lateral_sclerosis&DE_00510[DisEnhancer]||
20	7106289	20_7106289_T/C	T	C	.	.	ANN=C|intron_variant&non_coding_transcript_variant|MODIFIER|RP4-764O22.1|ENSG00000232271|Transcript|ENST00000425900|lincRNA||1/1||||||||rs1884302||1||Clone_based_vega_gene||YES|||||0.4217|0.6551|0.3948|0.3899|0.328|0.2546|||1||||||BMP2&Sagittal_nonsyndromic_craniosynostosis&DE_01023[DisEnhancer]||
21	40283733	21_40283733_C/T	C	T	.	.	ANN=T|intron_variant&non_coding_transcript_variant|MODIFIER|AF064858.6|ENSG00000205622|Transcript|ENST00000380931|lincRNA||2/3||||||||rs9979250||-1||Clone_based_vega_gene||YES|||||0.0142|0.0045|0.0231|0|0.0398|0.0092|||1||||||ETS2&Periodontal_diseases&DE_00671[DisEnhancer]||
21	43796494	21_43796494_C/G	C	G	.	.	ANN=G|intron_variant|MODIFIER|TMPRSS3|ENSG00000160183|Transcript|ENST00000291532|protein_coding||11/12||||||||||-1||HGNC|11877|YES||1||||||||||||||||MX2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1196584&18971253[ORegAnno]&MX2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1663438&18971253[ORegAnno]&MX2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1605212&18971253[ORegAnno]&MX2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1520620&18971253[ORegAnno]&MX2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1540555&18971253[ORegAnno]&MX2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1685309&18971253[ORegAnno]&MX2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1531030&18971253[ORegAnno]|TFF1&Breast_cancer&DE_00536[DisEnhancer]&TFF1&Breast_cancer&DE_00428[DisEnhancer]||
21	43796913	21_43796913_A/T	A	T	.	.	ANN=T|intron_variant|MODIFIER|TMPRSS3|ENSG00000160183|Transcript|ENST00000291532|protein_coding||10/12||||||||||-1||HGNC|11877|YES||1||||||||||||||||MX2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1196584&18971253[ORegAnno]&MX2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1663438&18971253[ORegAnno]&MX2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1605212&18971253[ORegAnno]&N/A&1&REGULATORY_REGION&POSITIVE_OUTCOME&OREG0026238&N/A[ORegAnno]|TFF1&Breast_cancer&DE_00428[DisEnhancer]||
21	45615561	21_45615561_A/G	A	G	.	.	ANN=G|intergenic_variant|MODIFIER||||||||||||||||||||||||||||||||||||||||ICOSLG&Celiac_disease&DE_00628[DisEnhancer]&ICOSLG&Crohn_disease&DE_00630[DisEnhancer]&ICOSLG&Lupus&DE_00631[DisEnhancer]&ICOSLG&Multiple_sclerosis&DE_00629[DisEnhancer]&ICOSLG&Rheumatoid_arthritis&DE_00627[DisEnhancer]&ICOSLG&Ulcerative_colitis&DE_00626[DisEnhancer]||
21	45615561	21_45615561_A/G	A	G	.	.	ANN=G|intergenic_variant|MODIFIER||||||||||||||||||||||||||||||||||||||||ICOSLG&Celiac_disease&DE_00628[DisEnhancer]&ICOSLG&Crohn_disease&DE_00630[DisEnhancer]&ICOSLG&Lupus&DE_00631[DisEnhancer]&ICOSLG&Multiple_sclerosis&DE_00629[DisEnhancer]&ICOSLG&Rheumatoid_arthritis&DE_00627[DisEnhancer]&ICOSLG&Ulcerative_colitis&DE_00626[DisEnhancer]||
21	45615561	21_45615561_A/G	A	G	.	.	ANN=G|intergenic_variant|MODIFIER||||||||||||||||||||||||||||||||||||||||ICOSLG&Celiac_disease&DE_00628[DisEnhancer]&ICOSLG&Crohn_disease&DE_00630[DisEnhancer]&ICOSLG&Lupus&DE_00631[DisEnhancer]&ICOSLG&Multiple_sclerosis&DE_00629[DisEnhancer]&ICOSLG&Rheumatoid_arthritis&DE_00627[DisEnhancer]&ICOSLG&Ulcerative_colitis&DE_00626[DisEnhancer]||
21	45615561	21_45615561_A/G	A	G	.	.	ANN=G|intergenic_variant|MODIFIER||||||||||||||||||||||||||||||||||||||||ICOSLG&Celiac_disease&DE_00628[DisEnhancer]&ICOSLG&Crohn_disease&DE_00630[DisEnhancer]&ICOSLG&Lupus&DE_00631[DisEnhancer]&ICOSLG&Multiple_sclerosis&DE_00629[DisEnhancer]&ICOSLG&Rheumatoid_arthritis&DE_00627[DisEnhancer]&ICOSLG&Ulcerative_colitis&DE_00626[DisEnhancer]||
21	45615561	21_45615561_A/G	A	G	.	.	ANN=G|intergenic_variant|MODIFIER||||||||||||||||||||||||||||||||||||||||ICOSLG&Celiac_disease&DE_00628[DisEnhancer]&ICOSLG&Crohn_disease&DE_00630[DisEnhancer]&ICOSLG&Lupus&DE_00631[DisEnhancer]&ICOSLG&Multiple_sclerosis&DE_00629[DisEnhancer]&ICOSLG&Rheumatoid_arthritis&DE_00627[DisEnhancer]&ICOSLG&Ulcerative_colitis&DE_00626[DisEnhancer]||
21	45615561	21_45615561_A/G	A	G	.	.	ANN=G|intergenic_variant|MODIFIER||||||||||||||||||||||||||||||||||||||||ICOSLG&Celiac_disease&DE_00628[DisEnhancer]&ICOSLG&Crohn_disease&DE_00630[DisEnhancer]&ICOSLG&Lupus&DE_00631[DisEnhancer]&ICOSLG&Multiple_sclerosis&DE_00629[DisEnhancer]&ICOSLG&Rheumatoid_arthritis&DE_00627[DisEnhancer]&ICOSLG&Ulcerative_colitis&DE_00626[DisEnhancer]||
22	19743578	22_19743578_C/T	C	T	.	.	ANN=T|upstream_gene_variant|MODIFIER|TBX1|ENSG00000184058|Transcript|ENST00000332710|protein_coding|||||||||||648|1||HGNC|11592|YES||1||||||||||||||||TBX1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1946617&18971253[ORegAnno]&TBX1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1508368&18971253[ORegAnno]|TBX1&Ventricular_septal_defect&DE_00256[DisEnhancer]||
22	29196757	22_29196757_G/C	G	C	.	.	ANN=C|upstream_gene_variant|MODIFIER|XBP1|ENSG00000100219|Transcript|ENST00000216037|protein_coding||||||||||rs2269577|172|-1||HGNC|12801|YES||1|||0.5002|0.5764|0.3343|0.6528|0.2972|0.5665||||||||XBP1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1265558&18971253[ORegAnno]&XBP1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1820111&18971253[ORegAnno]&XBP1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1621387&18971253[ORegAnno]&XBP1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1791432&18971253[ORegAnno]&XBP1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1550271&18971253[ORegAnno]&XBP1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1804658&18971253[ORegAnno]&XBP1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1785093&18971253[ORegAnno]&XBP1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1720556&18971253[ORegAnno]&XBP1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1744618&18971253[ORegAnno]|CHEK2&Breast_cancer&DE_00260[DisEnhancer]&CHEK2&Breast_cancer&DE_00261[DisEnhancer]&XBP1&Bipolar_disorder&DE_00262[DisEnhancer]||
22	38412215	22_38412215_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|POLR2F|ENSG00000100142|Transcript|ENST00000407936|protein_coding||5/5||||||||rs606231342||1||HGNC|9193||||||||||||likely_pathogenic||1||||||SOX10&Hirschsprung_disease&DE_00264[DisEnhancer]||
22	38412323	22_38412323_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|POLR2F|ENSG00000100142|Transcript|ENST00000407936|protein_coding||5/5||||||||rs73886229||1||HGNC|9193||||||0.0096|0.0356|0|0|0.001|0|||||||||SOX10&Hirschsprung_disease&DE_00264[DisEnhancer]||
22	38412402	22_38412402_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|POLR2F|ENSG00000100142|Transcript|ENST00000407936|protein_coding||5/5||||||||rs73886230||1||HGNC|9193||||||0.0096|0.0356|0|0|0.001|0|||||||||SOX10&Hirschsprung_disease&DE_00264[DisEnhancer]||
22	38412423	22_38412423_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|POLR2F|ENSG00000100142|Transcript|ENST00000407936|protein_coding||5/5||||||||rs141110859||1||HGNC|9193||||||0.0072|0.0008|0.036|0.0079|0.001|0.001|||||||||SOX10&Hirschsprung_disease&DE_00264[DisEnhancer]||
22	38412781	22_38412781_G/C	G	C	.	.	ANN=C|intron_variant|MODIFIER|POLR2F|ENSG00000100142|Transcript|ENST00000407936|protein_coding||5/5||||||||rs533778281||1||HGNC|9193||||||0.0008|0|0|0|0.004|0|likely_pathogenic||1||||||SOX10&Hirschsprung_disease&DE_00264[DisEnhancer]||
22	39542292	22_39542292_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|CBX7|ENSG00000100307|Transcript|ENST00000216133|protein_coding||2/5||||||||rs877529||-1||HGNC|1557|YES|||||0.3654|0.4977|0.2334|0.2302|0.4384|0.3446|||1|||||CBX7&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1261588&18971253[ORegAnno]|CBX7&Multiple_myeloma&DE_00652[DisEnhancer]||
22	39542292	22_39542292_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|CBX7|ENSG00000100307|Transcript|ENST00000216133|protein_coding||2/5||||||||rs877529||-1||HGNC|1557|YES|||||0.3654|0.4977|0.2334|0.2302|0.4384|0.3446|||1|||||CBX7&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1261588&18971253[ORegAnno]|CBX7&Multiple_myeloma&DE_00652[DisEnhancer]||
22	40742514	22_40742514_T/C	T	C	.	.	ANN=C|5_prime_UTR_variant|MODIFIER|ADSL|ENSG00000239900|Transcript|ENST00000216194|protein_coding|1/13||||8|||||||1||HGNC|291|YES||1||||||||||||||||ADSL&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1255317&18971253[ORegAnno]&ADSL&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1883777&18971253[ORegAnno]&ADSL&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1173535&18971253[ORegAnno]&ADSL&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1814988&18971253[ORegAnno]&ADSL&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1799403&18971253[ORegAnno]&ADSL&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1712292&18971253[ORegAnno]&ADSL&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1545282&18971253[ORegAnno]&N/A&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG0155025&24194598[ORegAnno]&N/A&-1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG0632669&24194598[ORegAnno]|ADSL&Adenylosuccinate_lyase_deficiency&DE_00265[DisEnhancer]||promoter_+_chr22:40742512-40742543[Fantom_promoter]
22	45676678	22_45676678_A/G	A	G	.	.	ANN=G|upstream_gene_variant|MODIFIER|UPK3A|ENSG00000100373|Transcript|ENST00000216211|protein_coding||||||||||rs2742624|4185|1||HGNC|12580|YES||1|||0.4491|0.1445|0.5533|0.4653|0.6899|0.5225||||||||UPK3A&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1633760&18971253[ORegAnno]&UPK3A&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1575033&18971253[ORegAnno]&UPK3A&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1169932&18971253[ORegAnno]&UPK3A&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1702319&18971253[ORegAnno]&N/A&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG0115506&24194598[ORegAnno]|UPK3A&Prostate_cancer&DE_00531[DisEnhancer]||
3	115377646	3_115377646_G/T	G	T	.	.	ANN=T|intron_variant|MODIFIER|GAP43|ENSG00000172020|Transcript|ENST00000393780|protein_coding||1/3||||||||||1||HGNC|4140|YES||||||||||||||||||GAP43&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1795383&18971253[ORegAnno]&GAP43&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1811023&18971253[ORegAnno]&GAP43&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1776986&18971253[ORegAnno]&GAP43&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1790723&18971253[ORegAnno]|GAP43&Schizophrenia&DE_00266[DisEnhancer]||
3	121793187	3_121793187_C/A	C	A	.	.	ANN=A|intron_variant|MODIFIER|CD86|ENSG00000114013|Transcript|ENST00000330540|protein_coding||1/6||||||||rs4308217||1||HGNC|1705|YES|||||0.2029|0.0272|0.5029|0.1389|0.338|0.1544|||1||||||CD86&Multiple_sclerosis&DE_00557[DisEnhancer]||
3	123065778	3_123065778_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|ADCY5|ENSG00000173175|Transcript|ENST00000462833|protein_coding||3/20||||||||rs11708067||-1||HGNC|236|YES||1|||0.1504|0.1309|0.3127|0.004|0.171|0.1912|||1||||||ADCY5&Type-2_diabetes&DE_01010[DisEnhancer]||
3	123415781	3_123415781_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|MYLK|ENSG00000065534|Transcript|ENST00000360304|protein_coding||18/33||||||||||-1||HGNC|7590|YES||1||||||||||||||||MYLK&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1748040&18971253[ORegAnno]&MYLK&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1724194&18971253[ORegAnno]|MYLK&Asthma&DE_00650[DisEnhancer]||
3	128202154	3_128202154_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|GATA2|ENSG00000179348|Transcript|ENST00000341105|protein_coding||4/5||||||||||-1||HGNC|4171|YES||1||||||||||||||||GATA2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1271707&18971253[ORegAnno]&GATA2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1240533&18971253[ORegAnno]&GATA2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1190366&18971253[ORegAnno]&GATA2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1903207&18971253[ORegAnno]&GATA2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1676160&18971253[ORegAnno]&GATA2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1930022&18971253[ORegAnno]|GATA2&Monomac_syndrome&DE_00268[DisEnhancer]||
3	136801938	3_136801938_A/C	A	C	.	.	ANN=C|intergenic_variant|MODIFIER|||||||||||||||rs1866813|||||||||||0.1733|0.0908|0.2651|0.251|0.1501|0.1636|||||||||NCK1&Diabetic_nephropathy&DE_00495[DisEnhancer]||
3	141807137	3_141807137_C/C	C	C	.	.	.
3	169150632	3_169150632_T/C	T	C	.	.	ANN=C|intron_variant|MODIFIER|MECOM|ENSG00000085276|Transcript|ENST00000494292|protein_coding||1/15||||||||rs16853722||-1||HGNC|3498|||1|||0.1392|0.0272|0.0937|0.2956|0.1252|0.1759|||1||||||MECOM/MYNN/ARPM1&Chronic_kidney_disease&DE_01020[DisEnhancer]||
3	185513392	3_185513392_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|IGF2BP2|ENSG00000073792|Transcript|ENST00000382199|protein_coding||2/15||||||||rs7651090||-1||HGNC|28867|YES|||||0.4006|0.6104|0.2853|0.249|0.3042|0.454|||||||||IGF2BP2&Type-2_diabetes&DE_00598[DisEnhancer]||
3	185514393	3_185514393_T/C	T	C	.	.	ANN=C|intron_variant|MODIFIER|IGF2BP2|ENSG00000073792|Transcript|ENST00000382199|protein_coding||2/15||||||||rs6444081||-1||HGNC|28867|YES|||||0.4026|0.6172|0.2853|0.249|0.3042|0.455||||||||IGF2BP2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1660739&18971253[ORegAnno]&IGF2BP2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1602449&18971253[ORegAnno]&IGF2BP2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1627001&18971253[ORegAnno]|IGF2BP2&Type-2_diabetes&DE_00598[DisEnhancer]||
3	185514931	3_185514931_T/C	T	C	.	.	ANN=C|intron_variant|MODIFIER|IGF2BP2|ENSG00000073792|Transcript|ENST00000382199|protein_coding||2/15||||||||rs7646518||-1||HGNC|28867|YES|||||0.4028|0.618|0.2853|0.249|0.3042|0.455||||||||IGF2BP2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1660739&18971253[ORegAnno]&IGF2BP2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1602449&18971253[ORegAnno]|IGF2BP2&Type-2_diabetes&DE_00598[DisEnhancer]||
3	185515635	3_185515635_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|IGF2BP2|ENSG00000073792|Transcript|ENST00000382199|protein_coding||2/15||||||||rs7637773||-1||HGNC|28867|YES|||||0.4028|0.618|0.2853|0.249|0.3042|0.455|||||||||IGF2BP2&Type-2_diabetes&DE_00598[DisEnhancer]||
3	24204984	3_24204984_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|THRB|ENSG00000151090|Transcript|ENST00000396671|protein_coding||5/10||||||||rs2596623||-1||HGNC|11799|YES||1|||0.4125|0.5371|0.4395|0.3869|0.3171|0.3497|||||||||THRB&The_syndrome_of_resistance_to_thyroid_hormone&DE_00521[DisEnhancer]||
3	27548900	3_27548900_C/T	C	T	.	.	ANN=T|intergenic_variant|MODIFIER||||||||||||||||||||||||||||||||||||||||SLC4A7&Hypertension&DE_00651[DisEnhancer]||
3	37034946	3_37034946_G/A	G	A	.	.	ANN=A|5_prime_UTR_variant|MODIFIER|MLH1|ENSG00000076242|Transcript|ENST00000231790|protein_coding|1/19||||124|||||rs1800734||1||HGNC|7127|YES||1|||0.3205|0.1528|0.2968|0.5476|0.2654|0.3865|benign||1|||||EPM2AIP1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1247603&18971253[ORegAnno]&EPM2AIP1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1610944&18971253[ORegAnno]&EPM2AIP1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1811151&18971253[ORegAnno]&EPM2AIP1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1790806&18971253[ORegAnno]&EPM2AIP1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1217723&18971253[ORegAnno]&EPM2AIP1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1860733&18971253[ORegAnno]&EPM2AIP1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1844466&18971253[ORegAnno]&EPM2AIP1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1279333&18971253[ORegAnno]&EPM2AIP1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1839860&18971253[ORegAnno]&EPM2AIP1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1795513&18971253[ORegAnno]&MLH1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1555221&18971253[ORegAnno]&MLH1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1789809&18971253[ORegAnno]&MLH1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1855741&18971253[ORegAnno]|MLH1/DCLK3&Colorectal_cancer&DE_00307[DisEnhancer]||
3	37035012	3_37035012_C/A	C	A	.	.	ANN=A|5_prime_UTR_variant|MODIFIER|MLH1|ENSG00000076242|Transcript|ENST00000231790|protein_coding|1/19||||190|||||rs587779001||1||HGNC|7127|YES||1|||||||||uncertain_significance&pathogenic||1|||||EPM2AIP1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1247603&18971253[ORegAnno]&EPM2AIP1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1610944&18971253[ORegAnno]&EPM2AIP1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1811151&18971253[ORegAnno]&EPM2AIP1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1790806&18971253[ORegAnno]&EPM2AIP1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1217723&18971253[ORegAnno]&EPM2AIP1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1860733&18971253[ORegAnno]&EPM2AIP1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1844466&18971253[ORegAnno]&EPM2AIP1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1279333&18971253[ORegAnno]&EPM2AIP1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1839860&18971253[ORegAnno]&EPM2AIP1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1795513&18971253[ORegAnno]&MLH1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1555221&18971253[ORegAnno]&MLH1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1789809&18971253[ORegAnno]&MLH1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1855741&18971253[ORegAnno]&N/A&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG0698888&24194598[ORegAnno]|MLH1/DCLK3&Colorectal_cancer&DE_00307[DisEnhancer]||promoter_+_chr3:37034966-37035041[Fantom_promoter]
3	46410171	3_46410171_C/T	C	T	.	.	ANN=T|upstream_gene_variant|MODIFIER|CCR5|ENSG00000160791|Transcript|ENST00000343801|protein_coding||||||||||rs553615728|1462|1||HGNC|1606|YES||1||||||||||||||||CCR2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1220151&18971253[ORegAnno]&CCR2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1341057&18971253[ORegAnno]|CCR5&Hiv&DE_00580[DisEnhancer]|enhancer_chr3:46410114-46410344[Fantom_enhancer]|
3	52742537	3_52742537_A/T	A	T	.	.	ANN=T|upstream_gene_variant|MODIFIER|GLT8D1|ENSG00000016864|Transcript|ENST00000407584|protein_coding||||||||||rs12486554|2489|-1||HGNC|24870|YES|||||0.3608|0.2784|0.4899|0.4256|0.4264|0.2464|||||||||GNL3&Schizophrenia&DE_00456[DisEnhancer]||
3	52804487	3_52804487_T/C	T	C	.	.	ANN=C|intron_variant|MODIFIER|NEK4|ENSG00000114904|Transcript|ENST00000233027|protein_coding||1/15||||||||rs13071584||-1||HGNC|11399|YES|||||0.4309|0.4644|0.5|0.4266|0.4294|0.3425|||||||||SPCS1&Schizophrenia&DE_00462[DisEnhancer]||
3	66798950	3_66798950_C/G	C	G	.	.	ANN=G|intergenic_variant|MODIFIER|||||||||||||||rs13069000|||||||||||0.1304|0.09|0.1326|0.1964|0.1839|0.0603|||1||||||LRIG1&Chronic_kidney_disease&DE_01017[DisEnhancer]||
4	100078751	4_100078751_T/G	T	G	.	.	ANN=G|intron_variant&non_coding_transcript_variant|MODIFIER|RP11-696N14.1|ENSG00000246090|Transcript|ENST00000500358|antisense||3/9||||||||||1||Clone_based_vega_gene||YES||||||||||||||||||ADH4&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1640917&18971253[ORegAnno]&ADH4&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1582363&18971253[ORegAnno]&ADH4&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1738908&18971253[ORegAnno]&ADH4&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1714454&18971253[ORegAnno]&ADH4&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1289246&18971253[ORegAnno]|ADH4&Alcoholism&DE_00633[DisEnhancer]||
4	100078890	4_100078890_G/T	G	T	.	.	ANN=T|intron_variant&non_coding_transcript_variant|MODIFIER|RP11-696N14.1|ENSG00000246090|Transcript|ENST00000500358|antisense||3/9||||||||||1||Clone_based_vega_gene||YES||||||||||||||||||ADH4&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1640917&18971253[ORegAnno]&ADH4&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1582363&18971253[ORegAnno]&ADH4&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1738908&18971253[ORegAnno]&ADH4&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1714454&18971253[ORegAnno]&ADH4&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1289246&18971253[ORegAnno]|ADH4&Alcoholism&DE_00633[DisEnhancer]||
4	111710169	4_111710169_C/T	C	T	.	.	ANN=T|intergenic_variant|MODIFIER|||||||||||||||rs2200733|||||||||||0.2470|0.2315|0.2767|0.4514|0.1551|0.1309|||1||||||PITX2&Atrial_fibrillation&DE_00503[DisEnhancer]||
4	145487934	4_145487934_G/A	G	A	.	.	ANN=A|intergenic_variant|MODIFIER||||||||||||||||||||||||||||||||||||||||HHIP&Chronic_obstructive_pulmonary_disease&DE_00601[DisEnhancer]&HHIP&Chronic_obstructive_pulmonary_disease&DE_00480[DisEnhancer]||
4	145488334	4_145488334_T/C	T	C	.	.	ANN=C|intergenic_variant|MODIFIER||||||||||||||||||||||||||||||||||||||||HHIP&Chronic_obstructive_pulmonary_disease&DE_00601[DisEnhancer]&HHIP&Chronic_obstructive_pulmonary_disease&DE_00480[DisEnhancer]||
4	185569801	4_185569801_T/G	T	G	.	.	ANN=G|intron_variant|MODIFIER|CASP3|ENSG00000164305|Transcript|ENST00000308394|protein_coding||1/7||||||||||-1||HGNC|1504|YES||||||||||||||||||PRIMPOL&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1256214&18971253[ORegAnno]&PRIMPOL&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1174591&18971253[ORegAnno]|CASP3&Esophageal_carcinoma&DE_00311[DisEnhancer]||
4	26085480	4_26085480_A/G	A	G	.	.	ANN=G|intergenic_variant|MODIFIER|||||||||||||||rs34185821|||||||||||0.1859|0.2837|0.2061|0.003|0.3022|0.1084|||||||||RBPJ&Type-1_diabetes&DE_01031[DisEnhancer]||
4	62861941	4_62861941_G/C	G	C	.	.	ANN=C|intron_variant|MODIFIER|LPHN3|ENSG00000150471|Transcript|ENST00000514591|protein_coding||18/24||||||||rs17226398||1||HGNC|20974|YES|||||0.2470|0.2254|0.2248|0.3393|0.2276|0.2168|||||||||ADGRL3&Attention-deficit/hyperactivity_disorder&DE_00486[DisEnhancer]&ADGRL3&Attention-deficit/hyperactivity_disorder&DE_00582[DisEnhancer]&ADGRL3&Attention-deficit/hyperactivity_disorder&DE_00509[DisEnhancer]||
4	62861964	4_62861964_A/T	A	T	.	.	ANN=T|intron_variant|MODIFIER|LPHN3|ENSG00000150471|Transcript|ENST00000514591|protein_coding||18/24||||||||rs56038622||1||HGNC|20974|YES|||||0.2426|0.2088|0.2248|0.3393|0.2276|0.2168|||||||||ADGRL3&Attention-deficit/hyperactivity_disorder&DE_00486[DisEnhancer]&ADGRL3&Attention-deficit/hyperactivity_disorder&DE_00582[DisEnhancer]&ADGRL3&Attention-deficit/hyperactivity_disorder&DE_00509[DisEnhancer]||
4	62862251	4_62862251_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|LPHN3|ENSG00000150471|Transcript|ENST00000514591|protein_coding||19/24||||||||rs2271338||1||HGNC|20974|YES|||||0.2676|0.2988|0.2262|0.3393|0.2266|0.2229|||||||||ADGRL3&Attention-deficit/hyperactivity_disorder&DE_00486[DisEnhancer]&ADGRL3&Attention-deficit/hyperactivity_disorder&DE_00582[DisEnhancer]&ADGRL3&Attention-deficit/hyperactivity_disorder&DE_00509[DisEnhancer]||
4	6299387	4_6299387_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|WFS1|ENSG00000109501|Transcript|ENST00000226760|protein_coding||7/7||||||||rs4689397||1||HGNC|12762|YES||1||||0.466|0.6758|0.9038|0.6203|0.6339|||||||||WFS1&Type-2_diabetes&DE_00552[DisEnhancer]||
4	6299940	4_6299940_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|WFS1|ENSG00000109501|Transcript|ENST00000226760|protein_coding||7/7||||||||rs3821943||1||HGNC|12762|YES||1|||0.5619|0.3442|0.5836|0.8145|0.5656|0.5767|||||||||WFS1&Type-2_diabetes&DE_00552[DisEnhancer]||
4	74301817	4_74301817_G/A	G	A	.	.	ANN=A|upstream_gene_variant|MODIFIER|AFP|ENSG00000081051|Transcript|ENST00000395792|protein_coding||||||||||rs587776861|63|1||HGNC|317|YES||1|||||||||||1|||||AFP&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1165236&18971253[ORegAnno]|AFP&Hereditary_persistence_of_foetal_haemoglobin&DE_00312[DisEnhancer]||
4	77368847	4_77368847_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|SHROOM3|ENSG00000138771|Transcript|ENST00000296043|protein_coding||1/10||||||||rs17319721||1||HGNC|30422|YES||1|||0.2238|0.1861|0.3545|0.0893|0.4115|0.1278|||1||||||CCNI/NUP54/STBD1/SDAD1/CXCL10/CCNG2/SCARB2/SHROOM3/CXCL9&Chronic_kidney_disease&DE_01021[DisEnhancer]||
4	77412140	4_77412140_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|SHROOM3|ENSG00000138771|Transcript|ENST00000296043|protein_coding||1/10||||||||rs13146355||1||HGNC|30422|YES||1|||0.2276|0.0908|0.3487|0.2034|0.4324|0.1411|||1||||||CCNI/SCARB2/STBD1/CCNG2/NUP54/SHROOM3/CXCL10/SDAD1/CXCL9&Chronic_kidney_disease&DE_01018[DisEnhancer]||
4	88924371	4_88924371_A/G	A	G	.	.	ANN=G|upstream_gene_variant|MODIFIER|PKD2|ENSG00000118762|Transcript|ENST00000237596|protein_coding||||||||||rs12508471|4449|1||HGNC|9009|YES||1|||0.2119|0.2042|0.1455|0.4018|0.0805|0.2086|||||||||ABCG2&Breast_cancer&DE_01015[DisEnhancer]||
4	88959922	4_88959922_G/C	G	C	.	.	ANN=C|intron_variant|MODIFIER|PKD2|ENSG00000118762|Transcript|ENST00000237596|protein_coding||4/14||||||||rs2725220||1||HGNC|9009|YES||1|||0.4914|0.8011|0.3948|0.2411|0.4861|0.4049|||1||||||HERC5/PIGY/ABCG2/PPM1K/SPARCL1/HERC6/PKD2&Chronic_kidney_disease&DE_01030[DisEnhancer]||
4	89073197	4_89073197_A/C	A	C	.	.	ANN=C|intron_variant|MODIFIER|ABCG2|ENSG00000118777|Transcript|ENST00000237612|protein_coding||1/15||||||||rs9999111||-1||HGNC|74|YES||1|||0.0463|0.059|0.0389|0|0.0775|0.0501|||||||||ABCG2&Breast_cancer&DE_01059[DisEnhancer]||
4	90674431	4_90674431_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|SNCA|ENSG00000145335|Transcript|ENST00000394986|protein_coding||4/5||||||||rs356168||-1||HGNC|11138|YES||1|||0.3936|0.1755|0.487|0.4117|0.5169|0.4765||||||||SNCA&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1898074&18971253[ORegAnno]&SNCA&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1593207&18971253[ORegAnno]|SNCA&Parkinson_disease&DE_00549[DisEnhancer]||
4	9995182	4_9995182_G/G	G	G	.	.	.
5	110176128	5_110176128_G/T	G	T	.	.	ANN=T|intergenic_variant|MODIFIER|||||||||||||||rs9885413|||||||||||0.2442|0.4849|0.1239|0.1736|0.0805|0.2454|||1||||||TSLP&Heart_failure&DE_00665[DisEnhancer]||
5	1286516	5_1286516_A/C	A	C	.	.	ANN=C|intron_variant|MODIFIER|TERT|ENSG00000164362|Transcript|ENST00000310581|protein_coding||2/15||||||||||-1||HGNC|11730|YES||1|||||||||||||||||TERT&Lung_cancer&DE_00524[DisEnhancer]&TERT&Papillary_thyroid_carcinoma&DE_00523[DisEnhancer]&TERT&Lung_cancer&DE_00537[DisEnhancer]||
5	1286516	5_1286516_T/G	T	G	.	.	ANN=G|intron_variant|MODIFIER|TERT|ENSG00000164362|Transcript|ENST00000310581|protein_coding||2/15||||||||||-1||HGNC|11730|YES||1|||||||||||||||||TERT&Lung_cancer&DE_00524[DisEnhancer]&TERT&Papillary_thyroid_carcinoma&DE_00523[DisEnhancer]&TERT&Lung_cancer&DE_00537[DisEnhancer]||
5	1287194	5_1287194_T/C	T	C	.	.	ANN=C|intron_variant|MODIFIER|TERT|ENSG00000164362|Transcript|ENST00000310581|protein_coding||2/15||||||||||-1||HGNC|11730|YES||1|||||||||||||||||TERT&Lung_cancer&DE_00524[DisEnhancer]&TERT&Papillary_thyroid_carcinoma&DE_00523[DisEnhancer]&TERT&Lung_cancer&DE_00537[DisEnhancer]||
5	132009154	5_132009154_C/T	C	T	.	.	ANN=T|upstream_gene_variant|MODIFIER|IL4|ENSG00000113520|Transcript|ENST00000231449|protein_coding||||||||||rs2243250|524|1||HGNC|6014|YES||1|||0.4698|0.73|0.366|0.7788|0.168|0.184||||||||IL4&1&REGULATORY_REGION&POSITIVE_OUTCOME&OREG0003465&12566409[ORegAnno]|IL4&Bronchial_asthma&DE_00320[DisEnhancer]||
5	1326501	5_1326501_T/C	T	C	.	.	ANN=C|intron_variant|MODIFIER|CLPTM1L|ENSG00000049656|Transcript|ENST00000320895|protein_coding||9/16||||||||||-1||HGNC|24308|YES||||||||||||||||||CLPTM1L&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1929089&18971253[ORegAnno]|TERT&Neuroblastoma&DE_00322[DisEnhancer]&CLPTM1L&Breast_cancer&DE_01000[DisEnhancer]||
5	1326505	5_1326505_C/G	C	G	.	.	ANN=G|intron_variant|MODIFIER|CLPTM1L|ENSG00000049656|Transcript|ENST00000320895|protein_coding||9/16||||||||||-1||HGNC|24308|YES||||||||||||||||||CLPTM1L&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1929089&18971253[ORegAnno]|TERT&Neuroblastoma&DE_00322[DisEnhancer]&CLPTM1L&Breast_cancer&DE_01000[DisEnhancer]||
5	1326904	5_1326904_G/C	G	C	.	.	ANN=C|intron_variant|MODIFIER|CLPTM1L|ENSG00000049656|Transcript|ENST00000320895|protein_coding||9/16||||||||||-1||HGNC|24308|YES||||||||||||||||||CLPTM1L&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1929089&18971253[ORegAnno]|TERT&Neuroblastoma&DE_00322[DisEnhancer]&CLPTM1L&Breast_cancer&DE_01000[DisEnhancer]||
5	1326988	5_1326988_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|CLPTM1L|ENSG00000049656|Transcript|ENST00000320895|protein_coding||9/16||||||||||-1||HGNC|24308|YES||||||||||||||||||CLPTM1L&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1929089&18971253[ORegAnno]|TERT&Neuroblastoma&DE_00322[DisEnhancer]&CLPTM1L&Breast_cancer&DE_01000[DisEnhancer]||
5	1327062	5_1327062_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|CLPTM1L|ENSG00000049656|Transcript|ENST00000320895|protein_coding||9/16||||||||||-1||HGNC|24308|YES||||||||||||||||||CLPTM1L&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1929089&18971253[ORegAnno]|TERT&Neuroblastoma&DE_00322[DisEnhancer]&CLPTM1L&Breast_cancer&DE_01000[DisEnhancer]||
5	1327333	5_1327333_T/G	T	G	.	.	ANN=G|intron_variant|MODIFIER|CLPTM1L|ENSG00000049656|Transcript|ENST00000320895|protein_coding||9/16||||||||rs75471300||-1||HGNC|24308|YES||||||||||||||||||CLPTM1L&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1929089&18971253[ORegAnno]|TERT&Neuroblastoma&DE_00322[DisEnhancer]&CLPTM1L&Breast_cancer&DE_01000[DisEnhancer]||
5	1327445	5_1327445_C/G	C	G	.	.	ANN=G|intron_variant|MODIFIER|CLPTM1L|ENSG00000049656|Transcript|ENST00000320895|protein_coding||9/16||||||||||-1||HGNC|24308|YES||||||||||||||||||CLPTM1L&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1929089&18971253[ORegAnno]|TERT&Neuroblastoma&DE_00322[DisEnhancer]&CLPTM1L&Breast_cancer&DE_01000[DisEnhancer]||
5	1327544	5_1327544_T/C	T	C	.	.	ANN=C|intron_variant|MODIFIER|CLPTM1L|ENSG00000049656|Transcript|ENST00000320895|protein_coding||9/16||||||||||-1||HGNC|24308|YES||||||||||||||||||CLPTM1L&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1929089&18971253[ORegAnno]|TERT&Neuroblastoma&DE_00322[DisEnhancer]&CLPTM1L&Breast_cancer&DE_01000[DisEnhancer]||
5	1327722	5_1327722_T/C	T	C	.	.	ANN=C|intron_variant|MODIFIER|CLPTM1L|ENSG00000049656|Transcript|ENST00000320895|protein_coding||9/16||||||||rs372823651||-1||HGNC|24308|YES||||||||||||||||||CLPTM1L&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1929089&18971253[ORegAnno]|TERT&Neuroblastoma&DE_00322[DisEnhancer]&CLPTM1L&Breast_cancer&DE_01000[DisEnhancer]||
5	141014494	5_141014494_A/G	A	G	.	.	ANN=G|synonymous_variant|LOW|HDAC3|ENSG00000171720|Transcript|ENST00000305264|protein_coding|3/15||||245|165|55|H|caT/caC|||-1||HGNC|4854|YES|||||||||||||||||||DIAPH1&Psychiatric_diseases&DE_00517[DisEnhancer]||
5	147211221	5_147211221_G/A	G	A	.	.	ANN=A|5_prime_UTR_variant|MODIFIER|SPINK1|ENSG00000164266|Transcript|ENST00000296695|protein_coding|1/4||||129|||||||-1||HGNC|11244|YES||1|||||||||||||||||SPINK1&Pancreatitis&DE_00325[DisEnhancer]||promoter_-_chr5:147211220-147211225[Fantom_promoter]
5	147211355	5_147211355_C/T	C	T	.	.	ANN=T|upstream_gene_variant|MODIFIER|SPINK1|ENSG00000164266|Transcript|ENST00000296695|protein_coding||||||||||rs191068215|6|-1||HGNC|11244|YES||1|||0.0008|0|0.0014|0.003|0|0|uncertain_significance||1||||||SPINK1&Pancreatitis&DE_00325[DisEnhancer]||
5	147258162	5_147258162_G/A	G	A	.	.	ANN=A|upstream_gene_variant|MODIFIER|SCGB3A2|ENSG00000164265|Transcript|ENST00000296694|protein_coding||||||||||rs1368408|112|1||HGNC|18391|YES|||||0.2376|0.3396|0.3357|0.2153|0.1421|0.1513|||||||||SCGB3A2&Asthma&DE_00326[DisEnhancer]||
5	156607793	5_156607793_C/T	C	T	.	.	ANN=T|upstream_gene_variant|MODIFIER|ITK|ENSG00000113263|Transcript|ENST00000422843|protein_coding||||||||||rs146866105|44|1||HGNC|6171|YES||1|||0.0042|0|0|0.0188|0|0.002||||||||ITK&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1549670&18971253[ORegAnno]|ITK&Asthma&DE_00327[DisEnhancer]||
5	158759900	5_158759900_A/G	A	G	.	.	ANN=G|upstream_gene_variant|MODIFIER|IL12B|ENSG00000113302|Transcript|ENST00000231228|protein_coding||||||||||rs2546890|2005|-1||HGNC|5970|YES||1|||0.5597|0.6505|0.5879|0.5913|0.5089|0.4366|||1||||||IL12B&Multiple_sclerosis&DE_00519[DisEnhancer]||
5	175109219	5_175109219_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|HRH2|ENSG00000113749|Transcript|ENST00000377291|protein_coding||1/2||||||||||1||HGNC|5183|YES|||||||||||||||||||HRH2&Gastric_cancer&DE_00500[DisEnhancer]||
5	176817636	5_176817636_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|SLC34A1|ENSG00000131183|Transcript|ENST00000324417|protein_coding||8/12||||||||rs6420094||1||HGNC|11019|YES||1|||0.2562|0.1853|0.2795|0.2133|0.332|0.3016|||1|||||N/A&N/A&REGULATORY_REGION&N/A&OREG0070936&17130149[ORegAnno]&N/A&1&REGULATORY_REGION&POSITIVE_OUTCOME&OREG0017087&N/A[ORegAnno]&SLC34A1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1404732&18971253[ORegAnno]&SLC34A1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1358786&18971253[ORegAnno]&SLC34A1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1241136&18971253[ORegAnno]&SLC34A1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1553259&18971253[ORegAnno]|NSD1/MXD3/LMAN2/RAB24/PRELID1/GRK6/PRR7/RGS14/F12/DOK3/DDX41/FAM193B/UIMC1/FGFR4/SLC34A1/TMED9/B4GALT7/PDLIM7/DBN1&Chronic_kidney_disease&DE_01042[DisEnhancer]||
5	177422391	5_177422391_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|PROP1|ENSG00000175325|Transcript|ENST00000308304|protein_coding||1/2||||||||||-1||HGNC|9455|YES||1|||||||||||||||||PROP1&Combined_pituitary_hormone_deficiency&DE_00479[DisEnhancer]||
5	25967703	5_25967703_C/T	C	T	.	.	ANN=T|intergenic_variant|MODIFIER||||||||||||||||||||||||||||||||||||||||MSNP1AS&Autism_spectrum_disorder&DE_00556[DisEnhancer]||
5	44706498	5_44706498_A/G	A	G	.	.	ANN=G|intergenic_variant|MODIFIER|||||||||||||||rs10941679|||||||||||0.3161|0.1823|0.3862|0.4871|0.2326|0.3569|||1|||||MRPS30&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1572369&18971253[ORegAnno]|MRPS30/FGF10&Breast_cancer&DE_00430[DisEnhancer]||
5	44706498	5_44706498_A/G	A	G	.	.	ANN=G|intergenic_variant|MODIFIER|||||||||||||||rs10941679|||||||||||0.3161|0.1823|0.3862|0.4871|0.2326|0.3569|||1|||||MRPS30&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1572369&18971253[ORegAnno]|MRPS30/FGF10&Breast_cancer&DE_00430[DisEnhancer]||
5	56034207	5_56034207_A/G	A	G	.	.	ANN=G|regulatory_region_variant|MODIFIER|||RegulatoryFeature|ENSR00000180950|open_chromatin_region||||||||||rs4700485|||||||||||0.6414|0.7648|0.598|0.4643|0.7187|0.6084|||1||||||C5orf35&Breast_cancer&DE_00564[DisEnhancer]||
5	95261538	5_95261538_G/C	G	C	.	.	ANN=C|intron_variant|MODIFIER|ELL2|ENSG00000118985|Transcript|ENST00000237853|protein_coding||2/11||||||||||-1||HGNC|17064|YES||||||||||||||||||ELL2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1259110&18971253[ORegAnno]|ELL2&Multiple_myeloma&DE_01045[DisEnhancer]||
5	96273298	5_96273298_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|LNPEP|ENSG00000113441|Transcript|ENST00000231368|protein_coding||1/17||||||||||1||HGNC|6656|YES||||||||||||||||||LNPEP&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1257110&18971253[ORegAnno]|ERAP2&Autoimmune_disease&DE_00532[DisEnhancer]||
6	117210052	6_117210052_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|RFX6|ENSG00000185002|Transcript|ENST00000332958|protein_coding||4/18||||||||||1||HGNC|21478|YES||1||||||||||||||||RFX6&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1580857&18971253[ORegAnno]&RFX6&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1639461&18971253[ORegAnno]|RFX6&Prostate_cancer&DE_00547[DisEnhancer]||
6	117210052	6_117210052_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|RFX6|ENSG00000185002|Transcript|ENST00000332958|protein_coding||4/18||||||||||1||HGNC|21478|YES||1||||||||||||||||RFX6&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1580857&18971253[ORegAnno]&RFX6&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1639461&18971253[ORegAnno]|RFX6&Prostate_cancer&DE_00547[DisEnhancer]||
6	127436064	6_127436064_C/C	C	C	.	.	.
6	12903957	6_12903957_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|PHACTR1|ENSG00000112137|Transcript|ENST00000379348|protein_coding||3/3||||||||rs9349379||1||HGNC|20990|YES|||||0.3774|0.0303|0.3761|0.6855|0.4006|0.5061|||1||||||EDN1&Cervical_artery_dissection&DE_01055[DisEnhancer]&EDN1&Coronary_artery_disease&DE_01053[DisEnhancer]&EDN1&Fibromuscular_dysplasia&DE_01056[DisEnhancer]&EDN1&Hypertension&DE_01052[DisEnhancer]&EDN1&Migraine_headache&DE_01054[DisEnhancer]&PHACTR1&Myocardial_infarction&DE_00656[DisEnhancer]||
6	12903957	6_12903957_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|PHACTR1|ENSG00000112137|Transcript|ENST00000379348|protein_coding||3/3||||||||rs9349379||1||HGNC|20990|YES|||||0.3774|0.0303|0.3761|0.6855|0.4006|0.5061|||1||||||EDN1&Cervical_artery_dissection&DE_01055[DisEnhancer]&EDN1&Coronary_artery_disease&DE_01053[DisEnhancer]&EDN1&Fibromuscular_dysplasia&DE_01056[DisEnhancer]&EDN1&Hypertension&DE_01052[DisEnhancer]&EDN1&Migraine_headache&DE_01054[DisEnhancer]&PHACTR1&Myocardial_infarction&DE_00656[DisEnhancer]||
6	12903957	6_12903957_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|PHACTR1|ENSG00000112137|Transcript|ENST00000379348|protein_coding||3/3||||||||rs9349379||1||HGNC|20990|YES|||||0.3774|0.0303|0.3761|0.6855|0.4006|0.5061|||1||||||EDN1&Cervical_artery_dissection&DE_01055[DisEnhancer]&EDN1&Coronary_artery_disease&DE_01053[DisEnhancer]&EDN1&Fibromuscular_dysplasia&DE_01056[DisEnhancer]&EDN1&Hypertension&DE_01052[DisEnhancer]&EDN1&Migraine_headache&DE_01054[DisEnhancer]&PHACTR1&Myocardial_infarction&DE_00656[DisEnhancer]||
6	12903957	6_12903957_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|PHACTR1|ENSG00000112137|Transcript|ENST00000379348|protein_coding||3/3||||||||rs9349379||1||HGNC|20990|YES|||||0.3774|0.0303|0.3761|0.6855|0.4006|0.5061|||1||||||EDN1&Cervical_artery_dissection&DE_01055[DisEnhancer]&EDN1&Coronary_artery_disease&DE_01053[DisEnhancer]&EDN1&Fibromuscular_dysplasia&DE_01056[DisEnhancer]&EDN1&Hypertension&DE_01052[DisEnhancer]&EDN1&Migraine_headache&DE_01054[DisEnhancer]&PHACTR1&Myocardial_infarction&DE_00656[DisEnhancer]||
6	12903957	6_12903957_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|PHACTR1|ENSG00000112137|Transcript|ENST00000379348|protein_coding||3/3||||||||rs9349379||1||HGNC|20990|YES|||||0.3774|0.0303|0.3761|0.6855|0.4006|0.5061|||1||||||EDN1&Cervical_artery_dissection&DE_01055[DisEnhancer]&EDN1&Coronary_artery_disease&DE_01053[DisEnhancer]&EDN1&Fibromuscular_dysplasia&DE_01056[DisEnhancer]&EDN1&Hypertension&DE_01052[DisEnhancer]&EDN1&Migraine_headache&DE_01054[DisEnhancer]&PHACTR1&Myocardial_infarction&DE_00656[DisEnhancer]||
6	12903957	6_12903957_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|PHACTR1|ENSG00000112137|Transcript|ENST00000379348|protein_coding||3/3||||||||rs9349379||1||HGNC|20990|YES|||||0.3774|0.0303|0.3761|0.6855|0.4006|0.5061|||1||||||EDN1&Cervical_artery_dissection&DE_01055[DisEnhancer]&EDN1&Coronary_artery_disease&DE_01053[DisEnhancer]&EDN1&Fibromuscular_dysplasia&DE_01056[DisEnhancer]&EDN1&Hypertension&DE_01052[DisEnhancer]&EDN1&Migraine_headache&DE_01054[DisEnhancer]&PHACTR1&Myocardial_infarction&DE_00656[DisEnhancer]||
6	134214525	6_134214525_G/C	G	C	.	.	ANN=C|3_prime_UTR_variant|MODIFIER|TCF21|ENSG00000118526|Transcript|ENST00000367882|protein_coding|2/2||||2385|||||||1||HGNC|11632|YES|||||||||||||||||||TCF21&Coronary_heart_disease&DE_00444[DisEnhancer]||
6	138196066	6_138196066_T/G	T	G	.	.	ANN=G|missense_variant|MODERATE|TNFAIP3|ENSG00000118503|Transcript|ENST00000237289|protein_coding|3/9||||446|380|127|F/C|tTc/tGc|rs2230926||1||HGNC|11896|YES||1|tolerated|benign|0.1396|0.4092|0.0778|0.0506|0.0239|0.0297|not_provided||1|||||TNFAIP3&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1228238&18971253[ORegAnno]|TNFAIP3&Systemic_lupus_erythematosus&DE_00504[DisEnhancer]||
6	151924498	6_151924498_T/C	T	C	.	.	ANN=C|intron_variant|MODIFIER|CCDC170|ENSG00000120262|Transcript|ENST00000239374|protein_coding||9/10||||||||||1||HGNC|21177|YES|||||||||||||||||||ESR1&Breast_cancer&DE_00334[DisEnhancer]||
6	151949312	6_151949312_G/A	G	A	.	.	ANN=A|intergenic_variant|MODIFIER|||||||||||||||rs7763637|||||||||||0.3542|0.4947|0.2493|0.3403|0.2982|0.3108|||1||||||ESR1/RMND1/CCDC170&Breast_cancer&DE_00602[DisEnhancer]||
6	151949582	6_151949582_A/C	A	C	.	.	ANN=C|intergenic_variant|MODIFIER|||||||||||||||rs6557160|||||||||||0.3544|0.4955|0.2493|0.3403|0.2982|0.3108|||1||||||ESR1/RMND1/CCDC170&Breast_cancer&DE_00602[DisEnhancer]||
6	151955192	6_151955192_A/G	A	G	.	.	ANN=G|intergenic_variant|MODIFIER|||||||||||||||||||||||||||||||||||||||CCDC170&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1572482&18971253[ORegAnno]&CCDC170&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1631188&18971253[ORegAnno]&CCDC170&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1167575&18971253[ORegAnno]|ESR1&Breast_cancer&DE_00337[DisEnhancer]||
6	151955219	6_151955219_G/T	G	T	.	.	ANN=T|intergenic_variant|MODIFIER|||||||||||||||||||||||||||||||||||||||CCDC170&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1572482&18971253[ORegAnno]&CCDC170&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1631188&18971253[ORegAnno]&CCDC170&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1167575&18971253[ORegAnno]|ESR1&Breast_cancer&DE_00337[DisEnhancer]||
6	151958815	6_151958815_T/C	T	C	.	.	ANN=C|intergenic_variant|MODIFIER|||||||||||||||rs17081533|||||||||||0.2484|0.5061|0.1052|0.3323|0.1004|0.0675|||||||||ESR1&Breast_cancer&DE_00338[DisEnhancer]&ESR1&Breast_cancer&DE_00339[DisEnhancer]&ESR1/RMND1&Breast_cancer&DE_00485[DisEnhancer]||
6	152024472	6_152024472_C/G	C	G	.	.	ANN=G|intron_variant|MODIFIER|ESR1|ENSG00000091831|Transcript|ENST00000440973|protein_coding||2/9||||||||||1||HGNC|3467|YES||1||||||||||||||||ESR1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1571873&18971253[ORegAnno]&ESR1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1630623&18971253[ORegAnno]&ESR1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1167039&18971253[ORegAnno]|ESR1&Breast_cancer&DE_00341[DisEnhancer]||
6	152360637	6_152360637_T/C	T	C	.	.	ANN=C|intron_variant|MODIFIER|ESR1|ENSG00000091831|Transcript|ENST00000440973|protein_coding||7/9||||||||||1||HGNC|3467|YES||1||||||||||||||||ESR1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1571895&18971253[ORegAnno]&ESR1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1704205&18971253[ORegAnno]|ESR1&Breast_cancer&DE_00343[DisEnhancer]||
6	152432902	6_152432902_T/C	T	C	.	.	ANN=C|intron_variant|MODIFIER|ESR1|ENSG00000091831|Transcript|ENST00000427531|protein_coding||6/6||||||||||1||HGNC|3467|||1|||||||||||||||||ESR1/RMND1&Breast_cancer&DE_00654[DisEnhancer]||
6	154986664	6_154986664_G/G	G	G	.	.	.
6	160668389	6_160668389_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|SLC22A2|ENSG00000112499|Transcript|ENST00000366953|protein_coding||4/10||||||||rs2279463||-1||HGNC|10966|YES|||||0.1170|0.1861|0.0663|0.0823|0.1282|0.0838|||1||||||SOD2/SLC22A2/SLC22A1&Chronic_kidney_disease&DE_01026[DisEnhancer]||
6	161143608	6_161143608_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|PLG|ENSG00000122194|Transcript|ENST00000308192|protein_coding||10/18||||||||||1||HGNC|9071|YES||1|||||||||||||||||PLG&Coronary_artery_disease&DE_00555[DisEnhancer]||
6	163212465	6_163212465_T/C	T	C	.	.	ANN=C|intron_variant|MODIFIER|PACRG|ENSG00000112530|Transcript|ENST00000337019|protein_coding||2/6||||||||rs9365492||1||HGNC|19152|YES||1|||0.2194|0.0189|0.1657|0.4901|0.2028|0.2669|||||||||PARK2&Leprosy&DE_00658[DisEnhancer]&PARK2&Leprosy&DE_00657[DisEnhancer]||
6	163212578	6_163212578_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|PACRG|ENSG00000112530|Transcript|ENST00000337019|protein_coding||2/6||||||||rs9355403||1||HGNC|19152|YES||1|||0.2260|0.0446|0.1657|0.4891|0.2028|0.2669|||||||||PARK2&Leprosy&DE_00658[DisEnhancer]&PARK2&Leprosy&DE_00657[DisEnhancer]||
6	28234597	6_28234597_C/T	C	T	.	.	ANN=T|upstream_gene_variant|MODIFIER|RP5-874C20.3|ENSG00000197062|Transcript|ENST00000421553|unprocessed_pseudogene||||||||||rs2799077|191|1||Clone_based_vega_gene||YES|||||0.1520|0.261|0.1254|0.13|0.1163|0.0828||||||||ZSCAN26&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1257488&18971253[ORegAnno]|BTN3A2&Gastric_cancer&DE_00534[DisEnhancer]&BTN3A2&Gastric_cancer&DE_00535[DisEnhancer]||
6	28235176	6_28235176_A/C	A	C	.	.	ANN=C|intron_variant&non_coding_transcript_variant|MODIFIER|RP5-874C20.3|ENSG00000197062|Transcript|ENST00000421553|unprocessed_pseudogene||1/4||||||||rs2799079||1||Clone_based_vega_gene||YES|||||0.1518|0.261|0.1254|0.13|0.1163|0.0818||||||||ZSCAN26&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1257488&18971253[ORegAnno]&NKAPL&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1824887&18971253[ORegAnno]&NKAPL&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1789453&18971253[ORegAnno]&ZSCAN26&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1714166&18971253[ORegAnno]&ZSCAN26&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1738643&18971253[ORegAnno]|BTN3A2&Gastric_cancer&DE_00535[DisEnhancer]||
6	28949254	6_28949254_A/C	A	C	.	.	ANN=C|upstream_gene_variant|MODIFIER|HCG15|ENSG00000227214|Transcript|ENST00000438190|antisense|||||||||||4726|1||HGNC|18361|YES||||||||||||||||||HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1259355&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1888497&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1228933&18971253[ORegAnno]|TRIM27&Breast_cancer&DE_01001[DisEnhancer]||
6	28949312	6_28949312_C/T	C	T	.	.	ANN=T|upstream_gene_variant|MODIFIER|HCG15|ENSG00000227214|Transcript|ENST00000438190|antisense||||||||||rs990904576|4668|1||HGNC|18361|YES||||||||||||||||||HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1259355&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1888497&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1228933&18971253[ORegAnno]|TRIM27&Breast_cancer&DE_01001[DisEnhancer]||
6	28949469	6_28949469_C/A	C	A	.	.	ANN=A|upstream_gene_variant|MODIFIER|HCG15|ENSG00000227214|Transcript|ENST00000438190|antisense|||||||||||4511|1||HGNC|18361|YES||||||||||||||||||HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1259355&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1888497&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1228933&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1617813&18971253[ORegAnno]|TRIM27&Breast_cancer&DE_01001[DisEnhancer]||
6	28949509	6_28949509_G/A	G	A	.	.	ANN=A|upstream_gene_variant|MODIFIER|HCG15|ENSG00000227214|Transcript|ENST00000438190|antisense|||||||||||4471|1||HGNC|18361|YES||||||||||||||||||HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1259355&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1888497&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1228933&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1617813&18971253[ORegAnno]|TRIM27&Breast_cancer&DE_01001[DisEnhancer]||
6	28949511	6_28949511_G/A	G	A	.	.	ANN=A|upstream_gene_variant|MODIFIER|HCG15|ENSG00000227214|Transcript|ENST00000438190|antisense||||||||||rs376016890|4469|1||HGNC|18361|YES||||||||||||||||||HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1259355&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1888497&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1228933&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1617813&18971253[ORegAnno]|TRIM27&Breast_cancer&DE_01001[DisEnhancer]||
6	28949524	6_28949524_C/T	C	T	.	.	ANN=T|upstream_gene_variant|MODIFIER|HCG15|ENSG00000227214|Transcript|ENST00000438190|antisense||||||||||rs937984847|4456|1||HGNC|18361|YES||||||||||||||||||HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1259355&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1888497&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1228933&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1617813&18971253[ORegAnno]&N/A&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG0390865&24194598[ORegAnno]|TRIM27&Breast_cancer&DE_01001[DisEnhancer]||
6	28949535	6_28949535_C/G	C	G	.	.	ANN=G|upstream_gene_variant|MODIFIER|HCG15|ENSG00000227214|Transcript|ENST00000438190|antisense|||||||||||4445|1||HGNC|18361|YES||||||||||||||||||HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1259355&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1888497&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1228933&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1617813&18971253[ORegAnno]|TRIM27&Breast_cancer&DE_01001[DisEnhancer]||
6	28949821	6_28949821_C/T	C	T	.	.	ANN=T|upstream_gene_variant|MODIFIER|HCG15|ENSG00000227214|Transcript|ENST00000438190|antisense|||||||||||4159|1||HGNC|18361|YES||||||||||||||||||HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1259355&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1888497&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1228933&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1617813&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1608626&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1547229&18971253[ORegAnno]|TRIM27&Breast_cancer&DE_01001[DisEnhancer]||
6	28949841	6_28949841_G/A	G	A	.	.	ANN=A|upstream_gene_variant|MODIFIER|HCG15|ENSG00000227214|Transcript|ENST00000438190|antisense|||||||||||4139|1||HGNC|18361|YES||||||||||||||||||HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1259355&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1888497&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1228933&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1617813&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1608626&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1547229&18971253[ORegAnno]&N/A&-1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG0990899&24194598[ORegAnno]|TRIM27&Breast_cancer&DE_01001[DisEnhancer]||
6	28949944	6_28949944_C/A	C	A	.	.	ANN=A|upstream_gene_variant|MODIFIER|HCG15|ENSG00000227214|Transcript|ENST00000438190|antisense|||||||||||4036|1||HGNC|18361|YES||||||||||||||||||HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1259355&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1888497&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1228933&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1617813&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1608626&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1547229&18971253[ORegAnno]|TRIM27&Breast_cancer&DE_01001[DisEnhancer]||
6	28950014	6_28950014_C/T	C	T	.	.	ANN=T|upstream_gene_variant|MODIFIER|HCG15|ENSG00000227214|Transcript|ENST00000438190|antisense||||||||||rs546018964|3966|1||HGNC|18361|YES|||||0.0008|0|0|0.002|0|0.002||||||||HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1259355&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1888497&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1228933&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1617813&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1608626&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1547229&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1197882&18971253[ORegAnno]|TRIM27&Breast_cancer&DE_01001[DisEnhancer]||
6	28950039	6_28950039_G/A	G	A	.	.	ANN=A|upstream_gene_variant|MODIFIER|HCG15|ENSG00000227214|Transcript|ENST00000438190|antisense||||||||||rs955879491|3941|1||HGNC|18361|YES||||||||||||||||||HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1888497&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1228933&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1617813&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1608626&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1547229&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1197882&18971253[ORegAnno]|TRIM27&Breast_cancer&DE_01001[DisEnhancer]||
6	28950050	6_28950050_G/A	G	A	.	.	ANN=A|upstream_gene_variant|MODIFIER|HCG15|ENSG00000227214|Transcript|ENST00000438190|antisense|||||||||||3930|1||HGNC|18361|YES||||||||||||||||||HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1888497&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1228933&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1617813&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1608626&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1547229&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1197882&18971253[ORegAnno]|TRIM27&Breast_cancer&DE_01001[DisEnhancer]||
6	28950052	6_28950052_G/A	G	A	.	.	ANN=A|upstream_gene_variant|MODIFIER|HCG15|ENSG00000227214|Transcript|ENST00000438190|antisense||||||||||rs1057191269|3928|1||HGNC|18361|YES||||||||||||||||||HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1888497&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1228933&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1617813&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1608626&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1547229&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1197882&18971253[ORegAnno]|TRIM27&Breast_cancer&DE_01001[DisEnhancer]||
6	28950056	6_28950056_T/C	T	C	.	.	ANN=C|upstream_gene_variant|MODIFIER|HCG15|ENSG00000227214|Transcript|ENST00000438190|antisense|||||||||||3924|1||HGNC|18361|YES||||||||||||||||||HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1888497&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1228933&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1617813&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1608626&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1197882&18971253[ORegAnno]|TRIM27&Breast_cancer&DE_01001[DisEnhancer]||
6	28950486	6_28950486_G/T	G	T	.	.	ANN=T|upstream_gene_variant|MODIFIER|HCG15|ENSG00000227214|Transcript|ENST00000438190|antisense|||||||||||3494|1||HGNC|18361|YES||||||||||||||||||HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1888497&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1228933&18971253[ORegAnno]&HCG15&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1395736&18971253[ORegAnno]|TRIM27&Breast_cancer&DE_01001[DisEnhancer]||
6	28950885	6_28950885_A/G	A	G	.	.	ANN=G|upstream_gene_variant|MODIFIER|HCG15|ENSG00000227214|Transcript|ENST00000438190|antisense|||||||||||3095|1||HGNC|18361|YES|||||||||||||||||||TRIM27&Breast_cancer&DE_01001[DisEnhancer]||
6	31526856	6_31526856_T/C	T	C	.	.	ANN=C|downstream_gene_variant|MODIFIER|NFKBIL1|ENSG00000204498|Transcript|ENST00000376148|protein_coding||||||||||rs13192469|250|1||HGNC|7800|YES||1|||0.0657|0.0159|0.0245|0.0952|0.0437|0.1544||||||||NFKBIL1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1221407&18971253[ORegAnno]&NFKBIL1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1543515&18971253[ORegAnno]|LTA&Leprosy&DE_00463[DisEnhancer]||
6	31542308	6_31542308_T/C	T	C	.	.	ANN=C|upstream_gene_variant|MODIFIER|TNF|ENSG00000232810|Transcript|ENST00000449264|protein_coding||||||||||rs1799964|1036|1||HGNC|11892|YES||1|||0.2191|0.149|0.219|0.1954|0.2097|0.3476|||1||||||TNF&Falciparum_malaria&DE_00490[DisEnhancer]||
6	31542476	6_31542476_C/A	C	A	.	.	ANN=A|upstream_gene_variant|MODIFIER|TNF|ENSG00000232810|Transcript|ENST00000449264|protein_coding||||||||||rs1800630|868|1||HGNC|11892|YES||1|||0.1542|0.0998|0.134|0.1637|0.1451|0.2413|||||||||TNF&Falciparum_malaria&DE_00490[DisEnhancer]||
6	31888367	6_31888367_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|C2|ENSG00000166278|Transcript|ENST00000452323|protein_coding||1/13||||||||||1||HGNC|1248|||1|||||||||||||||||HLA-DRB1/HLA-C/HLA-DRB5/HLA-DQB1&Lung_cancer&DE_00546[DisEnhancer]||
6	37775652	6_37775652_G/A	G	A	.	.	ANN=A|regulatory_region_variant|MODIFIER|||RegulatoryFeature|ENSR00000196457|open_chromatin_region|||||||||||||||||||||||||||||||||||ZFAND3&Type-2_diabetes&DE_00585[DisEnhancer]||
6	42928461	6_42928461_C/T	C	T	.	.	ANN=T|upstream_gene_variant|MODIFIER|GNMT|ENSG00000124713|Transcript|ENST00000372808|protein_coding||||||||||rs10948059|35|1||HGNC|4415|YES||1|||0.3922|0.5303|0.3674|0.129|0.4871|0.3967|||||||||PEX6&Prostate_cancer&DE_00431[DisEnhancer]||
6	43806609	6_43806609_G/G	G	G	.	.	.
6	72115621	6_72115621_G/A	G	A	.	.	ANN=A|intron_variant&non_coding_transcript_variant|MODIFIER|RP3-331H24.5|ENSG00000269966|Transcript|ENST00000602823|lincRNA||2/6||||||||||-1||Clone_based_vega_gene||YES|||||||||||||||||||mir30a&Lung_cancer&DE_00632[DisEnhancer]||
6	86205323	6_86205323_G/T	G	T	.	.	ANN=T|3_prime_UTR_variant|MODIFIER|NT5E|ENSG00000135318|Transcript|ENST00000257770|protein_coding|9/9||||3375|||||||1||HGNC|8021|YES||1|||||||||||||||||SNHG5&Breast_cancer&DE_00605[DisEnhancer]&SNHG5&Melanoma&DE_00606[DisEnhancer]||
6	86205323	6_86205323_G/T	G	T	.	.	ANN=T|3_prime_UTR_variant|MODIFIER|NT5E|ENSG00000135318|Transcript|ENST00000257770|protein_coding|9/9||||3375|||||||1||HGNC|8021|YES||1|||||||||||||||||SNHG5&Breast_cancer&DE_00605[DisEnhancer]&SNHG5&Melanoma&DE_00606[DisEnhancer]||
6	86223316	6_86223316_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|SNX14|ENSG00000135317|Transcript|ENST00000314673|protein_coding||26/28||||||||||-1||HGNC|14977|YES||1|||||||||||||||||SNHG5&Breast_cancer&DE_00448[DisEnhancer]&SNHG5&Melanoma&DE_00447[DisEnhancer]&SNHG5&Breast_cancer&DE_00600[DisEnhancer]&SNHG5&Melanoma&DE_00599[DisEnhancer]||
6	86223316	6_86223316_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|SNX14|ENSG00000135317|Transcript|ENST00000314673|protein_coding||26/28||||||||||-1||HGNC|14977|YES||1|||||||||||||||||SNHG5&Breast_cancer&DE_00448[DisEnhancer]&SNHG5&Melanoma&DE_00447[DisEnhancer]&SNHG5&Breast_cancer&DE_00600[DisEnhancer]&SNHG5&Melanoma&DE_00599[DisEnhancer]||
6	86224053	6_86224053_G/T	G	T	.	.	ANN=T|intron_variant|MODIFIER|SNX14|ENSG00000135317|Transcript|ENST00000314673|protein_coding||24/28||||||||||-1||HGNC|14977|YES||1||||||||||||||||SNX14&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1631588&18971253[ORegAnno]&SNX14&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1572898&18971253[ORegAnno]&SNX14&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1703588&18971253[ORegAnno]|SNHG5&Breast_cancer&DE_00448[DisEnhancer]&SNHG5&Melanoma&DE_00447[DisEnhancer]&SNHG5&Breast_cancer&DE_00600[DisEnhancer]&SNHG5&Melanoma&DE_00599[DisEnhancer]||
6	86224053	6_86224053_G/T	G	T	.	.	ANN=T|intron_variant|MODIFIER|SNX14|ENSG00000135317|Transcript|ENST00000314673|protein_coding||24/28||||||||||-1||HGNC|14977|YES||1||||||||||||||||SNX14&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1631588&18971253[ORegAnno]&SNX14&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1572898&18971253[ORegAnno]&SNX14&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1703588&18971253[ORegAnno]|SNHG5&Breast_cancer&DE_00448[DisEnhancer]&SNHG5&Melanoma&DE_00447[DisEnhancer]&SNHG5&Breast_cancer&DE_00600[DisEnhancer]&SNHG5&Melanoma&DE_00599[DisEnhancer]||
6	86246709	6_86246709_A/C	A	C	.	.	ANN=C|intron_variant|MODIFIER|SNX14|ENSG00000135317|Transcript|ENST00000314673|protein_coding||16/28||||||||||-1||HGNC|14977|YES||1||||||||||||||||SNX14&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1219629&18971253[ORegAnno]&SNX14&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1340603&18971253[ORegAnno]|SNHG5&Breast_cancer&DE_00445[DisEnhancer]&SNHG5&Melanoma&DE_00446[DisEnhancer]||
6	86246709	6_86246709_A/C	A	C	.	.	ANN=C|intron_variant|MODIFIER|SNX14|ENSG00000135317|Transcript|ENST00000314673|protein_coding||16/28||||||||||-1||HGNC|14977|YES||1||||||||||||||||SNX14&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1219629&18971253[ORegAnno]&SNX14&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1340603&18971253[ORegAnno]|SNHG5&Breast_cancer&DE_00445[DisEnhancer]&SNHG5&Melanoma&DE_00446[DisEnhancer]||
6	86247799	6_86247799_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|SNX14|ENSG00000135317|Transcript|ENST00000314673|protein_coding||16/28||||||||||-1||HGNC|14977|YES||1|||||||||||||||||SNHG5&Breast_cancer&DE_00661[DisEnhancer]&SNHG5&Melanoma&DE_00660[DisEnhancer]||
6	86247799	6_86247799_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|SNX14|ENSG00000135317|Transcript|ENST00000314673|protein_coding||16/28||||||||||-1||HGNC|14977|YES||1|||||||||||||||||SNHG5&Breast_cancer&DE_00661[DisEnhancer]&SNHG5&Melanoma&DE_00660[DisEnhancer]||
6	86258614	6_86258614_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|SNX14|ENSG00000135317|Transcript|ENST00000314673|protein_coding||8/28||||||||||-1||HGNC|14977|YES||1|||||||||||||||||SNHG5&Breast_cancer&DE_00450[DisEnhancer]&SNHG5&Melanoma&DE_00449[DisEnhancer]||
6	86258614	6_86258614_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|SNX14|ENSG00000135317|Transcript|ENST00000314673|protein_coding||8/28||||||||||-1||HGNC|14977|YES||1|||||||||||||||||SNHG5&Breast_cancer&DE_00450[DisEnhancer]&SNHG5&Melanoma&DE_00449[DisEnhancer]||
7	107301201	7_107301201_T/C	T	C	.	.	ANN=C|5_prime_UTR_variant|MODIFIER|SLC26A4|ENSG00000091137|Transcript|ENST00000265715|protein_coding|1/21||||122|||||rs60284988||1||HGNC|8818|YES||1|||||||||uncertain_significance&likely_pathogenic&pathogenic||1||||||SLC26A4&Pendred_syndrome&DE_00358[DisEnhancer]||
7	117256712	7_117256712_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|CFTR|ENSG00000001626|Transcript|ENST00000003084|protein_coding||21/26||||||||rs17451754||1||HGNC|1884|YES||1|||0.0595|0.0121|0.1095|0|0.164|0.0419|||1||||||CFTR&Oesophagus_and_oesophageal_adenocarcinoma&DE_00488[DisEnhancer]||
7	1285195	7_1285195_A/T	A	T	.	.	ANN=T|intergenic_variant|MODIFIER|||||||||||||||rs10277115|||||||||||0.4507|0.1165|0.5331|0.3075|0.7545|0.6789|||1|||||UNCX&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1169862&18971253[ORegAnno]|INTS1/MICALL2&Chronic_kidney_disease&DE_01004[DisEnhancer]||
7	128573967	7_128573967_G/A	G	A	.	.	ANN=A|upstream_gene_variant|MODIFIER|IRF5|ENSG00000128604|Transcript|ENST00000357234|protein_coding||||||||||rs4728142|4027|1||HGNC|6120|YES||1|||0.2945|0.2398|0.3098|0.1042|0.4493|0.3947|||1||||||IRF5&Celiac_disease&DE_00569[DisEnhancer]&IRF5&Crohn_disease&DE_00570[DisEnhancer]&IRF5&Lupus&DE_00565[DisEnhancer]&IRF5&Multiple_sclerosis&DE_00567[DisEnhancer]&IRF5&Rheumatoid_arthritis&DE_00566[DisEnhancer]&IRF5&Ulcerative_colitis&DE_00568[DisEnhancer]||
7	128573967	7_128573967_G/A	G	A	.	.	ANN=A|upstream_gene_variant|MODIFIER|IRF5|ENSG00000128604|Transcript|ENST00000357234|protein_coding||||||||||rs4728142|4027|1||HGNC|6120|YES||1|||0.2945|0.2398|0.3098|0.1042|0.4493|0.3947|||1||||||IRF5&Celiac_disease&DE_00569[DisEnhancer]&IRF5&Crohn_disease&DE_00570[DisEnhancer]&IRF5&Lupus&DE_00565[DisEnhancer]&IRF5&Multiple_sclerosis&DE_00567[DisEnhancer]&IRF5&Rheumatoid_arthritis&DE_00566[DisEnhancer]&IRF5&Ulcerative_colitis&DE_00568[DisEnhancer]||
7	128573967	7_128573967_G/A	G	A	.	.	ANN=A|upstream_gene_variant|MODIFIER|IRF5|ENSG00000128604|Transcript|ENST00000357234|protein_coding||||||||||rs4728142|4027|1||HGNC|6120|YES||1|||0.2945|0.2398|0.3098|0.1042|0.4493|0.3947|||1||||||IRF5&Celiac_disease&DE_00569[DisEnhancer]&IRF5&Crohn_disease&DE_00570[DisEnhancer]&IRF5&Lupus&DE_00565[DisEnhancer]&IRF5&Multiple_sclerosis&DE_00567[DisEnhancer]&IRF5&Rheumatoid_arthritis&DE_00566[DisEnhancer]&IRF5&Ulcerative_colitis&DE_00568[DisEnhancer]||
7	128573967	7_128573967_G/A	G	A	.	.	ANN=A|upstream_gene_variant|MODIFIER|IRF5|ENSG00000128604|Transcript|ENST00000357234|protein_coding||||||||||rs4728142|4027|1||HGNC|6120|YES||1|||0.2945|0.2398|0.3098|0.1042|0.4493|0.3947|||1||||||IRF5&Celiac_disease&DE_00569[DisEnhancer]&IRF5&Crohn_disease&DE_00570[DisEnhancer]&IRF5&Lupus&DE_00565[DisEnhancer]&IRF5&Multiple_sclerosis&DE_00567[DisEnhancer]&IRF5&Rheumatoid_arthritis&DE_00566[DisEnhancer]&IRF5&Ulcerative_colitis&DE_00568[DisEnhancer]||
7	128573967	7_128573967_G/A	G	A	.	.	ANN=A|upstream_gene_variant|MODIFIER|IRF5|ENSG00000128604|Transcript|ENST00000357234|protein_coding||||||||||rs4728142|4027|1||HGNC|6120|YES||1|||0.2945|0.2398|0.3098|0.1042|0.4493|0.3947|||1||||||IRF5&Celiac_disease&DE_00569[DisEnhancer]&IRF5&Crohn_disease&DE_00570[DisEnhancer]&IRF5&Lupus&DE_00565[DisEnhancer]&IRF5&Multiple_sclerosis&DE_00567[DisEnhancer]&IRF5&Rheumatoid_arthritis&DE_00566[DisEnhancer]&IRF5&Ulcerative_colitis&DE_00568[DisEnhancer]||
7	128573967	7_128573967_G/A	G	A	.	.	ANN=A|upstream_gene_variant|MODIFIER|IRF5|ENSG00000128604|Transcript|ENST00000357234|protein_coding||||||||||rs4728142|4027|1||HGNC|6120|YES||1|||0.2945|0.2398|0.3098|0.1042|0.4493|0.3947|||1||||||IRF5&Celiac_disease&DE_00569[DisEnhancer]&IRF5&Crohn_disease&DE_00570[DisEnhancer]&IRF5&Lupus&DE_00565[DisEnhancer]&IRF5&Multiple_sclerosis&DE_00567[DisEnhancer]&IRF5&Rheumatoid_arthritis&DE_00566[DisEnhancer]&IRF5&Ulcerative_colitis&DE_00568[DisEnhancer]||
7	151407801	7_151407801_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|PRKAG2|ENSG00000106617|Transcript|ENST00000287878|protein_coding||3/15||||||||rs7805747||-1||HGNC|9386|YES||1|||0.1819|0.3245|0.1729|0.003|0.2883|0.0706|||1||||||NUB1/RHEB/PRKAG2&Chronic_kidney_disease&DE_01047[DisEnhancer]||
7	156583831	7_156583831_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|LMBR1|ENSG00000105983|Transcript|ENST00000353442|protein_coding||5/16||||||||||-1||HGNC|13243|YES||1|||||||||||||||||SHH&Limb_malformation&DE_00367[DisEnhancer]&SHH&Limb_malformation&DE_00024[DisEnhancer]||
7	156583831	7_156583831_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|LMBR1|ENSG00000105983|Transcript|ENST00000353442|protein_coding||5/16||||||||||-1||HGNC|13243|YES||1|||||||||||||||||SHH&Limb_malformation&DE_00367[DisEnhancer]&SHH&Limb_malformation&DE_00024[DisEnhancer]||
7	156583949	7_156583949_C/G	C	G	.	.	ANN=G|intron_variant|MODIFIER|LMBR1|ENSG00000105983|Transcript|ENST00000353442|protein_coding||5/16||||||||||-1||HGNC|13243|YES||1|||||||||||||||||SHH&Limb_malformation&DE_00367[DisEnhancer]&SHH&Limb_malformation&DE_00024[DisEnhancer]||
7	156583949	7_156583949_C/G	C	G	.	.	ANN=G|intron_variant|MODIFIER|LMBR1|ENSG00000105983|Transcript|ENST00000353442|protein_coding||5/16||||||||||-1||HGNC|13243|YES||1|||||||||||||||||SHH&Limb_malformation&DE_00367[DisEnhancer]&SHH&Limb_malformation&DE_00024[DisEnhancer]||
7	156583951	7_156583951_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|LMBR1|ENSG00000105983|Transcript|ENST00000353442|protein_coding||5/16||||||||||-1||HGNC|13243|YES||1|||||||||||||||||SHH&Limb_malformation&DE_00367[DisEnhancer]&SHH&Limb_malformation&DE_00024[DisEnhancer]||
7	156584107	7_156584107_T/G	T	G	.	.	ANN=G|intron_variant|MODIFIER|LMBR1|ENSG00000105983|Transcript|ENST00000353442|protein_coding||5/16||||||||||-1||HGNC|13243|YES||1|||||||||||||||||SHH&Limb_malformation&DE_00367[DisEnhancer]&SHH&Limb_malformation&DE_00024[DisEnhancer]||
7	156584107	7_156584107_T/G	T	G	.	.	ANN=G|intron_variant|MODIFIER|LMBR1|ENSG00000105983|Transcript|ENST00000353442|protein_coding||5/16||||||||||-1||HGNC|13243|YES||1|||||||||||||||||SHH&Limb_malformation&DE_00367[DisEnhancer]&SHH&Limb_malformation&DE_00024[DisEnhancer]||
7	156584166	7_156584166_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|LMBR1|ENSG00000105983|Transcript|ENST00000353442|protein_coding||5/16||||||||||-1||HGNC|13243|YES||1|||||||||||||||||SHH&Limb_malformation&DE_00367[DisEnhancer]&SHH&Limb_malformation&DE_00024[DisEnhancer]||
7	156584166	7_156584166_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|LMBR1|ENSG00000105983|Transcript|ENST00000353442|protein_coding||5/16||||||||||-1||HGNC|13243|YES||1|||||||||||||||||SHH&Limb_malformation&DE_00367[DisEnhancer]&SHH&Limb_malformation&DE_00024[DisEnhancer]||
7	156584166	7_156584166_G/C	G	C	.	.	ANN=C|intron_variant|MODIFIER|LMBR1|ENSG00000105983|Transcript|ENST00000353442|protein_coding||5/16||||||||||-1||HGNC|13243|YES||1|||||||||||||||||SHH&Limb_malformation&DE_00367[DisEnhancer]&SHH&Limb_malformation&DE_00024[DisEnhancer]||
7	156584166	7_156584166_G/C	G	C	.	.	ANN=C|intron_variant|MODIFIER|LMBR1|ENSG00000105983|Transcript|ENST00000353442|protein_coding||5/16||||||||||-1||HGNC|13243|YES||1|||||||||||||||||SHH&Limb_malformation&DE_00367[DisEnhancer]&SHH&Limb_malformation&DE_00024[DisEnhancer]||
7	156584174	7_156584174_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|LMBR1|ENSG00000105983|Transcript|ENST00000353442|protein_coding||5/16||||||||||-1||HGNC|13243|YES||1|||||||||||||||||SHH&Limb_malformation&DE_00367[DisEnhancer]&SHH&Limb_malformation&DE_00024[DisEnhancer]||
7	156584174	7_156584174_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|LMBR1|ENSG00000105983|Transcript|ENST00000353442|protein_coding||5/16||||||||||-1||HGNC|13243|YES||1|||||||||||||||||SHH&Limb_malformation&DE_00367[DisEnhancer]&SHH&Limb_malformation&DE_00024[DisEnhancer]||
7	156584236	7_156584236_T/G	T	G	.	.	ANN=G|intron_variant|MODIFIER|LMBR1|ENSG00000105983|Transcript|ENST00000353442|protein_coding||5/16||||||||||-1||HGNC|13243|YES||1|||||||||||||||||SHH&Limb_malformation&DE_00367[DisEnhancer]&SHH&Limb_malformation&DE_00024[DisEnhancer]||
7	156584241	7_156584241_T/C	T	C	.	.	ANN=C|intron_variant|MODIFIER|LMBR1|ENSG00000105983|Transcript|ENST00000353442|protein_coding||5/16||||||||||-1||HGNC|13243|YES||1|||||||||||||||||SHH&Limb_malformation&DE_00367[DisEnhancer]&SHH&Limb_malformation&DE_00024[DisEnhancer]||
7	156584241	7_156584241_T/C	T	C	.	.	ANN=C|intron_variant|MODIFIER|LMBR1|ENSG00000105983|Transcript|ENST00000353442|protein_coding||5/16||||||||||-1||HGNC|13243|YES||1|||||||||||||||||SHH&Limb_malformation&DE_00367[DisEnhancer]&SHH&Limb_malformation&DE_00024[DisEnhancer]||
7	156584266	7_156584266_A/T	A	T	.	.	ANN=T|intron_variant|MODIFIER|LMBR1|ENSG00000105983|Transcript|ENST00000353442|protein_coding||5/16||||||||||-1||HGNC|13243|YES||1|||||||||||||||||SHH&Limb_malformation&DE_00367[DisEnhancer]&SHH&Limb_malformation&DE_00024[DisEnhancer]||
7	156584273	7_156584273_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|LMBR1|ENSG00000105983|Transcript|ENST00000353442|protein_coding||5/16||||||||||-1||HGNC|13243|YES||1|||||||||||||||||SHH&Limb_malformation&DE_00367[DisEnhancer]&SHH&Limb_malformation&DE_00024[DisEnhancer]||
7	156584275	7_156584275_T/C	T	C	.	.	ANN=C|intron_variant|MODIFIER|LMBR1|ENSG00000105983|Transcript|ENST00000353442|protein_coding||5/16||||||||||-1||HGNC|13243|YES||1|||||||||||||||||SHH&Limb_malformation&DE_00367[DisEnhancer]&SHH&Limb_malformation&DE_00024[DisEnhancer]||
7	156584465	7_156584465_C/G	C	G	.	.	ANN=G|intron_variant|MODIFIER|LMBR1|ENSG00000105983|Transcript|ENST00000353442|protein_coding||5/16||||||||||-1||HGNC|13243|YES||1|||||||||||||||||SHH&Limb_malformation&DE_00367[DisEnhancer]&SHH&Limb_malformation&DE_00024[DisEnhancer]||
7	156584465	7_156584465_C/G	C	G	.	.	ANN=G|intron_variant|MODIFIER|LMBR1|ENSG00000105983|Transcript|ENST00000353442|protein_coding||5/16||||||||||-1||HGNC|13243|YES||1|||||||||||||||||SHH&Limb_malformation&DE_00367[DisEnhancer]&SHH&Limb_malformation&DE_00024[DisEnhancer]||
7	21938240	7_21938240_A/C	A	C	.	.	ANN=C|downstream_gene_variant|MODIFIER|CDCA7L|ENSG00000164649|Transcript|ENST00000406877|protein_coding|||||||||||2279|-1||HGNC|30777|YES||||||||||||||||||DNAH11&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1231751&18971253[ORegAnno]|CDCA7L&Multiple_myeloma&DE_00560[DisEnhancer]||
7	21938240	7_21938240_T/G	T	G	.	.	ANN=G|downstream_gene_variant|MODIFIER|CDCA7L|ENSG00000164649|Transcript|ENST00000406877|protein_coding|||||||||||2279|-1||HGNC|30777|YES||||||||||||||||||DNAH11&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1231751&18971253[ORegAnno]|CDCA7L&Multiple_myeloma&DE_00560[DisEnhancer]||
7	22766542	7_22766542_A/C	A	C	.	.	ANN=C|intron_variant|MODIFIER|IL6|ENSG00000136244|Transcript|ENST00000404625|protein_coding||1/5||||||||||1||HGNC|6018|YES||1||||||||||||||||N/A&1&REGULATORY_REGION&POSITIVE_OUTCOME&OREG0017891&N/A[ORegAnno]&IL6&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1881117&18971253[ORegAnno]&IL6&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1491567&18971253[ORegAnno]&N/A&-1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG0857304&24194598[ORegAnno]&N/A&-1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG0888789&24194598[ORegAnno]&N/A&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG0726818&24194598[ORegAnno]&N/A&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG0650815&24194598[ORegAnno]&N/A&-1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG0740838&24194598[ORegAnno]|IL6&Systemic_lupus_erythematosus&DE_00368[DisEnhancer]||
7	27976563	7_27976563_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|JAZF1|ENSG00000153814|Transcript|ENST00000283928|protein_coding||2/4||||||||||-1||HGNC|28917|YES||1|||||||||||||||||JAZF1&Prostate_cancer&DE_00410[DisEnhancer]||
7	6515150	7_6515150_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|KDELR2|ENSG00000136240|Transcript|ENST00000258739|protein_coding||1/4||||||||rs7799635||-1||HGNC|6305|YES|||||||||||||||||||KDELR2&Pancreatic_cancer&DE_00636[DisEnhancer]||
7	77416439	7_77416439_T/C	T	C	.	.	ANN=C|downstream_gene_variant|MODIFIER|RSBN1L|ENSG00000187257|Transcript|ENST00000334955|protein_coding||||||||||rs6465825|4100|1||HGNC|24765|YES|||||0.3776|0.5068|0.3112|0.2202|0.4264|0.362|||1||||||RSBN1L/TMEM60/PTPN12/PION/PHTF2&Chronic_kidney_disease&DE_01043[DisEnhancer]||
8	11343973	8_11343973_C/T	C	T	.	.	ANN=T|intergenic_variant|MODIFIER|||||||||||||||rs2736340|||||||||||0.3614|0.1188|0.487|0.7212|0.2435|0.3507|||1||||||FAM167A&Celiac_disease&DE_00528[DisEnhancer]&FAM167A&Crohn_disease&DE_00529[DisEnhancer]&FAM167A&Lupus&DE_00526[DisEnhancer]&FAM167A&Multiple_sclerosis&DE_00527[DisEnhancer]&FAM167A&Rheumatoid_arthritis&DE_00530[DisEnhancer]&FAM167A&Ulcerative_colitis&DE_00525[DisEnhancer]||
8	11343973	8_11343973_C/T	C	T	.	.	ANN=T|intergenic_variant|MODIFIER|||||||||||||||rs2736340|||||||||||0.3614|0.1188|0.487|0.7212|0.2435|0.3507|||1||||||FAM167A&Celiac_disease&DE_00528[DisEnhancer]&FAM167A&Crohn_disease&DE_00529[DisEnhancer]&FAM167A&Lupus&DE_00526[DisEnhancer]&FAM167A&Multiple_sclerosis&DE_00527[DisEnhancer]&FAM167A&Rheumatoid_arthritis&DE_00530[DisEnhancer]&FAM167A&Ulcerative_colitis&DE_00525[DisEnhancer]||
8	11343973	8_11343973_C/T	C	T	.	.	ANN=T|intergenic_variant|MODIFIER|||||||||||||||rs2736340|||||||||||0.3614|0.1188|0.487|0.7212|0.2435|0.3507|||1||||||FAM167A&Celiac_disease&DE_00528[DisEnhancer]&FAM167A&Crohn_disease&DE_00529[DisEnhancer]&FAM167A&Lupus&DE_00526[DisEnhancer]&FAM167A&Multiple_sclerosis&DE_00527[DisEnhancer]&FAM167A&Rheumatoid_arthritis&DE_00530[DisEnhancer]&FAM167A&Ulcerative_colitis&DE_00525[DisEnhancer]||
8	11343973	8_11343973_C/T	C	T	.	.	ANN=T|intergenic_variant|MODIFIER|||||||||||||||rs2736340|||||||||||0.3614|0.1188|0.487|0.7212|0.2435|0.3507|||1||||||FAM167A&Celiac_disease&DE_00528[DisEnhancer]&FAM167A&Crohn_disease&DE_00529[DisEnhancer]&FAM167A&Lupus&DE_00526[DisEnhancer]&FAM167A&Multiple_sclerosis&DE_00527[DisEnhancer]&FAM167A&Rheumatoid_arthritis&DE_00530[DisEnhancer]&FAM167A&Ulcerative_colitis&DE_00525[DisEnhancer]||
8	11343973	8_11343973_C/T	C	T	.	.	ANN=T|intergenic_variant|MODIFIER|||||||||||||||rs2736340|||||||||||0.3614|0.1188|0.487|0.7212|0.2435|0.3507|||1||||||FAM167A&Celiac_disease&DE_00528[DisEnhancer]&FAM167A&Crohn_disease&DE_00529[DisEnhancer]&FAM167A&Lupus&DE_00526[DisEnhancer]&FAM167A&Multiple_sclerosis&DE_00527[DisEnhancer]&FAM167A&Rheumatoid_arthritis&DE_00530[DisEnhancer]&FAM167A&Ulcerative_colitis&DE_00525[DisEnhancer]||
8	11343973	8_11343973_C/T	C	T	.	.	ANN=T|intergenic_variant|MODIFIER|||||||||||||||rs2736340|||||||||||0.3614|0.1188|0.487|0.7212|0.2435|0.3507|||1||||||FAM167A&Celiac_disease&DE_00528[DisEnhancer]&FAM167A&Crohn_disease&DE_00529[DisEnhancer]&FAM167A&Lupus&DE_00526[DisEnhancer]&FAM167A&Multiple_sclerosis&DE_00527[DisEnhancer]&FAM167A&Rheumatoid_arthritis&DE_00530[DisEnhancer]&FAM167A&Ulcerative_colitis&DE_00525[DisEnhancer]||
8	127924659	8_127924659_C/A	C	A	.	.	ANN=A|intron_variant&non_coding_transcript_variant|MODIFIER|PCAT1|ENSG00000253438|Transcript|ENST00000519319|lincRNA||3/4||||||||rs12543663||1||HGNC|43022||||||0.7979|0.9009|0.6427|0.9276|0.7127|0.7229|||||||||MYC&Prostate_cancer&DE_00457[DisEnhancer]||
8	128011937	8_128011937_T/C	T	C	.	.	ANN=C|intron_variant&non_coding_transcript_variant|MODIFIER|PCAT1|ENSG00000253438|Transcript|ENST00000519319|lincRNA||3/4||||||||rs10086908||1||HGNC|43022||||||0.2682|0.2247|0.3602|0.2163|0.3161|0.2658|||1||||||MYC&Prostate_cancer&DE_00405[DisEnhancer]||
8	128093297	8_128093297_C/T	C	T	.	.	ANN=T|intron_variant&non_coding_transcript_variant|MODIFIER|PCAT2|ENSG00000253264|Transcript|ENST00000523510|lincRNA||1/3||||||||rs1016343||-1||HGNC|45089|YES|||||0.2061|0.2103|0.1225|0.2986|0.2177|0.1524|||1||||||MYC&Prostate_cancer&DE_00407[DisEnhancer]||
8	128095156	8_128095156_A/G	A	G	.	.	ANN=G|upstream_gene_variant|MODIFIER|PCAT2|ENSG00000253264|Transcript|ENST00000523510|lincRNA||||||||||rs13252298|690|-1||HGNC|45089|YES|||||0.2925|0.0303|0.3948|0.3562|0.2883|0.5133|||1||||||MYC&Prostate_cancer&DE_00464[DisEnhancer]||
8	128104055	8_128104055_G/T	G	T	.	.	ANN=T|upstream_gene_variant|MODIFIER|PRNCR1|ENSG00000224722|Transcript|ENST00000519282|processed_pseudogene||||||||||rs7463708|4300|-1||HGNC|48942|YES|||||0.3444|0.2526|0.2478|0.6677|0.2793|0.271||||||||POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1602756&18971253[ORegAnno]|PCAT1&Prostate_cancer&DE_00622[DisEnhancer]||
8	128106880	8_128106880_A/C	A	C	.	.	ANN=C|intergenic_variant|MODIFIER|||||||||||||||rs6983561|||||||||||0.2173|0.5265|0.0591|0.2143|0.0358|0.1012|||1||||||MYC&Prostate_cancer&DE_00607[DisEnhancer]||
8	128124126	8_128124126_T/G	T	G	.	.	ANN=G|regulatory_region_variant|MODIFIER|||RegulatoryFeature|ENSR00000230489|open_chromatin_region||||||||||rs1551512|||||||||||0.2189|0.5348|0.0576|0.2133|0.0358|0.1002|||||||||MYC&Prostate_cancer&DE_00481[DisEnhancer]&MYC&Prostate_cancer&DE_00483[DisEnhancer]||
8	128124916	8_128124916_C/A	C	A	.	.	ANN=A|intergenic_variant|MODIFIER|||||||||||||||rs16901979|||||||||||0.2119|0.5106|0.0533|0.2133|0.0358|0.1002|||1||||||MYC&Prostate_cancer&DE_00481[DisEnhancer]&MYC&Prostate_cancer&DE_00483[DisEnhancer]||
8	128192981	8_128192981_A/G	A	G	.	.	ANN=G|downstream_gene_variant|MODIFIER|CASC19|ENSG00000254166|Transcript|ENST00000521815|lincRNA||||||||||rs2456449|4899|-1||HGNC|49476|YES|||||0.3083|0.1649|0.3646|0.4792|0.3121|0.2822|||||||||MYC&Acute_lymphoblastic_leukemia&DE_00514[DisEnhancer]||
8	128323819	8_128323819_A/G	A	G	.	.	ANN=G|intron_variant&non_coding_transcript_variant|MODIFIER|CASC8|ENSG00000246228|Transcript|ENST00000502082|antisense||5/5||||||||||-1||HGNC|45129|YES|||||||||||||||||||PVT1&Prostate_cancer&DE_00550[DisEnhancer]||
8	128335673	8_128335673_G/A	G	A	.	.	ANN=A|intron_variant&non_coding_transcript_variant|MODIFIER|CASC8|ENSG00000246228|Transcript|ENST00000502082|antisense||5/5||||||||rs620861||-1||HGNC|45129|YES|||||0.4010|0.3404|0.3228|0.4504|0.3618|0.5276|||||||||MYC&Prostate_cancer&DE_00595[DisEnhancer]||
8	128407443	8_128407443_A/G	A	G	.	.	ANN=G|intron_variant&non_coding_transcript_variant|MODIFIER|CASC8|ENSG00000246228|Transcript|ENST00000502082|antisense||5/5||||||||rs10505477||-1||HGNC|45129|YES|||||0.4231|0.1286|0.4683|0.6111|0.5209|0.4949|||1||||||MYC/CARLo-5&Prostate_cancer&DE_00377[DisEnhancer]&MYC/POU5F1B/CARLo-5&Colorectal_cancer&DE_00376[DisEnhancer]||
8	128407443	8_128407443_A/G	A	G	.	.	ANN=G|intron_variant&non_coding_transcript_variant|MODIFIER|CASC8|ENSG00000246228|Transcript|ENST00000502082|antisense||5/5||||||||rs10505477||-1||HGNC|45129|YES|||||0.4231|0.1286|0.4683|0.6111|0.5209|0.4949|||1||||||MYC/CARLo-5&Prostate_cancer&DE_00377[DisEnhancer]&MYC/POU5F1B/CARLo-5&Colorectal_cancer&DE_00376[DisEnhancer]||
8	128413305	8_128413305_G/T	G	T	.	.	ANN=T|intron_variant&non_coding_transcript_variant|MODIFIER|CASC8|ENSG00000246228|Transcript|ENST00000502082|antisense||5/5||||||||rs6983267||-1||HGNC|45129|YES|||||0.3902|0.0477|0.4496|0.6121|0.501|0.4683|||1|||||POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1306387&18971253[ORegAnno]&POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1836496&18971253[ORegAnno]|MYC/CARLo-5&Prostate_cancer&DE_00377[DisEnhancer]&MYC/POU5F1B/CARLo-5&Colorectal_cancer&DE_00376[DisEnhancer]||
8	128413305	8_128413305_G/T	G	T	.	.	ANN=T|intron_variant&non_coding_transcript_variant|MODIFIER|CASC8|ENSG00000246228|Transcript|ENST00000502082|antisense||5/5||||||||rs6983267||-1||HGNC|45129|YES|||||0.3902|0.0477|0.4496|0.6121|0.501|0.4683|||1|||||POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1306387&18971253[ORegAnno]&POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1836496&18971253[ORegAnno]|MYC/CARLo-5&Prostate_cancer&DE_00377[DisEnhancer]&MYC/POU5F1B/CARLo-5&Colorectal_cancer&DE_00376[DisEnhancer]||
8	128413305	8_128413305_G/T	G	T	.	.	ANN=T|intron_variant&non_coding_transcript_variant|MODIFIER|CASC8|ENSG00000246228|Transcript|ENST00000502082|antisense||5/5||||||||rs6983267||-1||HGNC|45129|YES|||||0.3902|0.0477|0.4496|0.6121|0.501|0.4683|||1|||||POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1306387&18971253[ORegAnno]&POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1836496&18971253[ORegAnno]|MYC/CARLo-5&Prostate_cancer&DE_00377[DisEnhancer]&MYC/POU5F1B/CARLo-5&Colorectal_cancer&DE_00376[DisEnhancer]||
8	128413305	8_128413305_G/T	G	T	.	.	ANN=T|intron_variant&non_coding_transcript_variant|MODIFIER|CASC8|ENSG00000246228|Transcript|ENST00000502082|antisense||5/5||||||||rs6983267||-1||HGNC|45129|YES|||||0.3902|0.0477|0.4496|0.6121|0.501|0.4683|||1|||||POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1306387&18971253[ORegAnno]&POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1836496&18971253[ORegAnno]|MYC/CARLo-5&Prostate_cancer&DE_00377[DisEnhancer]&MYC/POU5F1B/CARLo-5&Colorectal_cancer&DE_00376[DisEnhancer]||
8	128413305	8_128413305_G/T	G	T	.	.	ANN=T|intron_variant&non_coding_transcript_variant|MODIFIER|CASC8|ENSG00000246228|Transcript|ENST00000502082|antisense||5/5||||||||rs6983267||-1||HGNC|45129|YES|||||0.3902|0.0477|0.4496|0.6121|0.501|0.4683|||1|||||POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1306387&18971253[ORegAnno]&POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1836496&18971253[ORegAnno]|MYC/CARLo-5&Prostate_cancer&DE_00377[DisEnhancer]&MYC/POU5F1B/CARLo-5&Colorectal_cancer&DE_00376[DisEnhancer]||
8	128413305	8_128413305_T/G	T	G	.	.	ANN=G|intron_variant&non_coding_transcript_variant|MODIFIER|CASC8|ENSG00000246228|Transcript|ENST00000502082|antisense||5/5||||||||||-1||HGNC|45129|YES||||||||||||||||||POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1306387&18971253[ORegAnno]&POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1836496&18971253[ORegAnno]|MYC/CARLo-5&Prostate_cancer&DE_00377[DisEnhancer]&MYC/POU5F1B/CARLo-5&Colorectal_cancer&DE_00376[DisEnhancer]||
8	128413305	8_128413305_T/G	T	G	.	.	ANN=G|intron_variant&non_coding_transcript_variant|MODIFIER|CASC8|ENSG00000246228|Transcript|ENST00000502082|antisense||5/5||||||||||-1||HGNC|45129|YES||||||||||||||||||POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1306387&18971253[ORegAnno]&POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1836496&18971253[ORegAnno]|MYC/CARLo-5&Prostate_cancer&DE_00377[DisEnhancer]&MYC/POU5F1B/CARLo-5&Colorectal_cancer&DE_00376[DisEnhancer]||
8	128413305	8_128413305_T/G	T	G	.	.	ANN=G|intron_variant&non_coding_transcript_variant|MODIFIER|CASC8|ENSG00000246228|Transcript|ENST00000502082|antisense||5/5||||||||||-1||HGNC|45129|YES||||||||||||||||||POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1306387&18971253[ORegAnno]&POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1836496&18971253[ORegAnno]|MYC/CARLo-5&Prostate_cancer&DE_00377[DisEnhancer]&MYC/POU5F1B/CARLo-5&Colorectal_cancer&DE_00376[DisEnhancer]||
8	128413305	8_128413305_T/G	T	G	.	.	ANN=G|intron_variant&non_coding_transcript_variant|MODIFIER|CASC8|ENSG00000246228|Transcript|ENST00000502082|antisense||5/5||||||||||-1||HGNC|45129|YES||||||||||||||||||POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1306387&18971253[ORegAnno]&POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1836496&18971253[ORegAnno]|MYC/CARLo-5&Prostate_cancer&DE_00377[DisEnhancer]&MYC/POU5F1B/CARLo-5&Colorectal_cancer&DE_00376[DisEnhancer]||
8	128413305	8_128413305_T/G	T	G	.	.	ANN=G|intron_variant&non_coding_transcript_variant|MODIFIER|CASC8|ENSG00000246228|Transcript|ENST00000502082|antisense||5/5||||||||||-1||HGNC|45129|YES||||||||||||||||||POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1306387&18971253[ORegAnno]&POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1836496&18971253[ORegAnno]|MYC/CARLo-5&Prostate_cancer&DE_00377[DisEnhancer]&MYC/POU5F1B/CARLo-5&Colorectal_cancer&DE_00376[DisEnhancer]||
8	128413305	8_128413305_T/G	T	G	.	.	ANN=G|intron_variant&non_coding_transcript_variant|MODIFIER|CASC8|ENSG00000246228|Transcript|ENST00000502082|antisense||5/5||||||||||-1||HGNC|45129|YES||||||||||||||||||POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1306387&18971253[ORegAnno]&POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1836496&18971253[ORegAnno]|MYC/CARLo-5&Prostate_cancer&DE_00377[DisEnhancer]&MYC/POU5F1B/CARLo-5&Colorectal_cancer&DE_00376[DisEnhancer]||
8	128413305	8_128413305_T/G	T	G	.	.	ANN=G|intron_variant&non_coding_transcript_variant|MODIFIER|CASC8|ENSG00000246228|Transcript|ENST00000502082|antisense||5/5||||||||||-1||HGNC|45129|YES||||||||||||||||||POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1306387&18971253[ORegAnno]&POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1836496&18971253[ORegAnno]|MYC/CARLo-5&Prostate_cancer&DE_00377[DisEnhancer]&MYC/POU5F1B/CARLo-5&Colorectal_cancer&DE_00376[DisEnhancer]||
8	128413305	8_128413305_T/G	T	G	.	.	ANN=G|intron_variant&non_coding_transcript_variant|MODIFIER|CASC8|ENSG00000246228|Transcript|ENST00000502082|antisense||5/5||||||||||-1||HGNC|45129|YES||||||||||||||||||POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1306387&18971253[ORegAnno]&POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1836496&18971253[ORegAnno]|MYC/CARLo-5&Prostate_cancer&DE_00377[DisEnhancer]&MYC/POU5F1B/CARLo-5&Colorectal_cancer&DE_00376[DisEnhancer]||
8	128413305	8_128413305_T/G	T	G	.	.	ANN=G|intron_variant&non_coding_transcript_variant|MODIFIER|CASC8|ENSG00000246228|Transcript|ENST00000502082|antisense||5/5||||||||||-1||HGNC|45129|YES||||||||||||||||||POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1306387&18971253[ORegAnno]&POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1836496&18971253[ORegAnno]|MYC/CARLo-5&Prostate_cancer&DE_00377[DisEnhancer]&MYC/POU5F1B/CARLo-5&Colorectal_cancer&DE_00376[DisEnhancer]||
8	128413305	8_128413305_T/G	T	G	.	.	ANN=G|intron_variant&non_coding_transcript_variant|MODIFIER|CASC8|ENSG00000246228|Transcript|ENST00000502082|antisense||5/5||||||||||-1||HGNC|45129|YES||||||||||||||||||POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1306387&18971253[ORegAnno]&POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1836496&18971253[ORegAnno]|MYC/CARLo-5&Prostate_cancer&DE_00377[DisEnhancer]&MYC/POU5F1B/CARLo-5&Colorectal_cancer&DE_00376[DisEnhancer]||
8	128424792	8_128424792_A/G	A	G	.	.	ANN=G|upstream_gene_variant|MODIFIER|POU5F1B|ENSG00000212993|Transcript|ENST00000465342|protein_coding||||||||||rs7014346|1743|1||HGNC|9223|YES|||||0.6627|0.5991|0.7075|0.7143|0.665|0.6616|||1||||||POU5F1B&Colorectal_cancer&DE_00608[DisEnhancer]||
8	128485038	8_128485038_A/C	A	C	.	.	ANN=C|intron_variant&non_coding_transcript_variant|MODIFIER|CASC8|ENSG00000246228|Transcript|ENST00000502082|antisense||4/5||||||||rs1447295||-1||HGNC|45129|YES|||||0.8189|0.6498|0.8934|0.8581|0.8976|0.8732|||1||||||MYC&Prostate_cancer&DE_00476[DisEnhancer]||
8	128485038	8_128485038_C/A	C	A	.	.	ANN=A|intron_variant&non_coding_transcript_variant|MODIFIER|CASC8|ENSG00000246228|Transcript|ENST00000502082|antisense||4/5||||||||||-1||HGNC|45129|YES|||||||||||||||||||MYC&Prostate_cancer&DE_00476[DisEnhancer]||
8	128531689	8_128531689_A/T	A	T	.	.	ANN=T|intergenic_variant|MODIFIER|||||||||||||||rs11986220|||||||||||0.901|0.9448|0.9236|0.8621|0.8986|0.8681|||1|||||POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1661035&18971253[ORegAnno]&POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1602752&18971253[ORegAnno]|MYC&Prostate_cancer&DE_00441[DisEnhancer]&MYC&Prostate_cancer&DE_00442[DisEnhancer]&MYC&Prostate_cancer&DE_00406[DisEnhancer]||
8	128531873	8_128531873_G/A	G	A	.	.	ANN=A|intergenic_variant|MODIFIER|||||||||||||||rs11988857|||||||||||0.764|0.5915|0.8256|0.7649|0.8797|0.8333|||1|||||POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1661035&18971253[ORegAnno]&POU5F1B&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1602752&18971253[ORegAnno]|MYC&Prostate_cancer&DE_00441[DisEnhancer]&MYC&Prostate_cancer&DE_00442[DisEnhancer]&MYC&Prostate_cancer&DE_00406[DisEnhancer]||
8	128532137	8_128532137_C/T	C	T	.	.	ANN=T|intergenic_variant|MODIFIER||||||||||||||||||||||||||||||||||||||||MYC&Prostate_cancer&DE_00441[DisEnhancer]&MYC&Prostate_cancer&DE_00442[DisEnhancer]&MYC&Prostate_cancer&DE_00406[DisEnhancer]||
8	128532137	8_128532137_T/C	T	C	.	.	ANN=C|intergenic_variant|MODIFIER|||||||||||||||rs10090154|||||||||||0.8644|0.8094|0.9193|0.8621|0.8986|0.8671|||1||||||MYC&Prostate_cancer&DE_00441[DisEnhancer]&MYC&Prostate_cancer&DE_00442[DisEnhancer]&MYC&Prostate_cancer&DE_00406[DisEnhancer]||
8	128539360	8_128539360_T/G	T	G	.	.	ANN=G|intergenic_variant|MODIFIER|||||||||||||||rs7837688|||||||||||0.8942|0.9425|0.9222|0.8472|0.8907|0.8609|||1||||||MYC&Prostate_cancer&DE_00638[DisEnhancer]||
8	129076573	8_129076573_C/T	C	T	.	.	ANN=T|intron_variant&non_coding_transcript_variant|MODIFIER|PVT1|ENSG00000249859|Transcript|ENST00000513868|lincRNA||4/7||||||||rs13255292||1||HGNC|9709|YES|||||0.2007|0.0416|0.2291|0.1905|0.3718|0.2301|||1|||||PVT1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1256460&18971253[ORegAnno]|MYC&Acute_lymphoblastic_leukemia&DE_00465[DisEnhancer]||
8	129186548	8_129186548_A/T	A	T	.	.	ANN=T|regulatory_region_variant|MODIFIER|||RegulatoryFeature|ENSR00000230670|enhancer||||||||||rs7826019|||||||||||0.2520|0.444|0.281|0.131|0.2078|0.1421||||||||MIR1208&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1228726&18971253[ORegAnno]&MIR1208&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1259121&18971253[ORegAnno]|MYC&Lung_cancer&DE_00018[DisEnhancer]&MYC&Acute_lymphoblastic_leukemia&DE_00637[DisEnhancer]||
8	130645692	8_130645692_A/G	A	G	.	.	ANN=G|intron_variant&non_coding_transcript_variant|MODIFIER|CCDC26|ENSG00000229140|Transcript|ENST00000446592|lincRNA||1/3||||||||rs55705857||-1||HGNC|28416|YES|||||0.0182|0.0008|0.0159|0|0.0567|0.0225|||1|||||N/A&N/A&REGULATORY_REGION&N/A&OREG0070686&17130149[ORegAnno]&GSDMC&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1761745&18971253[ORegAnno]|MYC&Glioma&DE_00581[DisEnhancer]||
8	23082971	8_23082971_G/T	G	T	.	.	ANN=T|upstream_gene_variant|MODIFIER|TNFRSF10A|ENSG00000104689|Transcript|ENST00000221132|protein_coding||||||||||rs13278062|332|-1||HGNC|11904|YES|||||0.4008|0.1346|0.549|0.3413|0.503|0.6115|not_provided||1|||||TNFRSF10A&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1257616&18971253[ORegAnno]&TNFRSF10A&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1227327&18971253[ORegAnno]|TNFRSF10A&Bladder_cancer&DE_00383[DisEnhancer]||
8	23751151	8_23751151_C/T	C	T	.	.	ANN=T|intergenic_variant|MODIFIER|||||||||||||||rs10109414|||||||||||0.2913|0.3185|0.2867|0.2937|0.4344|0.1084|||1||||||SLC25A37/NKX3-1/ENTPD4/STC1/ADAM7&Chronic_kidney_disease&DE_01003[DisEnhancer]||
8	27456253	8_27456253_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|CLU|ENSG00000120885|Transcript|ENST00000316403|protein_coding||7/8||||||||||-1||HGNC|2095|YES||||||||||||||||||CLU&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1860895&18971253[ORegAnno]|PTK2B/CLU/EPHX2&Alzheimers_disease&DE_01027[DisEnhancer]||
8	31495581	8_31495581_C/T	C	T	.	.	ANN=T|upstream_gene_variant|MODIFIER|NRG1|ENSG00000157168|Transcript|ENST00000519301|protein_coding||||||||||rs6994992|1321|1||HGNC|7997|||1|||0.4421|0.3911|0.3372|0.5883|0.3847|0.4939|||||||||NRG1&Schizophrenia&DE_00384[DisEnhancer]||
8	580156	8_580156_C/G	C	G	.	.	ANN=G|intron_variant|MODIFIER|ERICH1|ENSG00000104714|Transcript|ENST00000522706|protein_coding||3/3||||||||rs377499017||-1||HGNC|27234|||||||||||||||||||ERICH1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1487886&18971253[ORegAnno]&ERICH1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1612229&18971253[ORegAnno]|ZNF596&Breast_cancer&DE_01002[DisEnhancer]||
8	580332	8_580332_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|ERICH1|ENSG00000104714|Transcript|ENST00000522706|protein_coding||3/3||||||||rs868188460||-1||HGNC|27234|||||||||||||||||||ERICH1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1487886&18971253[ORegAnno]&ERICH1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1612229&18971253[ORegAnno]&N/A&-1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG0722050&24194598[ORegAnno]|ZNF596&Breast_cancer&DE_01002[DisEnhancer]||
8	580370	8_580370_C/T	C	T	.	.	ANN=T|intron_variant|MODIFIER|ERICH1|ENSG00000104714|Transcript|ENST00000522706|protein_coding||3/3||||||||rs368411590||-1||HGNC|27234|||||||||||||||||||ERICH1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1487886&18971253[ORegAnno]&ERICH1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1612229&18971253[ORegAnno]|ZNF596&Breast_cancer&DE_01002[DisEnhancer]||
8	580698	8_580698_G/A	G	A	.	.	ANN=A|intron_variant|MODIFIER|ERICH1|ENSG00000104714|Transcript|ENST00000522706|protein_coding||3/3||||||||rs867744135||-1||HGNC|27234|||||||||||||||||||ERICH1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1487886&18971253[ORegAnno]&ERICH1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1219706&18971253[ORegAnno]|ZNF596&Breast_cancer&DE_01002[DisEnhancer]||
8	581293	8_581293_G/C	G	C	.	.	ANN=C|intron_variant|MODIFIER|ERICH1|ENSG00000104714|Transcript|ENST00000522706|protein_coding||3/3||||||||||-1||HGNC|27234|||||||||||||||||||ERICH1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1487886&18971253[ORegAnno]&ERICH1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1219706&18971253[ORegAnno]&ERICH1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1572987&18971253[ORegAnno]&ERICH1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1631674&18971253[ORegAnno]&ERICH1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1612227&18971253[ORegAnno]&ERICH1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1167981&18971253[ORegAnno]|ZNF596&Breast_cancer&DE_01002[DisEnhancer]||
9	100548934	9_100548934_T/C	T	C	.	.	ANN=C|intergenic_variant|MODIFIER||||||||||||||||||||||||||||||||||||||||FOXE1&Cleft_palate&DE_00639[DisEnhancer]&FOXE1/PTCSC2&Papillary_thyroid_cancer&DE_00641[DisEnhancer]|enhancer_chr9:100548546-100549029[Fantom_enhancer]|
9	100549013	9_100549013_A/G	A	G	.	.	ANN=G|intergenic_variant|MODIFIER|||||||||||||||rs7850258|||||||||||0.7921|0.8699|0.6931|0.8671|0.662|0.8139|||1||||||FOXE1&Cleft_palate&DE_00639[DisEnhancer]&FOXE1/PTCSC2&Papillary_thyroid_cancer&DE_00641[DisEnhancer]|enhancer_chr9:100548546-100549029[Fantom_enhancer]|
9	100551768	9_100551768_A/G	A	G	.	.	ANN=G|intergenic_variant|MODIFIER|||||||||||||||||||||||||||||||||||||||FOXE1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1197288&18971253[ORegAnno]&FOXE1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1910919&18971253[ORegAnno]&FOXE1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1754055&18971253[ORegAnno]&FOXE1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1730709&18971253[ORegAnno]&FOXE1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1308993&18971253[ORegAnno]|FOXE1/PTCSC2&Papillary_thyroid_cancer&DE_00453[DisEnhancer]||
9	100551908	9_100551908_A/C	A	C	.	.	ANN=C|intergenic_variant|MODIFIER|||||||||||||||||||||||||||||||||||||||FOXE1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1197288&18971253[ORegAnno]&FOXE1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1910919&18971253[ORegAnno]&FOXE1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1754055&18971253[ORegAnno]&FOXE1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1730709&18971253[ORegAnno]|FOXE1/PTCSC2&Papillary_thyroid_cancer&DE_00453[DisEnhancer]||
9	100556109	9_100556109_G/A	G	A	.	.	ANN=A|intergenic_variant|MODIFIER||||||||||||||||||||||||||||||||||||||||FOXE1/PTCSC2&Papillary_thyroid_cancer&DE_00663[DisEnhancer]||
9	100556972	9_100556972_G/A	G	A	.	.	ANN=A|intergenic_variant|MODIFIER||||||||||||||||||||||||||||||||||||||||FOXE1/PTCSC2&Papillary_thyroid_cancer&DE_00420[DisEnhancer]||
9	104198194	9_104198194_C/T	C	T	.	.	ANN=T|upstream_gene_variant|MODIFIER|ALDOB|ENSG00000136872|Transcript|ENST00000374855|protein_coding||||||||||rs185972191|89|-1||HGNC|417|YES||1|||0.0050|0.0008|0.0058|0|0.0139|0.0061|||||||||ALDOB&Fructose_intolerance&DE_00386[DisEnhancer]||
9	136536633	9_136536633_A/G	A	G	.	.	ANN=G|intron_variant|MODIFIER|SARDH|ENSG00000123453|Transcript|ENST00000371872|protein_coding||18/20||||||||||-1||HGNC|10536|YES||1|||||||||||||||||SARDH&Neural_tube_defects&DE_00533[DisEnhancer]||
9	21975127	9_21975127_C/T	C	T	.	.	ANN=T|upstream_gene_variant|MODIFIER|CDKN2A|ENSG00000147889|Transcript|ENST00000498124|protein_coding|||||||||||262|-1||HGNC|1787|YES||1|||||||||||||||||CDKN2A&Primary_sclerosing_cholangitis&DE_00392[DisEnhancer]||promoter_-_chr9:21975118-21975140[Fantom_promoter]
9	22072264	9_22072264_A/G	A	G	.	.	ANN=G|intron_variant&non_coding_transcript_variant|MODIFIER|CDKN2B-AS1|ENSG00000240498|Transcript|ENST00000428597|antisense||12/18||||||||rs10757269||1||HGNC|34341|YES|||||0.6955|0.9115|0.4928|0.8185|0.496|0.6258|||1||||||CDKN2A&Coronary_artery_disease&DE_00414[DisEnhancer]||
9	22072638	9_22072638_A/G	A	G	.	.	ANN=G|intron_variant&non_coding_transcript_variant|MODIFIER|CDKN2B-AS1|ENSG00000240498|Transcript|ENST00000428597|antisense||12/18||||||||||1||HGNC|34341|YES|||||||||||||||||||CDKN2A&Coronary_artery_disease&DE_00414[DisEnhancer]&CDKN2A&Coronary_artery_disease&DE_00662[DisEnhancer]||
9	22076795	9_22076795_A/G	A	G	.	.	ANN=G|intron_variant&non_coding_transcript_variant|MODIFIER|CDKN2B-AS1|ENSG00000240498|Transcript|ENST00000428597|antisense||12/18||||||||rs10757271||1||HGNC|34341|YES||||||0.9758|0.4986|0.8185|0.502|0.6288|||||||||CDKN2A&Coronary_artery_disease&DE_00415[DisEnhancer]||
9	22094330	9_22094330_A/G	A	G	.	.	ANN=G|intron_variant&non_coding_transcript_variant|MODIFIER|CDKN2B-AS1|ENSG00000240498|Transcript|ENST00000428597|antisense||12/18||||||||rs4977757||1||HGNC|34341|YES|||||0.6749|0.9599|0.4841|0.6964|0.499|0.5838|||||||||CDKN2A&Coronary_artery_disease&DE_00578[DisEnhancer]||
9	22096055	9_22096055_A/G	A	G	.	.	ANN=G|intron_variant&non_coding_transcript_variant|MODIFIER|CDKN2B-AS1|ENSG00000240498|Transcript|ENST00000428597|antisense||12/18||||||||rs10757274||1||HGNC|34341|YES|||||0.4040|0.1755|0.4179|0.5288|0.492|0.4836|||1||||||CDKN2A&Coronary_artery_disease&DE_00416[DisEnhancer]||
9	22106225	9_22106225_A/G	A	G	.	.	ANN=G|intron_variant&non_coding_transcript_variant|MODIFIER|CDKN2B-AS1|ENSG00000240498|Transcript|ENST00000428597|antisense||14/18||||||||||1||HGNC|34341|YES|||||||||||||||||||CDKN2A&Coronary_artery_disease&DE_00417[DisEnhancer]||
9	22106271	9_22106271_A/G	A	G	.	.	ANN=G|intron_variant&non_coding_transcript_variant|MODIFIER|CDKN2B-AS1|ENSG00000240498|Transcript|ENST00000428597|antisense||14/18||||||||rs6475609||1||HGNC|34341|YES|||||0.6887|0.966|0.5447|0.6944|0.507|0.5971|||||||||CDKN2A&Coronary_artery_disease&DE_00417[DisEnhancer]||
9	22116220	9_22116220_T/C	T	C	.	.	ANN=C|intron_variant&non_coding_transcript_variant|MODIFIER|CDKN2B-AS1|ENSG00000240498|Transcript|ENST00000428597|antisense||16/18||||||||rs1537376||1||HGNC|34341|YES|||||0.4868|0.4123|0.5014|0.5218|0.507|0.5204|||||||||ANRIL&Endometriosis&DE_00489[DisEnhancer]&CDKN2A/ANRIL&Coronary_artery_disease&DE_00466[DisEnhancer]||
9	22118102	9_22118102_T/G	T	G	.	.	ANN=G|intron_variant&non_coding_transcript_variant|MODIFIER|CDKN2B-AS1|ENSG00000240498|Transcript|ENST00000428597|antisense||16/18||||||||rs17761446||1||HGNC|34341|YES|||||0.0631|0.0431|0.0043|0.1786|0|0.0777||||||||N/A&N/A&REGULATORY_REGION&N/A&OREG0070678&17130149[ORegAnno]&CDKN2B-AS1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1902876&18971253[ORegAnno]|ANRIL&Endometriosis&DE_00489[DisEnhancer]&CDKN2A/ANRIL&Coronary_artery_disease&DE_00466[DisEnhancer]||
9	22119195	9_22119195_T/C	T	C	.	.	ANN=C|intron_variant&non_coding_transcript_variant|MODIFIER|CDKN2B-AS1|ENSG00000240498|Transcript|ENST00000428597|antisense||17/18||||||||rs1333045||1||HGNC|34341|YES|||||0.4982|0.4599|0.4899|0.5397|0.507|0.5041||||||||N/A&N/A&REGULATORY_REGION&N/A&OREG0070678&17130149[ORegAnno]&CDKN2B-AS1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1597765&18971253[ORegAnno]|ANRIL&Endometriosis&DE_00489[DisEnhancer]&CDKN2A/ANRIL&Coronary_artery_disease&DE_00466[DisEnhancer]||
9	22123766	9_22123766_A/C	A	C	.	.	ANN=C|downstream_gene_variant|MODIFIER|CDKN2B-AS1|ENSG00000240498|Transcript|ENST00000428597|antisense||||||||||rs10738610|2672|1||HGNC|34341|YES|||||0.4117|0.1634|0.464|0.5367|0.4901|0.501|||||||||ANRIL&Cardiovascular_disease&DE_00419[DisEnhancer]&CDKN2A/CDKN2B&Coronary_heart_disease&DE_00418[DisEnhancer]&CDKN2A/MTAP/CDKN2B-AS1/CDKN2B&Coronary_artery_disease&DE_00413[DisEnhancer]||
9	22124472	9_22124472_C/T	C	T	.	.	ANN=T|downstream_gene_variant|MODIFIER|CDKN2B-AS1|ENSG00000240498|Transcript|ENST00000428597|antisense||||||||||rs10811656|3378|1||HGNC|34341|YES|||||0.4531|0.4319|0.4841|0.4246|0.4662|0.4755||||||||CDKN2B-AS1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1902866&18971253[ORegAnno]&CDKN2B-AS1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1597762&18971253[ORegAnno]|ANRIL&Cardiovascular_disease&DE_00419[DisEnhancer]&CDKN2A/CDKN2B&Coronary_heart_disease&DE_00418[DisEnhancer]&CDKN2A/MTAP/CDKN2B-AS1/CDKN2B&Coronary_artery_disease&DE_00413[DisEnhancer]||
9	22124472	9_22124472_C/T	C	T	.	.	ANN=T|downstream_gene_variant|MODIFIER|CDKN2B-AS1|ENSG00000240498|Transcript|ENST00000428597|antisense||||||||||rs10811656|3378|1||HGNC|34341|YES|||||0.4531|0.4319|0.4841|0.4246|0.4662|0.4755||||||||CDKN2B-AS1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1902866&18971253[ORegAnno]&CDKN2B-AS1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1597762&18971253[ORegAnno]|ANRIL&Cardiovascular_disease&DE_00419[DisEnhancer]&CDKN2A/CDKN2B&Coronary_heart_disease&DE_00418[DisEnhancer]&CDKN2A/MTAP/CDKN2B-AS1/CDKN2B&Coronary_artery_disease&DE_00413[DisEnhancer]||
9	22124477	9_22124477_A/G	A	G	.	.	ANN=G|downstream_gene_variant|MODIFIER|CDKN2B-AS1|ENSG00000240498|Transcript|ENST00000428597|antisense||||||||||rs10757278|3383|1||HGNC|34341|YES|||||0.4081|0.1589|0.4553|0.5437|0.4742|0.5041|||1|||||CDKN2B-AS1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1902866&18971253[ORegAnno]&CDKN2B-AS1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1597762&18971253[ORegAnno]|ANRIL&Cardiovascular_disease&DE_00419[DisEnhancer]&CDKN2A/CDKN2B&Coronary_heart_disease&DE_00418[DisEnhancer]&CDKN2A/MTAP/CDKN2B-AS1/CDKN2B&Coronary_artery_disease&DE_00413[DisEnhancer]||
9	22124477	9_22124477_A/G	A	G	.	.	ANN=G|downstream_gene_variant|MODIFIER|CDKN2B-AS1|ENSG00000240498|Transcript|ENST00000428597|antisense||||||||||rs10757278|3383|1||HGNC|34341|YES|||||0.4081|0.1589|0.4553|0.5437|0.4742|0.5041|||1|||||CDKN2B-AS1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1902866&18971253[ORegAnno]&CDKN2B-AS1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1597762&18971253[ORegAnno]|ANRIL&Cardiovascular_disease&DE_00419[DisEnhancer]&CDKN2A/CDKN2B&Coronary_heart_disease&DE_00418[DisEnhancer]&CDKN2A/MTAP/CDKN2B-AS1/CDKN2B&Coronary_artery_disease&DE_00413[DisEnhancer]||
9	22124477	9_22124477_A/G	A	G	.	.	ANN=G|downstream_gene_variant|MODIFIER|CDKN2B-AS1|ENSG00000240498|Transcript|ENST00000428597|antisense||||||||||rs10757278|3383|1||HGNC|34341|YES|||||0.4081|0.1589|0.4553|0.5437|0.4742|0.5041|||1|||||CDKN2B-AS1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1902866&18971253[ORegAnno]&CDKN2B-AS1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1597762&18971253[ORegAnno]|ANRIL&Cardiovascular_disease&DE_00419[DisEnhancer]&CDKN2A/CDKN2B&Coronary_heart_disease&DE_00418[DisEnhancer]&CDKN2A/MTAP/CDKN2B-AS1/CDKN2B&Coronary_artery_disease&DE_00413[DisEnhancer]||
9	6365683	9_6365683_A/C	A	C	.	.	ANN=C|intergenic_variant|MODIFIER|||||||||||||||rs719725|||||||||||0.3057|0.2315|0.3401|0.2629|0.4076|0.3211|||||||||TPD52L3/TMED6/JMJD2C&Colorectal_cancer&DE_00620[DisEnhancer]||
9	71434707	9_71434707_A/A	A	A	.	.	.
9	89725269	9_89725269_T/C	T	C	.	.	ANN=C|intergenic_variant|MODIFIER|||||||||||||||rs7856774|||||||||||0.3600|0.556|0.2853|0.2649|0.334|0.273|||||||||DAPK1&Late_onset_alzheimers_disease&DE_00640[DisEnhancer]||
X	138612889	X_138612889_G/A	G	A	.	.	ANN=A|upstream_gene_variant|MODIFIER|F9|ENSG00000101981|Transcript|ENST00000218099|protein_coding|||||||||||28|1||HGNC|3551|YES||1||||||||||||||||F9&-1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1754449&18971253[ORegAnno]|F9&Haemophilia&DE_00393[DisEnhancer]||
X	154251046	X_154251046_G/A	G	A	.	.	ANN=A|upstream_gene_variant|MODIFIER|F8|ENSG00000185010|Transcript|ENST00000360256|protein_coding|||||||||||18|-1||HGNC|3546|YES||1||||||||||||||||F8&-1&REGULATORY_REGION&POSITIVE_OUTCOME&OREG0003626&12566409[ORegAnno]|F8&Haemophilia&DE_00394[DisEnhancer]||
X	1733783	X_1733783_A/G	A	G	.	.	ANN=G|upstream_gene_variant|MODIFIER|ASMT|ENSG00000196433|Transcript|ENST00000381241|protein_coding|||||||||||111|1||HGNC|750|YES|||||||||||||||||||ASMT&Autism_spectrum_disorder&DE_00395[DisEnhancer]&ASMT&Autism_spectrum_disorder&DE_00396[DisEnhancer]||
X	1733892	X_1733892_C/G	C	G	.	.	ANN=G|upstream_gene_variant|MODIFIER|ASMT|ENSG00000196433|Transcript|ENST00000381241|protein_coding|||||||||||2|1||HGNC|750|YES|||||||||||||||||||ASMT&Autism_spectrum_disorder&DE_00395[DisEnhancer]&ASMT&Autism_spectrum_disorder&DE_00396[DisEnhancer]||
X	37639262	X_37639262_A/C	A	C	.	.	ANN=C|upstream_gene_variant|MODIFIER|CYBB|ENSG00000165168|Transcript|ENST00000378588|protein_coding||||||||||CYBBbase_D0025:g.946A>C|2|1||HGNC|2578|YES||1|||||||||||||||||CYBB&Chronic_granulomatous_disease&DE_00397[DisEnhancer]||
X	37639264	X_37639264_T/C	T	C	.	.	ANN=C|5_prime_UTR_variant|MODIFIER|CYBB|ENSG00000165168|Transcript|ENST00000378588|protein_coding|1/13||||1|||||CYBBbase_D0025:g.948T>C||1||HGNC|2578|YES||1|||||||||||||||||CYBB&Chronic_granulomatous_disease&DE_00397[DisEnhancer]||
X	37639267	X_37639267_C/T	C	T	.	.	ANN=T|5_prime_UTR_variant|MODIFIER|CYBB|ENSG00000165168|Transcript|ENST00000378588|protein_coding|1/13||||4|||||CYBBbase_D0025:g.951C>T||1||HGNC|2578|YES||1|||||||||||||||||CYBB&Chronic_granulomatous_disease&DE_00397[DisEnhancer]||
X	51505931	X_51505931_T/C	T	C	.	.	ANN=C|intergenic_variant|MODIFIER||||||||||||||||||||||||||||||||||||||||NUDT11&Prostate_cancer&DE_00575[DisEnhancer]||
X	55057617	X_55057617_G/C	G	C	.	.	ANN=C|upstream_gene_variant|MODIFIER|ALAS2|ENSG00000158578|Transcript|ENST00000330807|protein_coding||||||||||rs140772352|120|-1||HGNC|397|YES||1|||0.0026|0|0.0057|0|0.0091|0|uncertain_significance&pathogenic||1|||||ALAS2&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1250015&18971253[ORegAnno]|ALAS2&Sideroblastic_anaemia&DE_00400[DisEnhancer]||
X	70443031	X_70443031_G/C	G	C	.	.	ANN=C|intron_variant|MODIFIER|GJB1|ENSG00000169562|Transcript|ENST00000374022|protein_coding||1/1||||||||||1||HGNC|4283|YES||1||||||||||||||||GJB1&1&TRANSCRIPTION_FACTOR_BINDING_SITE&N/A&OREG1765075&18971253[ORegAnno]|GJB1&Charcot-marie-tooth_disease&DE_00401[DisEnhancer]||
